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C H A P T E R 4.-D is c u s s io n  1 0 2
R eferences
S u m m a r y .
The aim of this project was to further characterize the HSV-1 strain 
17+  deletion variant 1703. Initial characterization  after isolation 
(MacLean & Brown, 1987a) demonstrated that 1703 had a deletion of 
approximately 7500 base pairs (bp); (4 .9x 10^ mol. wt.) in the U l / I R l
region of the genome. By restriction enzyme analysis, the deletion was 
shown to affect genes UL55, UL56 and one copy each of IE1 and LAT. 
P o lypep tide  analysis dem onstra ted  that, a lthough  the deletion 
terminated an estimated 500 base pairs downstream of the 3' end of 
IE2, the IE2 gene product Vmw63 was apparently not produced during 
immediate-early times of infection.
Further characterization of 1703 was achieved by: 1 . The
dideoxynucleotide sequence analysis of 1703 DNA fragments in which 
IE2 and the end points of the deletion were located, 2 . The analysis of 
1703 IE2 gene products, 3 .  The in vivo characterization of 1703 and 4 .  
The construction of a 1703 wild-type recom binant. Following the 
suggestion by Dr John McLauchlan that IE2 mRNA synthesis in 1703 
infected cells may be controlled by the production of transcripts 
initiating from the promoter of the IR l  copy of IE1 which was antisense
to IE2 RNA, the project was extended to determine if this could be 
su b s tan tia ted .
Dideoxynucleotide sequence analysis of IE2 demonstrated that the 
promoter, promoter associated, terminator, terminator associated signals 
and most of the open reading frame were homologous to the published 
wild-type sequence (McGeoch et al., 1988a). Sequencing of the deletion 
end points has shown that it spans the region between np (nucleotide 
position) 123623 and npil5839, removing UL56 and 343 base pairs of the
3' end of UL55 thus leaving 555 base pairs between the 3' end of IE2 
and the deletion end point.
The methods of polypeptide analysis, Western blot analysis and SI 
nuclease mapping were used to detect IE2 gene products at both protein 
and RNA levels. These techniques demonstrated that IE2 mRNA and 
Vmw63 synthesis were reduced, but not totally absent, at immediate- 
early times of infection. Western blot analysis of 17+ im m ediate-early 
polypeptide extracts titrated in mock infected extracts compared to 
1703 immediate-early polypeptide extracts demonstrated that, at most, 
Vmw63 production in 1703 infected cells was 1/8 that produced by 17+. 
At early and late times of infection, Vmw63 synthesis by 1703 was 
equivalent to 17+.
The in vivo effect of the loss of UL55, UL56, one copy of IE1 and LAT 
and the reduction in synthesis of Vmw63 during immediate-early times 
of infection was examined. Inoculation of 3 week old mice with 1703 via 
the intracranial route demonstrated that 1703 was as virulent as the 
wild-type virus. The latency characteristics of 1703 were also shown to 
be equivalent to those of 17+ indicating that the products of the genes 
mentioned above are not required for intracranial virulence or for the 
establishment, maintenance or reactivation of latent genomes.
Construction of a wild-type recombinant of 1703 was achieved by 
recombination of the 1703 DNA fragment in which the end points of the 
deletion were located into 17+ DNA. The characterization of the resultant 
recom binant's IE2 gene products indicated equivalence to those 
produced by 1703 and hence that the deletion was responsible for the 
underproduction of Vmw63 during immediate-early times of infection.
To examine the possibility of antisense transcripts controlling the 
production of IE2 mRNA, a polyadenylation signal was cloned between 
the 3' end of IE2 and the 5' end of the IRl  copy of IE1 in the correct
orientation to terminate the synthesis of a potential antisense transcript 
before IE2 coding sequences. A HSV-2 strain HG52 polyadenylation 
signal was chosen for this and, since the surrounding sequences were 
heterologous to 1703 DNA, two 1703 fragments were cloned around the 
polyadenylation signal and the construct recombined into 1703 DNA. 
The resultant recombinant was called 1703PA and analysis of 1703PA 
IE2 gene products demonstrated that IE2 mRNA and Vmw63 synthesis 
had returned to wild-type levels. The detection of the novel transcript 
generated as a result of the insertion of the polyadenylation signal 
substantiated the conclusion that antisense transcripts initiating from 
the IRl  copy of IE1 had the potential to control the production of IE2
mRNA in 1703 infected cells.
C h a p t e r  1
1
INTRODUCTION
1.1  O BJEC TIVES.
This project has involved the characterization of an HSV-1 17+ 
deletion variant 1703 which underproduces the essential immediate- 
early polypeptide Vmw63 under immediate-early conditions despite the 
fact that the deletion does not extend into, nor is there an apparent 
de le tion /in sertion  in IE2, the gene w hich codes for Vmw63. 
Characterization of 1703 involved the analysis of IE2 mRNA and Vmw63 
protein synthesis, the dideoxynucleotide sequence analysis of IE2 and 
determination of the end points of the deletion and the construction of 
relevant recombinant viruses. The analyses have allowed the conclusion 
that the production of Vmw63 by 1703 is due to interference with IE2 
transcription mediated by RNA initiating from the IRl  IE1 promoter
under imm ediate-early conditions.
The aim of the introduction is to provide a general overview of herpes 
simplex virus (HSV) with emphasis on those topics relating to the 
project.
1 .2  C l a s s i f i c a t i o n  o f  h e r p e s v i r u s e s .
Membership of the Herpesviridae family is based on the structure of 
the virion (Fenner, 1976) which consists of a . a core made up of a 
fibrillar spool around which the double stranded DNA is wrapped, b. an 
icosahedral capsid consisting of 12 pentam eric and 150 hexameric 
c a p so m e re s , c . various am ounts o f an am orphous m aterial 
asym m etrically  arranged around the capsid and designated  the
2tegument and d . a membrane or envelope of 150-200nm surrounding 
the entire structure (Wildy et a l.,1960; Roizman & Furlong, 1974).
Herpesviruses cannot be distinguished from each other on the basis of 
morphology, however they are readily separable using criteria such as 
biological properties, immunological cross-reactivity, and the size, base 
composition and structure of their genomes. More than eighty different 
members of the family have been identified by these criteria (Nahmias, 
1972) and have been classified on the basis of their biological properties 
(Roizman et a / . ,1978; Matthews, 1982; Roizman, 1982) and genome 
structure (Roizman, 1982; Honess & Watson, 1977; Honess, 1984); these 
are outlined below.
1.2.a. C lassification  on the  basis of biological p ro p ertie s .
Herpesviruses have biological as well as structural properties in 
common, for example, they specify a large array of enzymes involved in 
nucleotide metabolism, synthesis of viral DNA and encapsidation occurs 
in the nucleus, the host cell is destroyed after productive infection and 
herpesviruses are able to remain latent in their natural host where only 
limited transcription occurs. Biological properties provide an empirical 
means of grouping herpesviruses according to features such as host cell 
range, cytotoxicity and type of cell in which the viral genome establishes 
latency. These features have enabled the classification of herpesviruses 
into 3 groups, alpha, beta and gamma.
Alphaherpesviruses are classified on the basis of variable host range, 
relatively short replication cycle, rapid spread in culture, efficient 
destruction of infected cells and capacity to establish latency in infected 
cells primarily in the sensory ganglia. This subfamily includes 3 human
herpes viruses, herpes simplex viruses type 1 and 2 (HSV-1 & 2) and 
varicella-zoster virus (VZV).
Betaherpesviruses are mainly characterized by having a restricted 
host range, long replicative cycle and an infection that progresses slowly 
in tissue culture. The infected cells frequently  become enlarged 
(cytomegalia) and carrier cultures are readily established. The virus can 
be m ain tained  in the la ten t form  in the secre to ry  glands, 
lymphoreticular cells, kidney and other tissues. Human cytomegalovirus 
(HCMV) is a member of this subfamily.
The in vivo experimental host range of Gammaherpesviruses is limited 
to the family or order to which the natural host belongs. In vitro , all 
members of this family replicate in lymphoblastoid cells, and some also 
cause lytic infections in some types of epithelial and fibroblastic cells.
Viruses in this group are specific for either T or B lymphocytes. In the 
lymphocyte, infection is at the pre-lytic or lytic stage, but without the 
p roduction  of in fec tious p rogeny. L aten t v irus is frequently  
demonstrated in the lymphoid tissues. Epstein-Barr virus (EBV) is a 
member of this subfamily.
1.2.b. Classification on the basis o f genome structure.
It is relatively simple to assign herpesviruses to groups on the basis of 
visible criteria such as characteristics of infection, host/cell range and 
cell type in which the virus is capable of becoming latent. It is more 
difficult to do this on the basis of genome structure which requires 
detailed analysis (Honess & W atson, 1977; Roizman, 1982; Honess,
1984). H erpesv iruses d iffer considerab ly  in the ir overall base 
composition (32-75% G+C), the size of their genomes (80-150xl()6m ol. 
wt.) and the arrangement of repeated elements. Classification on the
basis of genome structure is dependent on the latter property and is
outlined below and in figure 1.1.
G roup A
The DNA of members of this group is present as only one isomer and is
characterized by a single direct repeat at both termini. Channel catfish
virus (CCV) is a member of this group (Chousterman et al., 1979)
G roup B
The DNA of members of this group is present as only one isomer and is
characterized by containing multiple copies of a sequence present as a
direct repeat at both termini. The number of repeats in each genome is
roughly constant, although the number at each end varies extensively
(Stamminger et al., 1987). Herpes virus saimiri (HVS) is a member of this
group.
G roup C
Again the DNA of members of this group is present as only one isomer
(Raab-Traub et al., 1980) whose genomes contain multiple copies of a
sequence present as a direct repeat at both termini and internal tandem
reiterations of a second set of sequences. A member of this group is
Epstein-Barr virus (EBV).
G roup D
The DNA of members of this group exists as two isomers since there
are two unique regions (Ul  and U s) and the U s region is flanked by
inverted  repeats (IR l  and T R s ) which allow inversion of Us.
Pseudorabies virus (PRV) is a member of this group.
G roup E
This group has been further divided into two subgroups, E land E2. 
Subgroup E l consists of those viruses eg. VZV whose unique regions 
( U l  and U s) are flanked by inverted repeats (TR l/IR L» IR s/T R s)- U l  is 
flanked by small inverted repeats (88bp in the case of VZV) and inverts
Figure 1.1 Genome structures of the herpesviruses.
The structures of herpesvirus genomes are dem onstrated. Repeat
sequences are shown as open boxes. U s and Ul  indicate the short and
long unique sequences a, b and c indicate repeat sequences with a', b' 
and c' their complement. Arrows indicate the relative orientations of the 
unique segment. An exam ple of each group A-E2, is illustrated and the 
numbers of isomers indicated. In VZV, U s is in either orientation 50% of 
the time, while Ul  is in one orientation 95% of the time.
CCV is channel catfish virus, HVS is herpesvirus saim iri, EBV is
E pstein-B arr virus, PRV is pseudorabies virus, VZV is varicella-zoster 
virus and HSV is herpes simplex virus.
(Adapted from MacLean, 1988)
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5inefficiently. The short unique region is flanked by longer repeats and 
inverts to give both orientations of U s in equimolar amounts. Hence U l  
is found predom inantly in one orientation and U s is found equally in 
both orientations leading to the presence of 2 m ajor and 2 minor 
isomers (Davison, 1984).
Viruses belonging to subgroup E2, eg HSV-1 and 2 have two unique 
segm ents (U l  and U s )  both of which are flanked by inverted repeats 
(T R l /IRL> IR S /T R s ) which share a short region of DNA directly repeated 
at the term ini and indirectly  repeated at the junction  between the 
internal inverted repeats. This allows equal isom erisation of both unique 
segm ents resu lting  in 4 isom ers w hich are equally  p resen t in a 
population of DNA molecules.
1 .3  H u m a n  h e r p e s v i r u s e s .
There are seven herpesviruses known to infect hum ans, herpes 
simplex virus types 1 and 2, (HSV-1&2) varicella-zoster virus (VZV), 
Epstein-Barr virus (EBV), cytomegalovirus (CMV) [these viruses are also 
known as human herpesviruses (HHV) 1-5 respectively], HHV-6 and 
HHV-7. Primary infection with HSV-1 occurs in early childhood and is 
often asymptomatic but may lead to a range of illnesses including fever, 
sore throat, ulcerative and vesicular lesions, oedema, localised general 
lym phadenopathy  and general m alaise  (W hite ly ,1985 ). Follow ing 
prim ary infection, a latent state is norm ally established (sec tion l.9 ) 
usually  in the trigem inal ganglia of the peripheral nervous system 
(Bastion et al., 1972). Reactivation of HSV-1 causes recurrent herpetic 
lesions (cold sores) localised to the dermatome supplied by the latently 
infected dorsal root ganglion (Wildy et al., 1982)
6HSV-2 has similar biological properties to HSV-1 and shows 50% DNA 
hom ology. However HSV-2 is prim arily a sexually transm itted disease 
and is associated with genital lesions (Dowdle et al., 1967; K essler,1977). 
The virus normally establishes latency in the sacral dorsal root ganglia 
and periodically reactivates (Baringer & Swoveland, 1973). HSV-2 can
also cause herpetic lesions on the mucocutaneous regions of the face, and 
HSV-1 can cause genital lesions. An association between HSV-2 and 
cervical carcinom a has been suggested (Naib et al., 1966; Eglin et al., 
1981; Park et al., 1983). A link between HSV-2, papillom a virus and 
cervical carcinoma has also been reported (zur Hausen, 1982).
Human cytom egalovirus infection in children and adults is mainly 
asymtomatic or associated with a mild fever. Infection of the foetus via 
their mothers is thought to be a major cause of intrauterine death and 
congenital defects (W eller, 1971; Rapp, 1980). Human CMV is also 
associated with the European form  of K aposi's sarcom a (G iraldo et
al., 1975) and HCMV pneum onia is common among AIDS patients and 
those undergoing im m unosuppressive therapy.
V aricella-zoster virus causes a prim ary childhood illness called 
chicken-pox (varicella). The virus becom es latent in the dorsal root 
ganglia (G ilden et al., 1978) and may reactivate mostly in older people to 
cause shingles (zoster). Reactivation may to some extent be dependent 
on the immunological status of the individual (Rifkind,1966; Gleb, 1985).
Epstein-Barr virus (EBV) infection in childhood is often asymtomatic 
but can cause a debilitating infection in adolescents and adults, called
glandular fever, when prim ary infection occurs at these times. EBV is 
also associated with Burkitts lymphoma and nasopharyngeal carcinoma 
in South East Asia.
Recently a novel herpes virus called HH V-6 (or human B-cell
lym photropic virus [HBLV]) was isolated from patients with AIDS and
Figure 1.2 Gross organisation of the HSV-1 genome.
A conventional representation of the HSV genome is shown, with 
unique sequences as solid lines (U s and Ul ) and the m ajor repeat 
elem ents as open boxes (TRl  and IRl , IR s  an^ TR §). The a, b and c 
sequences and the same sequences in the opposite orientation a', b' and 
c’ are indicated. Below the genome representation, the isom erisation of
the HSV-1 genome is illustrated. The four isomers are: P (prototype), I I
(L inverted with respect to P), Is  (S inverted with respect to P) and Is l
(S and L inverted with respect to P).
At
A A
CD
t
t t
H30
00
(/)
C/7
Woo
CO CO I—
7other lym phpro lifera tive  d isorders (Salahuddin  et a l.,1986) and was 
later found to be the causative agent of exanthem  subitum which is a 
ch ildhood  illn ess  charac terized  by sp ik ing  fever and skin rash 
(Yamanishi et al., 1988).
A seventh herpesvirus called HHV-7 was isolated from activated CD4+ 
lym phocytes of a healthy indiv idual (Frenkel et al., 1990), and was 
shown to be unrelated to HHV-6 (Wyatt et al, 1991).
1 .4  T h e  h e r p e s  s i m p l e x  v i r u s  g e n o m e .
1.4.a. Structural features of the HSV genome.
The complete sequence of the HSV-1 genome has been established and 
shows that it has a total length of 152260 residues (M cGeoch e t  
a l. ,1988a) of base composition 68.3% G+C which is unevenly distributed 
throughout the genome. For example, the short repeat region has a base
com position of 79.5% G+C (M cGeoch et al., 1986) whereas the short
unique segment has 64.3% G+C (McGeoch et al., 1985).
The genome is made up of a long (L) segment and a short (S) segment 
which are covalently linked and comprise 82% and 18% of the total DNA 
respec tive ly  (R oizm an, 1979a,b). Each segm ent con tains a unique 
sequence flanked by a pair of inverted repeat sequences (figure 1.2a), 
the long repeat ( R l )  and short repeat (Rs) which are distinct from each 
other. The molecules also possess a terminal redundancy of between 250 
and 500 base pairs (b .p .), term ed the 'a ' sequence; one or more 
additional copies of this sequence are located internally  at the joint 
between the L and S segm ents in the opposite orientation to the 'a'
sequence (Sheldrick & Berthelot, 1974). The HSV-1 genome isomerises
to give equ im o lar am ounts of each o rien ta tio n  (figu re  1.2b).
8Isomerization is thought to be mediated by the ’a’ sequence (section 1.5). 
The four isomers are P (prototype), I I  (L inverted with respect to P), Is 
(S inverted with respect to P), ISL (S and L inverted with respect to P).
The num ber and size of 'a' sequences varies between and within 
strains of HSV-1 as does the num ber, size and location of tandem 
reiterations outwith the ’a* sequence (Rixon et al., 1984). Both of these 
factors contribute to the variability  in genome length found between 
strains. The length of the latter short reiterated sequences varies from 
10-100 b.p. (M cGeoch, 1989). The copy num ber of reiterations varies 
among virus isolates, serial passage of viral stocks, and upon recloning 
virus isolates (W atson et al., 1981a; M urchie & M cGeoch, 1982; Perry & 
M cGeoch, 1988). These short tandem  repeats may serve to promote 
exchange of genetic m aterial betw een HSV DNA m olecules thus 
m aintaining hom ology (Umene, 1987) or they could prom ote a high 
degree of recom bination , but the function of such reitera tions is 
basically  unknown.
1*4.b. Organisation of HSV genes.
The genome of HSV-1 strain 17+ has been sequenced and the genetic 
content analysed (McGeoch et al., 1985, 1986, 1988a; Perry & McGeoch, 
1988). The genome contains at least 75 genes which code for 72 distinct 
proteins, UL49.5 being the m ost recently  identified gene (Barker & 
Roizman, 1992). Figure 1.3 shows the orientations and locations of these 
genes. Three open reading frames (IE1, IE3 and the RL1 gene encoding 
ICP 34.5) are w ithin the repeats and are therefore diploid. The gene 
encoding ICP 34.5 was originally demonstrated in HSV strain F, as was 
the protein (Chou & Roizm an, 1986; Ackerm an et al., 1986; Chou & 
Roizman, 1990; Chou et al., 1990). The gene is positioned upstream of the
Figure 1.3 Layout of genes in the HSV-1 genome.
The HSV-1 genome is shown on four successive lines, with 40 kilo base 
pairs per line. Location of open reading frames are shown by arrows, 
with splicing within the coding regions indicated. In the top three lines, 
UL51 to UL56 are shown as 1-56, and in the bottom line, genes US1 to 
US 12 as 1-12. Two recently characterized additional genes are UL49.5 
(Barker & Roizman, 1992) and RL1 (Dolan et a l ., 1992)
(Adapted from McGeoch, 1989)
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95' end of IE1 in R l  in the same orientation as IE1. The assignment of a 
gene in this region has been confirmed in HSV-1 17+ (Dolan et al., 1992) 
and in HSV-2 strain HG52 (McGeoch et al., 1991).
The detection of the latency associated transcripts (LATs) in latently 
infected animal and human ganglia (Stevens et al., 1987; Krause et al., 
1988) has dem onstrated that, during latency, v iral transcrip tion  is 
lim ited to the part of the genome that expresses LAT. However these 
transcrip ts are not thought to be essential for the establishm ent or 
m aintenance of latency but may control the tem poral regulation of 
reactivation from latency (Steiner et al ., 1989).
The sequence of U l ,  and the functions of some of the genes contained 
therein, has been elucidated (M cGeoch et al., 1988a) and is outlined 
below .
The only im m ediate-early gene contained within the long unique 
segment is UL54 (or IE2) which codes for Vmw 63 (Watson et al., 1979). 
Many genes in U l  are known to have a role in the replication of viral 
DNA. There is a set of seven genes whose products are required to 
promote the amplification of a test plasmid encoding an HSV origin of 
replication (Challberg, 1986; Wu et al., 1988; M cGeoch et al., 1988b). 
These include the gene which encodes the viral DNA polymerase (UL30), 
the major DNA binding protein (UL29), the subunit of DNA polymerase 
(UL42) (Gottlieb et al .,1990), and an origin binding protein (UL9); (Weir 
et al., 1989; W eir & Stow, 1990), but little is known about the other three 
(UL5, UL8 and UL52), although there is evidence indicating that these 
three gene products form a primase/helicase complex (Crute et al., 1989). 
The UL5 amino acid sequence exhibits an ATP binding site consensus 
and is proposed to represent an ATP using enzym e such as helicase 
(McGeoch et al., 1988a).
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Other genes encoded in the U l  segment of the genome are known to 
specify proteins involved in DNA synthesis or nucleotide metabolism. 
T hese inc lude  UL1 (u rac il DNA g ly co sy la se ) U L 12 [alkaline  
deoxyribonuclease (W eller et al., 1990)], UL23 (thym idine kinase), UL39 
and U L40 (the subunits o f ribonucleo tide  reduc tase) and UL50 
[deoxyuridine triphosphatase (dUTPase)]. Gene UL26 is known to encode 
a virion structural protein which is involved in processing and packaging 
of progeny DNA (Preston  et a l . ,1983). Lui & R oizm an, (1991) 
dem onstrated that UL26 encodes a protease which cleaves the UL26
gene product to produce UL26a, which functions as a scaffolding protein.
Genes encoding virion structural proteins also lie within U l .  These 
include UL19 (the m ajor capsid protein), UL48 (the m ajor tegument 
protein); (Campbell et al, 1984), three surface glycoproteins (UL22 [gH], 
UL27 [gB] and UL44 [gC]) and three virion proteins (UL26, UL34 and 
UL36). The UL28 gene product is important for the formation of mature 
capsids (Addison et al., 1990) and UL41 codes for the virion host shut off 
protein (Fenwick & Everett, 1990).
Mutation in some Ul  genes can result in a syncitial plaque phenotype 
which may arise from  changes in structural proteins. One of these
corresponds to UL27 which specifies the virion glycoprotein gB (Bzik et
al., 1984), another to UL53 which is multiply hydrophobic (Debroy et al.,
1985) and one corresponds to UL1 (Little & Schaffer, 1981).
Several U l  genes are dispensable in tissue culture. These include UL2 
(M ullaney et al., 1989), UL10 (MacLean et al., 1991), UL41 (Fenwick & 
E verett, 1990), UL43 (M acLean et al., 1991), UL13 (M iss L. Coulter, 
personal comm unication), UL23 [thymidine kinase (Jamieson et al., 1974; 
Sanders et al., 1982), UL24 (unknown function), UL39 [large subunit of 
ribonucleotide reductase (Goldstein & W eller, 1988)], UL44 (gC) (Frink et
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a l . ,1983), UL50 (dUTPase) (Preston & F isch e r,1984), UL55 and 56 
[functions unknown (MacLean & Brown, 1987a,b].
Analysis of the short unique segment of the HSV-1 genome (McGeoch 
et a l ., 1985) has shown that it contains 12 genes m ost of which are 
arranged as 3' co-term inal fam ilies, that is, the genes have common 3' 
ends but distinct 5' term ini and prom oters. US1 and 12 both encode 
im m edia te-early  po lypep tides (M cG eoch et al., 1985; M arsden et al., 
1982), US4,6,7 and 8 encode glycoproteins gG, gD, gl and gE respectively. 
US5 is thought to encode a small glycoprotein (McGeoch et al., 1985). 
US 11 encodes a sequence specific RNA binding protein  (Roller & 
Roizman, 1990), US3 a protein kinase, US9 a tegum ent phosphoprotein 
(Frame et al., 1986) and US 10 encodes a virion protein (Rixon & McGeoch,
1984).
In the synthesis and processing of virus specific RNAs 
and eukaryotic RNA, host encoded RNA polymerase II is utilised
and transcrip tion occurs in the nuclei of infected cells (W agner & 
Roizman, 1969; Ben-Zeeve & Becker, 1977: Constanzo et al., 1977). Most 
HSV genes possess upstream  and downstream regulatory regions similar 
to those of host cell genes (McKnight, 1980). These include 5' promoter 
sequences such as a TATAA box, a CAAT box m otif and a 3' pre-mRNA 
polyadenylation signal AATAAA (Zarkower et al 1986). There is another 
m otif, YGTGTTYY, where Y represents C or T, and which is found 
downstream  from  the polyadenylation signal (M cLauchlan e t al
1985) and has been shown to be required for the efficient processing of 
the 3 ’ end of mRNA (McLauchlan et al., 1985). One aspect in which HSV 
differs from host is the degree of gene splicing. There are relatively few 
spliced genes: (IE1, UL15, IE4, IE5 and UL44) (Rixon & Clements, 1982; 
W atson et al.,1981b Perry et a l. ,1986; M cGeoch et al., 1988$ Frink e t
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a l . ,1983). RL1 (ICP 34.5) is predicted to be spliced in HSV-2 but not in 
HSV-1 (McGeoch et al.y 1991; Dolan et al., 1992).
1 .5  TH E HERPES SIMPLEX VIRUS 'A' SE Q U E N C E .
HSV-1 DNA possesses a direct terminal repeat of about 250-500 base 
pairs termed the 'a' sequence. The 'a1 sequence is also located in inverted 
orientation at the joint between L and S segments. In some molecules of 
an HSV DNA preparation, the L term inus and the jo in t may possess 
multiple copies of the 'a' sequence.
The HSV genome can be represented as:
ai an b-U L-b'a’m C '-U s-c as 
where aj and as are terminal sequences with unique properties, and an 
and am are term inal ’a’ sequences directly repeated 0-9 times (n) or 
present in 1-10 (m) copies (Davison & W ilkie, 1981; Roizman, 1979 a, b; 
W adsworth et al., 1975; W agner & Summers, 1978).
1.5.a. Structure of the V  sequence.
The structure of the 'a' sequence is highly conserved and consists of a 
variable number of repeat elements. In HSV-1 strain F, the sequence is 
made up of a 20 base pair direct repeat (DR1), a 64 base pair unique 
sequence (Ub), a 12 base pair direct repeat (DR2) present in 19-22 
copies per 'a' sequence, a 37 base pair direct repeat (DR4) present in 2-3 
copies, a 58 base pair unique sequence (Uc), and a final copy of DR1 
(M ocarski & Roizman, 1981, 1982). The size of the 'a' sequence varies 
between and within strains reflecting differing numbers of copies of DR2 
and DR4, The structure of the ’a' sequence can be represented as follows 
and in figure 1.4:
DR 1 -Ub-DR2n-DR4m-Uc-DR 1
Figure 1.4 Structure of the HSV-1 V sequence.
a. A HSV-1 genome in the prototype orientation, b . An expansion of 
the IRl /IR §  junction showing the structure of the 'a' sequence. The 'a'
sequence consists  o f unique and d irec tly  repeated  e lem ents (the 
inform ation given concerns the HSV-1 strain F 'a' sequence [Mocarski & 
Roizman, 1981, 1982])
Ub- a unique region located towards the b’ region of the genome.
Uc- a unique region located towards the c' region of the genome. 
DR1- A 20 base pair element present as a direct repeat at the edge of
the ’a’ sequence.
DR2- a directly repeated 12 base pair element present in 19-22 copies. 
DR4- a directly repeated 37 base pair sequence present in 2-3 copies.
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with adjacent ’a' sequences sharing the intervening DR1. Linear virion 
DNA contains asymmetric ends with the term inal 'a' sequence of the L 
com ponent (aL) ending with 18 base pairs and one 3' nucleotide 
extension, and the terminal 'a' sequence of the S component (aS) ending 
with a DR1 containing only 1 base pair and one 3' overhang (Mocarski & 
Roizm an,1982). Thus genome inversion leads to form ation of 1 DR1 
between aL and aS. V ariability of the copy num ber of DR elements 
accounts for m ost of the observed 'a ' sequence polym orphism  in 
different strains. For example, HSV-2 strain HG52 has only one copy of 
DR2 (Davison & W ilkie, 1981) while HSV-1 strain F has 19-22 copies 
(M ocarski & Roizm an,1982). Sim ilarly, HSV-1 strain 17+ and HSV-2 
strain HG52 contain one copy of DR4 homology, which is thus a part of 
Uc (Davison & W ilkie, 1981). Although there is variation in the copy 
number of the DR2 and DR4 elements, some regions of the 'a' sequence 
are highly conserved in different strains. These are within Ub and Uc 
and are represented by a short, well conserved sequence about 20bp in 
length located approxim ately 40bp and 35bp respectively from the end 
of the 'a' sequence (Davison & W ilkie, 1981; Deiss & Frenkel, 1986).
1.5.b. The V  sequence m ediates circularization.
Follow ing infection, the HSV genome rapidly circularizes: this is 
believed to be mediated by the 'a' sequence (Davison & W ilkie, 1983a; 
Poffenberger et a l ., 1983; Poffenberger & Roizman, 1985). It is likely 
that circularization takes place by ligation of the two termini aided by 
the com plem entary single base at the 3' end overhang (M ocarski & 
Roizman, 1982)
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1.5.c. V  sequence prom oter activity.
Chou & Roizman (1986) have mapped the promoter of the gene coding 
for the neurovirulence factor ICP 34.5 (Chou et al., 1990) to the Ub 
segment of the ’a’ sequence. The 5' end of the transcript and the coding 
region is in the long repeat region of the genome in the same orientation 
as IE1 (Ackerman et a/., 1986). Resequencing and confirm ation of the 
presence of ICP 34.5 in HSV-1 strain F but not in HSV-1 strain 17+ (Chou 
& Roizman, 1990) led to a more extensive analysis of this region of HSV- 
1 strain 17+ and to the conclusion that HSV-1 17+ does indeed encode a 
neurovirulence conferring gene in this region (Dolan et al., 1992).
1.5.d. Isomerization of the HSV genome.
HSV-1 DNA contains equimolar amounts of four isomers (section 1.4a). 
The existence of four isom ers was dem onstrated by restriction enzyme 
analysis (Hayward et al., 1975; ClementSer al., 1976). Studies of intertypic 
recom binants between HSV-1 and -2 demonstrated that inversion of the 
L and S segm ents was specifically dependent upon the ’a' sequence 
(Davison & W ilkie 1983b). Detailed analysis of the 'a' sequence (Chou & 
Roizman, 1985) has shown that deletion within the DR2 element resulted 
in a low frequency of inversion (Varamuza & Smiley, 1985), deletion of 
DR4 sequences resulted in com pletely abolishing inversion indicating 
that the presence of cis-acting signals for recom bination and inversion in 
the DR2 and DR4 sequences. Harland & Brown (1989) reported an 
approxim ately 13.5kb deletion in HSV-2 strain HG52 across the L-S 
junction with loss of the 'a' sequence and complete loss of I R l  and half 
of the IR s region, resulting in a fixed prototype orientation of the L 
segm ent. However, both IR s and T R s were present albeit in unequal 
proportions indicating that the 'a' sequence is not absolutely necessary
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for the isom erization of HSV. Longnecker & Roizman (1986) reported 
sim ilar findings.
(Section 1.6.d describes the cleavage packaging properties of the ’a' 
sequence and its protein binding properties).
1 .6 .  V IR A L  REPLICATION
Attachment of the virus to cell receptors is rapidly followed by fusion 
of the envelope with the plasma membrane. The de-enveloped capsid is 
then transported to the nuclear pores where the DNA is released into the 
nucleus. Transcription, replication of viral DNA and assem bly of new 
capsids takes place in the nucleus. Viral DNA is synthesized by a rolling 
circle mechanism to yield concatem ers that are cleaved into monomers 
and packaged in to  capsids. The virus then m atures and acquires 
in fec tiv ity  by budding through the inner lam ellae  of the nuclear 
m em brane. In fully perm issive tissue culture cells, the process takes 
approxim ately 18-20 hours.
1.6.a. Attachment and penetration o f  HSV to the cell.
Studies by W uDunn & Spear, (1989) indicate that the receptor 
m olecules recognized in one of the initial binding events are heparan 
sulphate proteoglycans and that either gB or gC is required for this step. 
Neom ycin and polylysine appear to block a sim ilar step in attachment 
(Langeland et al., 1987, 1988) and mapping data suggests that this step 
appears to involve gC. It has also been dem onstrated that gH may be 
required for an early step in viral replication (Buckm aster et al., 1984; 
Desai et al., 1988)
Penetration is also mediated by the HSV surface glycoproteins. An HSV 
ts m utant expressing an altered gB attaches to but does not penetrate
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into cells (M anservigi et  a / . , 1977) and gB" viruses attach but do not 
penetrate (Cai et al., 1988). In the same m anner, HSV-1 gD~ viruses 
attach but do not penetrate (Johnson & Ligas, 1988). Cells expressing 
HSV gD allow attachm ent and penetration of both HSV-1 and HSV-2, 
however fusion of viral and cellular membranes and penetration do not 
ensue (Campadelli-Fium e et al., 1988).
Hence, gB and gC recognize as well as attach to, cell receptors, gB and 
gD play an indispensable role in the fusion of the envelope with the 
p lasm a m em brane, and gD sequesters the cell m em brane proteins 
requ ired  for fusion of the v iral and ce llu la r m em branes. V irions 
attaching to the plasm a m em brane which cannot fuse are internalized 
and degraded in endocytotic vesicles.
Upon entry into the cell, the capsids are transported to the nuclear 
pores (Batterson et al., 1983; Tognon et al., 1981) where viral DNA is 
released into the nucleoplasm , a step which requires a viral function
(B atterson et al., 1983). Apart from DNA, other virion components are 
required for replication including a protein responsible for the shut off 
of host m acrom olecular synthesis (Fenw ick & E verett, 1990) and a 
tegum ent protein involved in the induction of im m ediate-early  gene
expression (Campbell et al., 1984).
1.6.b. Temporal control o f gene expression.
Transcription of viral genes takes place in the nucleus and mRNA is 
translated in the cytoplasm . The expression of HSV genes is tightly
controlled in that proteins form  several groups whose expression is 
ordered in a sequential fashion (Honess & Roizman, 1973, 1974, 1975). 
(An extensive discussion of the regulation of HSV genes is given in 
section 1.7)
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I .6 .C . Synthesis o f viral DNA.
The nature of the replicative forms of HSV DNA is obscure. It is known 
that newly replicated DNA does not posses detectable term ini and is 
probably c ircular or in head to tail m onom ers (Jacob et al. ,1 9 7 9 ;
Jongeneel & Bachenheimer, 1981). Late in infection replicated DNA is in 
a very rapidly sedimentable form, thought to be extensive concatemers
(Jacob et al .,1979). It is therefore likely that replication is by a rolling
circle mechanism . Concatem eric DNA is further processed in the cell 
nucleus by packaging into nascent nucleocapsids, and by cleavage into 
unit genome lengths (Vlazny et al.y 1982)
I.6.C .I. Origins of DNA replication.
HSV DNA has three origins of replication, one in Ul  situated between
divergently transcribed genes encoding the m ajor DNA binding protein 
and the DNA polymerase. This origin is termed ori\^. The other origin is 
situated between the prom oter of IE4/5 and that of IE3 in Rg and is 
therefore diploid. This origin is called ori$.
o r i§ activity has been localized to a region of 90 base pairs within the 
R § sequence of HSV-1 (Stow & McM onagle,1983). The ori$  sequence 
contains an im perfect palindrom e, with each arm consisting of 21 
residues. A lthough essential sequences are known to lie outside the 
palindrom e (Stow & M cM onagle,1983) there is (A-T)g at its centre 
essential for ori$  function (Stow, 1985).
o n 's  has homologues in HSV-2 strain HG52 (W hitton & Clements, 1984) 
and VZV (Stow & Davison, 1986) both of whose sequences are known and 
are similar to that of HSV-1. There is a stretch of 11 base pairs identical
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in HSV-1 and VZV which in HSV-1 lies across the boundary of the 
palindrom e and in VZV lies ju st outside it. These 11 base pairs are 
included in an 18 base pair region which has been shown to bind a 
protein (Elias et al., 1986). This region has been further characterized by 
W eir & Stow, (1990) who demonstrated that the interaction of the UL9 
gene product with o r is  (Elias & Lehman, 1988; Koff & Tegtmeyer,1988;
Olivio et al., 1988; W eir et al., 1989) was at part of the 11 base pair 
conserved elem ent and that the binding of the UL9 gene product to 
another related site was also required for efficient regulation.
Q lilt'
DNA containing functional ori\^  could not be cloned intact into a 
standard bacterial vector system . Any recom binant clones obtained 
contained deletions of >100 base pairs (Spaete & Frenkel, 1982) which 
rendered the origin inactive.
Sequencing of ori\^ was eventually achieved by using non-cloned viral
DNA fragm ents as sequencing substrates (W eller et al., 1985; Quinn & 
M cGeoch,1985). M olecular cloning of the region in an undeleted form 
was reported using a yeast plasmid (W eller et al., 1985). It was found 
that the deleting region contained a long perfect palindrom e with arms 
each of 72 residues which shows striking similarity to that of o r i$ .  As 
with o r i s ,  the ori\^ region contains an A-T rich region at the centre of the
palindrom e. Alignment of the two ori  sequences dem onstrates that the 
whole of ori$  shows homology to on 'L  (M cGeoch, 1987). The sequence 
similarity extends beyond the o r is  palindrome on one side only which is 
within the mapped functional limits of o r is  (Stow & M cM onagle,1983) 
and contains part of the o ris  binding site (Elias et a l . ,1986).
Lockshon & Galloway,(1986) found that the HSV-2 ori\^ equivalent was 
an alm ost perfect palindrom e of total length 136 base pairs with high 
sequence homology to the HSV-1 palindrome. VZV does not appear to
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contain any homology to 0h'l  in the equivalent genome location (Stow & 
Davison, 1986).
ori$  and ori\^ structures and flanking sequences have several elements
in common: 1. a palindrome sequence. 2. a repeating AT arp.a 3 a r<*<non
# *(in oris  alone)
conserved between HSV and VZV known to be protein binding* and 4.
the origins are located close to transcrip tional regulatory  signals of
divergently transcribed genes. In the case of o r i s  these are IE4/5 and 
IE3, IE3 encodes an essential transcriptional regulator. ori\^ is located 
between two genes whose products are com ponents of the viral DNA 
replicating  m achinery.
A variant lacking ori\^ has been isolated which grows normally in vitro
and w hich estab lishes laten t infection  in vivo (P o lv ino-B odnar e t
a /., 1987). Viable variants of HSV types 1 and 2 lacking a single copy of 
o r i s  have been iso lated  (Longnecker & Roizm an, 1986; Brown &
H arland,1987). Failure to isolate viable HSV deletion variants lacking 
both copies of o r is  may not indicate that both are essential since there is 
evidence of a transcript spanning o r is  (Hubenthal-Voss et a l , 1987). If 
both copies of o r is  were deleted then both copies of the proposed gene 
would also be disrupted making it difficult to dissociate the two effects. 
Recent evidence links these transcripts to replication of viral DNA (Wong 
& Schaffer, 1991).
1.6.C.II. HSV-1 gene products required for DNA synthesis.
By transfecting cells with plasmids containing an HSV origin of DNA 
synthesis and various fragments of the HSV-1 genome, the identification 
of 7 genes encoding products required for viral origin dependent DNA 
synthesis has been achieved (Wu et al., 1988; M cGeoch et a l . ,  1988b). 
These are UL5, UL8, UL9, UL29, UL30, UL42 and UL52. UL30 encodes
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the viral DNA polymerase (Chartrand et al., 1980; Quinn & McGeoch,
1985), a single stranded DNA binding protein is specified by UL29 
(Conley et al., 1981; Quinn & McGeoch, 1985) a protein binding to the 
origins of viral DNA synthesis is encoded by UL9 (Elias et al., 1986), a 
double stranded DNA binding protein  encoded by UL42 and three 
additional proteins encoded by UL5, UL8 and UL52 are thought to be 
subunits of a primase-helicase complex (Crute et al., 1989).
Other HSV encoded enzymes also play a role in DNA synthesis. Two 
enzymes which catalyse reactions in the biosynthesis of DNA precursors 
are thym idine kinase and ribonucleotide reductase.
T h ym id ine  k inase  (TK) is not essential for virus growth in dividing 
tissue culture cells, but is required in resting cells (Jamieson et al., 1974). 
The pathogenicity of TK “ mutants in experim ental anim als is reduced 
(Field & W ildy, 1978). The enzyme functions to phosphorylate purine 
pentosides and a wide variety of nucleoside analogues that are not 
phosphorylated efficiently by cellular kinases.
R ib o n u c leo tid e  re d u c ta se  (RR) catalyses the reduction of nucleoside 
diphosphates to deoxynucleoside diphosphates (Cohen, 1972; Dutia,1983), 
and is composed of two substrates which are encoded by separate but 
contiguous genes. (Preston et al.,1984; Bacchetti et al., 1986; Frame e t  
al., 1985; McLauchlan & Clements, 1983&). The enzyme has been shown to 
be non-essential under in vitro conditions for viral DNA replication by 
the construction of a viable variant deleted w ithin the ribonucleotide 
reductase coding region (Goldstein & W eller,1988). Preston et a l.,(1988) 
have also described a m utant, t s \2 2 2 ,  which has a single base pair 
deletion at the 3' end of the small subunit of RR. This mutant does not 
induce detectable amounts of RR activity at either 31°C or 39.5°C. In 
dividing cells at 31°C there is no growth defect, but 39.5°C was non 
perm issive for growth of the mutant. This suggests that at 31°C growth
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of the mutant is supported by cellular RR whereas virally encoded RR is 
necessary for viral replication at the higher tem perature. RR has been 
dem onstrated to be a determ inant of pathogen ic ity  in m ice since 
mutants with lesions in either the large or small subunit were reduced 
in virulence by about lO ^-fold when com pared to the parental virus 
(Cameron et al., 1988).
1.6.d. Cleavage and packaging of HSV DNA.
Newly synthesized viral DNA is processed and packaged into empty 
capsids, a process involving am plification of the 'a1 sequence and 
cleavage of 'endless' DNA (ie. in the circular or concatemeric form). Stow 
et al.,(1983) dem onstrated that signals required for encapsidation of 
HSV-1 DNA are located within the 'a' sequence and it has since been 
proposed that cleavage of HSV-1 DNA after replication is coupled to 
encapsidation (Deiss & Frenkel, 1986). The net results of these processes 
are that the free S component terminus consists of one 'a' sequence with 
a term inal DR1 elem ent containing only a single base pair and one 3' 
nucleotide extension (Mocarski & Roizman, 1982). The free L component 
term inus consists of one to several directly repeated 'a' sequences and 
ending in a DR1 element containing 18 base pairs and one 3’ nucleotide 
extension. The 3' extensions are thought to mediate the circularization of 
the genome after infection (M ocarski & Roizm an, 1982). Two separate 
signals designated P a d  and Pac2, located in the Ub and Uc regions 
respectively of the 'a' sequence, were essential for cleavage/packaging 
of viral genomes (Varmuza & Smiley, 1985; Deiss et al., 1986). Nasseri & 
M ocarski, (1988) have shown that a 179 base pair fragm ent (containing 
U c-D Rl-U b) from the junction of two tandem 'a' sequences carries all the 
elem ents necessary for cleavage recognition and encapsidation.
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The analysis of the processes of cleavage and packaging was achieved 
by Deiss et al., (1986) using a series of amplicons. A summary of the 
cleavage packaging model resulting from  this analysis begins with a 
cleavage packaging protein attaching to the Uc elem ent of the ’a' 
sequence (see section 1.5 for a description of the 'a' sequence structure). 
A potential structure on the surface of the capsid complexes with a Uc 
protein sequence, loops the viral DNA and scans from the bound 'a' 
sequence across the L component toward the end of the S component 
until it detects the first U c-D R l-U b domain of an 'a' sequence in an 
identical orientation. The DR1 sequence of one 'a' is then cleaved and the 
gap is repaired. Cleavage of the DR1 elem ent shared by the two 'a' 
sequences then ensues.
Several proteins have been shown to bind the 'a' sequence. These 
include a small polypeptide attaching to the L-S junction of virus DNA 
(Wu et al., 1979). Late polypeptides encoded by the gene US11 (Rixon & 
M cGeoch, 1984; Johnston et al., 1986) have been shown to interact with 
the HSV-1 'a' sequence in vitro (Dalziel & Marsden, 1984) and are strong 
DNA binding proteins (MacLean et al., 1987). The function of the US 11 
gene products rem ain unclear since deletion m utants viable in tissue 
culture have been isolated (Umene,1986; Brown & Harland,1987). Two 
further proteins (>250KDa and 140KDa) which form complexes with p a d  
and the DR1 region of the 'a' sequence have been reported (Chou & 
R o izm an ,1989).
The model described by Deiss et al.,{ 1986) and above dem onstrates 
that the 'a' sequences at the joint between the L and S component were 
not involved in cleavage and packaging is supported by the isolation of 
an HSV-2 variant lacking the internal ’a' sequence which was packaged 
norm ally (Brown & Harland,1987).
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1.6.e. Envelopm ent and egress.
A notable feature of infected cells late in infection is the appearance of 
red u p lica ted  m em branes and th ick  concave or convex patches, 
particularly in nuclear membranes. Nuclear envelopm ent takes place at 
these patches. Because the enveloped virions do not contain detectable 
am ounts of host m em brane proteins, it is likely that these patches 
rep re se n t ag g rega tions of v ira l m em brane p ro te in s presum ably  
including  viral glycoproteins on the outside surface and tegum ent 
proteins on the inside surface.
Nuclear DNA-containing capsids attach to these patches of the nuclear 
m embrane and become enveloped in the process. It has been observed 
tha t only DNA con ta in ing  capsids are enveloped  (R oizm an & 
Furlong, 1974) and that the envelopment of empty capsids rarely occurs. 
Vlazny et al.,(1982) dem onstrated that capsids containing fragm ents of 
HSV DNA less than standard genome length are retained in the nucleus 
leading to the suggestion that a capsid protein  is m odified after 
encapsidation of DNA and only modified capsids are able to bind to the 
patches of nuclear membrane containing viral proteins. The production 
of light particles indicates that capsids are not required for budding of 
envelopes (S zilag i & C unninghan ,1991 ; R ixon et al., 1992) and the 
possibility of cytoplasmic sites for acquisition of tegum ent and envelope 
has been indicated (Nii et al., 1968). Roffm an et a /.,(1 9 9 0 ) detected  
structures called  tegusom es in w hich HHV-6 virions acquire their 
tegument indicating a non-nuclear location for this process.
1.7. Regulation of viral gene expression.
The replication of HSV-1 is coordinated by temporal control of gene 
expression. The classification of three groups of genes, imm ediate-early
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(IE), early (E) and late (L) (Clements et al., 1977) or alpha, beta or gamma 
(Honess & Roizman, 1974) is based on their kinetics and expression in 
the presence and absence of metabolic inhibitors of translation or DNA 
replication (Kozak & Roizman, 1974). The IE genes are the first to be 
transcribed and their expression does not require de novo  protein 
synthesis, whereas early and late gene expression is dependent on prior
synthesis of IE polypeptides (Honess & Roizman, 1974; Clements et al,
1977). IE genes are first expressed directly after release of DNA into the
nucleus and their expression is stim ulated by a com ponent of the
tegument (Post et al., 1981; Batterson & Roizman, 1983).
1.7.a. Regulatory elements o f  HSV-1 genes.
The transcription of HSV-1 genes begins with the five immediate-
*viral
early  genes w hich are expressed in the absence of prior* protein 
synthesis. The im m ediate-early proteins in turn, activate early genes 
which encode mostly the viral DNA replicative machinery. The leaky late
genes are induced soon after the early genes. They are first expressed
prior to the onset of viral DNA replication, and expression increases at 
later tim es in a replication dependent fashion. Finally, the true late 
genes are activated only after DNA replication has begun. The replication 
step appears to induce a c i s -acting  m od ifica tion  o f the tem plate
rendering it perm issive for late gene expression (M avrom ara-Nazos &
Roizm an, 1987). Each HSV gene bears its own prom oter-regulatory 
region summarized by figure 1.5 and prom oter transplant and nuclear
run-on experim ents indicate that tem poral regulation occurs largely at
the transcriptional level (Godowski & Knipe, 1986; Post et al., 1981;
Silver & Roizman, 1985).
Figure 1.5 Regulatory elements of HSV-1 genes.
A summary of the HSV-1 regulatory elements showing far-upstream, 
distal and proxim al prom oters of im m ediate-early, early and late genes. 
(Adapted from Everett, 1986)
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Coordinate activation of HSV im m ediate-early gene expression is 
mediated through a class specific consensus sequence TAATGARAT that 
is found in one or more copies in each of the imm ediate-early 5' control 
regions (Cordingly et al., 1983: Gaffney et al., 1985; MacKem & Roizman, 
1982a,b; Preston et a l ., 1984; Triezenberg et a l ., 1988). IE transcription 
is m ediated by an abundant tegum ent component of the virion Vmw65 
(also called VP16, aTIF and ICP25), that is delivered into cells upon 
infection (Batterson & Roizman, 1983; Campbell et al., 1984; Post et al.y 
1981). Vmw65 forms a complex with cellular factors, including OCT-1, 
and the resulting activator complex binds to the TAATGARAT sequence 
in part through the DNA binding domain of OCT-1 (McKnight et al., 1987; 
Preston et al.y 1988). Four out of five immediate-early proteins (IE1, IE2, 
IE3, and IE4) contribute to the activation of the viral early and late 
genes. E xtensive analysis o f the IE3 prom oter region (M acKem  & 
Roizm an, 1982b) has dem onstrated that it possesses a TATA box at 
position  -20 from  the cap site, several SP1 binding sites scattered 
throughout the prom oter region and two Vmw65 binding sites. The IE3 
prom oter also contains a site to which V m w l75, the IE3 gene product, 
binds to regulate its own expression. Each im m ediate-early prom oter 
region in general has one or more Vmw65 binding sites, GC rich areas 
and a TATA box however the number of each varies according to the 
gene concerned. Ace et al.,( 1989) dem onstrated that each im m ediate- 
early gene has a different requirem ent for stim ulation by Vmw65 since 
infection with the variant in 1814 which contains a small insertion in the 
gene encoding Vmw65 rendering the tranactivating  function of the 
protein inactive, resulted in the differential accum ulation of immediate- 
early mRNAs. IE1 and 2 mRNAs accumulate to a lesser extent than that 
of IE4 and the accumulation of IE3 mRNA is unaffected. Transfection of a 
plasm id encoding V m w llO  before infection with zn 1814 results in the
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accum ulation of im m ediate-early mRNA to a sim ilar quantity to wild- 
type indicating that the function of V m w llO  can substitute for that of 
V m w 6 5 .
Although the classical definition of imm ediate-early genes is that they 
can be transactivated by Vmw65 in absence of prior protein synthesis, 
E lsh iekh  et a l . ,(1991) have dem onstra ted  that only V m w llO  is 
m axim ally expressed in the absence of infected cell protein synthesis. 
Vm w68/12 and Vmw63 are m axim ally expressed after 1/2 hour of 
protein synthesis and V m w l75 after 1 hour.
The mechanisms of activation of early and late prom oters remains 
unclear. Early and late prom oters do not contain obviously conserved 
c lass-spec ific  sequences analogous to TAATGARAT, and extensive 
m utational analyses have not uncovered c is -acting sequences solely and 
specifically  required for activation by im m ediate-early  polypeptides. 
The early and late prom oter elements that are required for activation by 
im m ediate-early proteins are the same as those needed for basal level 
activity in uninfected cells (Everett, 1987; Me Knight & Tjian,1986). These 
data have been in terpreted  to suggest that im m ediate-early  proteins 
induce early and late gene expression by altering the activity of one or 
m ore com ponen ts of the tran sc rip tio n  ap p ara tu s (E v ere tt, 1987; 
M cK night & T jian,1986). C onsistent with this hypothesis, the HSV 
im m ediate-early  proteins d isplay re la tively  relaxed target specificity  
and are able to activate a variety of heterologous genes that have been 
newly introduced into cells by transfection or as part of an infecting 
viral genome (Everett, 1984 a,b,1985). Some evidence suggests that the 
TATA box factor TFIID serves as a critical target of the immediate-early 
polypeptides since changes in TATA box sequence can markedly affect 
the response of the simian virus 40 early prom oter to imm ediate-early 
po lypep tides (E v e re tt ,1988$. A dditional ev idence  fo r a functional
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in teraction  betw een im m ediate-early proteins and TFIID comes from 
studies showing that the pseudorabies virus im m ediate-early protein (a 
hom ologue of HSV-1 V m w l75) activates transcrip tion  in vitro by 
increasing the rate of binding of TFIID to the TATA sequence (Abmayr 
et al., 1988).
HSV late prom oters appear to have a sim pler structure than early 
prom oters, and some evidence suggests that this d ifference plays an 
im portant regulatory role during transfection (Homa et al., 1 9 8 6 ,1 9 8 8 ; 
Johnson & Everett, 1986). The early promoters so far examined consist 
of a near upstream  region com posed of binding sites for cellular 
transcrip tion  factors linked to a TATA box/cap site (E verett, 1984a; 
McKnight & Tijan,1986). In contrast, the promoters of late genes US11, 
glycoprotein C and UL38 lack elem ents upstream  of the TATA box 
(Flanagan et a l . ,1991; Homa et al .,1986,1988; Johnson & Everett, 1986). 
Several observations suggest that true late prom oters contain specialised 
c is -a c tin g  sequences that actively  con tribu te  to true late  control. 
Im balzano et al.,( 1991) found that a mutant TK gene lacking all known 
prom oter elem ents upstream  of the TATA box rem ained under early 
control, im plying that upstream  elem ents are not always required for 
expression . Hom a et al.,( 1988) found that the TK TATA sequence was 
unable to function when translated to the gC locus, leading to the 
hypothesis that true late prom oter activity requires a specific type of 
TATA box sequence. Mavromara-Nazos & Roizman, (1987) observed that 
sequences downstream  of the TATA box of the true late g42 gene can 
confer some aspects of late regulation on an early prom oter. Lastly, 
Kibler et al.,(1991) demonstrate that sequences downstream of the US11 
TATA box play an active role in specifying true late temporal regulation.
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h U i— Th£ im m ed ia te -early  po lyp ep tid es .
There are five immediate-early genes in HSV-1 called IE1, IE2, IE3, 
IE4 and IE5, encoding V m w llO , Vmw63, V m w l75, Vmw68 and Vm wl2 
respectively. The location of each im m ediate-early gene in the HSV-1 
genome is shown in figure 1.6.
V m w 6 3
Central to this project is the im m ediate-early polypeptide Vmw63 
since the subject of this thesis, the variant 1703, apparently fails to 
synthesize it under imm ediate-early conditions of infection (MacLean & 
Brown, 1987a) despite it being classed as an essential regulatory protein 
(Sacks et al., 1985; M cCarthy et al., 1989). Vmw63 is encoded by the gene 
IE2, which is also called UL54, reflecting its position near the right hand 
end of the prototype orientation of the HSV-1 genome. IE2 is the only 
im m ediate-early gene mapping entirely w ithin a unique region of the 
genome (McGeoch et al., 1988a). It contains no splice sites and its product 
has a size of 63 KDa by SDS-PAGE. The IE2 prom oter region has one 
TAATGARAT element situated 158 base pairs upstream  of the IE2 cap 
site, several GC rich areas and a TATA box (Mackem & Roizman, 1982). 
The gene exhibits a strong requirement for stimulation by Vmw65 (Ace 
et al., 1989).
Phenotypic analysis of set of HSV-1 m utants with tem perature 
sensitive (ts) lesions in IE2 (Sacks et al., 1985) demonstrated that, at the 
non-perm issive tem perature, the variants were unable to activate a 
subset of early and late genes and show enhanced expression of most 
im m ediate-early  polypeptides. T ransient expression assays have shown 
that Vmw63 expressed in transfected cells can alter the expression of
Figure 1.6 HSV-1 immediate-early genes.
A HSV-1 genome in the prototype orientation showing the locations of 
im m ediate-early  genes. The genes are shown w ithout introns, IE1 has 
two introns and IE4 and IE5 have one each.
mr-
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many co-transfected HSV-1 target genes. Several studies have shown 
that Vmw63 can induce expression of chim eric target genes driven by
specific early or late prom oters (E verett, 1986; Rice & Knipe,1988; 
Sekulovich et a l . ,1988; Su & Knipe.,1989). For some of these promoters, 
the e ffec t requires the expression  of the HSV-1 im m ediate-early
proteins V m w l75, V m w llO  or both. How ever expression of Vmw63 
alone is able to stimulate expression of the glycoprotein B promoter in 
transfected Vero cells (Rice & Knipe, 1988) indicating that at least part 
of the positive regulatory effect of Vmw63 is independent of other viral 
proteins. Vmw63 is also able to inhibit gene expression from another set 
of chim eric genes driven by early or late prom oters (Sekulovich e t 
a /., 1988; Su & Knipe, 1989). The negative regulatory effect of Vmw63 is 
com plex in that Vmw63 has little or no effect on the basal promoter 
activity of these genes but rather counteracts the stimulatory effects of 
the HSV-1 transactivating polypeptides V m w llO  and V m w l75.
Characterization of an HSV-1 IE2 null mutant (McCarthy et al., 1989) 
has shown that Vmw63 was required to repress early gene expression,
to induce w ild-type levels of delayed-early  gene expression and to 
induce true late gene expression. The phenotypic characterization of IE2 
dele tion  m utants lacking various parts of the IE2 coding region 
dem onstrated that the deletion of different parts of the gene affect the 
regulatory functions of the product in various ways.
Hardwicke et al., (1989) constructed a series of in frame insertion and 
deletion m utants which were used to map the repressor and activator 
functions of Vmw63. The repressor activ ity  m aps to the carboxy- 
term inal 78 amino acid residues, whereas the activator function maps to 
the carboxy-term inal half of the m olecule encom passing a region of 
abou t 250 am ino acids. E x ten siv e  ana ly sis  o f these  varian ts
dem onstrated that m utations in the activator dom ain can be t r a n s
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dom inant, that is, when the m utant plasm ids are co-transfected with a
w ild-type plasm id and one specify ing  V m w l75  or V m w llO , the
activation of a reporter gene is affected (Smith et al., 1991). H ow ever 
m utants in the repressor domain can not interfere with either repressor 
or activa to r functions of the w ild-type pro tein  indicating  that the 
repressor region is required for the binding of Vmw63 to its substrate. 
There is a putative zinc finger binding domain in this region (Hardwicke 
et al.y 1989) supporting the hypothesis that the region is DNA binding.
M cM ahon & Schaffer,(1990) pursued a sim ilar strategy  and 
dem onstrated that there were two repressor dom ains w ithin Vmw63, 
both lying in the activator dom ain, one of which was not absolutely 
required for the repressing activity of the protein. They also show that 
the enhancer function of Vmw63 involves a large portion of the 
carboxyterm inal half of the molecule. The conclusion of M cM ahon's & 
Schaffer's work is that Vmw63 perform s it regulatory activities over 
time and that these effects are mediated indirectly via interactions with 
and m odifications of V m w l75 and perhaps other viral and cellular 
p ro te in s .
It is interesting to note that there is extensive amino acid sequence 
conservation between this region of Vmw63 and the carboxyterm inal 
halves of the related VZV gene 4 product, the EBV BMLF1 and the 
im m ediate-early  52K gene product of HVS (D avison & Taylor, 1987; 
Gompels et al., 1988). Vmw63 has also been shown to be essential for the 
accum ulation of the cellular protein p40 during lytic virus infection 
(E s tr id g e  et al., 1989). This finding  is s ig n ifican t since p40 is
overexpressed in cells transform ed with HSV or other agents and in 
human cervical cancers. Other HSV regulatory gene products such as
V m w l75  have also been shown to up-regulate  the expression of 
particular cellular genes during infection.
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V m w l l O .
V m w llO  is an im m ediate-early polypeptide which has a size of
llO K D a by SDS-PAGE and is encoded by two copies of the gene IE1 
which is contained within Rl . IE1 possesses two spice sites which appear 
to be dispensable for virus growth in tissue culture (Everett, 1991). 
V m w llO  is not an essential im m ediate-early polypeptide. A deletion
variant which lacks 700bp of each IE1 gene is viable in tissue culture 
(Sacks & Schaffer, 1987). Stow & Stow, 1986 have shown that a HSV-1 
variant which does not express V m w llO  because of a 2kb deletion in
both copies of IE1 was able to replicate in BHK21 C l3 cells and the
resu lts suggest that the effect of the deletion is m anifest at low
m ultip lic ities of infection  but can be overcom e by increasing the
infecting virus dose since at high m ultiplicities of infection the variant 
expressed similar amounts of viral proteins and replicated DNA as wild- 
ty p e .
V m w llO  is able to stimulate expression from delayed early promoters 
and, in conjunction with V m w l75 this stimulation is increased (Everett, 
1986). M utations in different domains of V m w llO  can have different
effects on function in the presence and absence of V m w l75 (Everett,
1988& indeed the production of V m w llO  itself has been shown to be 
regulated by V m w l75 (Resnick et al., 1989).
V m  w 1 7 5 .
V m w l75 is an essential imm ediate-early polypeptide whose size on 
SDS-PAGE is 175KDa, is unspliced and encoded by IE3 which is 
com plete ly  con tained  w ithin R s and is therefore diploid (Rixon e t  
al., 1982). M ost ts mutants with lesions in IE3 only express immediate-
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early  po lypep tides at the non-perm issive tem pera tu re  (W atson & 
Clements, 1978). Even when early and late transcription has commenced 
at the perm issive  tem perature , sh ift up to the non perm issive 
tem p era tu re  re su lts  in the rev e rs io n  to the  im m ed ia te -ea rly  
transcrip tional phase (Preston, 1979a,b).
The synergistic roles of  V m w l75 .  V m w llO  and Vmw63.
Through using the bacterial chloramphenicol actyl transferase (CAT) 
assay , it has been show n that V m w llO  and V m w l75  together 
transactivate early genes to a much greater extent than either gene 
alone. However, this com bination did not significantly transactivate a 
late prom oter, but when a plasmid expressing Vmw63 was included in 
the transfection , transactivation  of the late prom oter was increased 
about 6-fold (Everett, 1986 ). This work indicates that together these 
polypeptides function to transactivate early and late genes. Although 
stim ulation of imm ediate-early genes is achieved by the combination of 
Vmw65 and cellular transcription factors, HSV-1 DNA is itself infectious. 
Cai & Schaffer (1989) have shown that V m w llO  plays a critical role in 
the de novo synthesis of infectious virus following transfection of virus 
DNA.
There are two other immediate-early polypeptides encoded by HSV-1 
whose function have not yet been fully elucidated.
V m w 6 8 .
Vmw68 is coded by the gene IE4 and has a size of 68KDa on SDS-PAGE. 
The RNAs of IE4 and IE5 map across the junction between U s and Rs 
and have common 5' portions located in IR s and TR s and the 3' portions 
extend into the opposite ends of U s and are unique. The DNA sequence
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encoding the common 5' end com prises a leader region and a single 
intron of variable size due to the variable copy num ber of a 22bp 
reiteration (Rixon & Clements, 1982).
The construction of a deletion m utant which removes the carboxy- 
term inus th ird  of IE4 has shown that the gene appeared to be 
dispensable since the variant grew norm ally in tissue culture (Post & 
R oizm an, 1981). L ater analysis using several d ifferen t cell lines 
indicated that in some circumstances the virus grew very poorly and the 
activ ity  of at least one true late prom oter was greatly  reduced 
suggesting a host range function (Sears et al., 1985). The variant was not 
neurovirulent but could establish latency in mice. Since a truncated form 
of Vmw68 was still produced, these studies do not show a clear role for 
V m w 6 8 .
Jaquem ont et al. (1984) com pared the p roduction  of HSV-1 
imm ediate-early polypeptides in the presence of cyclohexim ide in HEp-2 
cells which host a lytic HSV infection to that of XC cells which do not. 
There was an accumulation of all five im m ediate-early polypeptides in 
infected HEp-2 cells but infected XC cells Vmw68 could not be detected. 
Analysis of RNA from both cell types indicated that all five immediate- 
early RNAs were present. The conclusion from this work was that the XC 
cell environment was not conducive to the translation of IE4 mRNA. This 
suggests an essential role for Vmw68 in XC cells.
V m w l  2 .
V m w l2 is encoded by the gene IE5 and has a size of 12KDa on SDS- 
PAGE. The position of IE5 on the HSV-1 genome has already been 
described. V m w l2 is not essential and viable deletion m utants have
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been isolated that lack the whole IE5 gene which indicates that it does 
not play an essential role in tissue culture (Brown & Harland, 1987).
1.7.C. Early gene expression.
After the immediate-early genes, the next set of genes to be expressed 
are the early genes. They appear after functional im m ediate-early gene 
products reach their peak, about 4-6 hours after infection, after which 
they decline (Honess & Roizman, 1974). Some early polypeptides, for 
example gD, require DNA synthesis for maximal expression (Johnson & 
Spear ,1984). T ran sfec tio n  assays have show n tha t ind iv idua lly  
V m w llO  and V m w l75 transactivate early gene expression and that a 
com bination of these two imm ediate-early polypeptides resulted in very 
high levels of activation (Everett, 1986). Early genes can be divided into 
two groups depending on the time they are first expressed: 1. eg. the 
m ajor DNA binding protein  or the large subunit of ribonucleotide 
reductase, and 2. eg. thymidine kinase and DNA polymerase.
1.7 .d .  Late gene expression.
Late gene products are detected 3 hours post infection and reach their 
peak 10-16 hour post infection (Roizman, 1979b). In contrast to early 
gene expression  which is stim ulated by V m w llO , V m w l75  or a 
combination of both, late gene expression is controlled by a combination 
of the above two im m ediate-early  polypeptides and the IE2 gene 
product, Vmw63 (Everett, 1986b). There are two subclasses of late 
genes: 1. The leaky-late genes, eg. the major capsid protein encoded by 
U l 19 and gB specified by Ul 27. The leaky-late genes are induced soon 
after early genes: they are first expressed prior to the onset of viral 
rep lication , and expression increases at later tim es in a replication-
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dependent fashion 2. The true late genes, eg. gC encoded by U l4 4 . These 
genes are expressed only after DNA synthesis has begun (Holland e t
al., 1980) and are not expressed in the absence of Vmw63 (Rice & Knipe, 
1990).
1 .8 . PATHOGENICITY OF H S V .
HSV is a neurotropic human herpesvirus responsible for a variety of 
conditions ranging from  mild cutaneous lesions to a very rare fatal 
encephalitis. After acute infection at the surface of the body, the virus 
travels via axons at the sensory nerves to establish a latent infection in
the dorsal root ganglia of the peripheral nervous system  (Stevens &
Cook, 1971). Follow ing reactivation , virus m ainly travels via the 
p e r ip h e ra l n e rv o u s sy stem  to p e rip h e ra l tis su e  re su ltin g  in
m ucocutaneous lesions but transport to the central nervous system 
(CNS) can result in encephalitis. Acute necrotizing encephalitis is the 
most serious neurological disease caused by HSV (Finelli, 1975) and as a 
direct study in humans is impossible, animal model systems have been 
employed. Intracranial inoculation of mice with HSV produces lesions 
similar to those seen in humans.
The identification of HSV genes involved in viral pathogenicity and the 
elucidation of their precise functions is of fundam ental im portance to 
the understanding of the biology of herpes simplex virus. Many host 
factors have been shown to influence virulence including animal age 
(Kohl & Loo, 1980), route of inoculation (Caspary et al., 1980) and strain 
of experimental animal (Lopez, 1975). Virus strain (Dix et al., 1983) and 
the consequences of serial passage of virus in vivo (Kaemer et al., 1983) 
and in vitro, (Goodman & Stevens, 1986) have also been implicated.
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M utation in, or deletion of, the viral thymidine kinase gene (TK) has 
been shown to im pair virulence (Field & W ildy, 1978). Sequences 
between 0.25 and 0.53 m.u. have also been implicated (Thompson et al.y 
1986) as has the viral DNA polym erase (Field & Coen, 1986). The 
virulence phenotype may be determined by sequences between 0.7 and
0.83mu (map units) (Thompson & Stevens, 1983; Thompson et al.y 1985; 
Javier et a / . ,1986; Rosen et al .y 1986). Evidence indicating that the 
sequences in both copies of R l  between IE1 and the 'a' sequence are 
involved in neurovirulence has accum ulated. Taha et al.y (1989 a,b) 
reported a 1488bp spontaneous deletion upstream  of IE1 in a HSV-2 
varian t that abolished  neu rov iru lence. C orrec tion  of the deletion 
re s to re d  the  w ild -ty p e  p h e n o ty p e . A ck erm an n  et al. (1986) 
dem onstrated that an open reading frame reported by Chou & Roizman 
(1986) between the term inal 'a' sequence and IE1 in HSV-1 strain F 
specified a protein. Thompson et al.y (1989) m apped a neurovirulence 
locus to between 0.82 and 0.832mu. The protein designated ICP34.5 has 
been shown to be a neurovirulence factor and to be non-essential for 
growth in tissue culture (Chou et a/., 1990). R ecently M acLean et al. 
(1991b) reported the isolation of a spontaneous deletion HSV-1 17+ 
varian t w ith a non-neuroviru len t phenotype. The dele tion  rem oved 
759bp of sequences upstream  of IE1 and correction of the deletion 
resulted in restoration of neurovirulence.
1.9. HSV L A T E N C Y .
After infection with HSV, the viral genome is maintained in a latent 
state in neuronal cells. Periodically, in response to various stimuli, virus 
can be reactivated from latency, often resulting in the development of a 
lesion at the appropriate peripheral site (Roizm an & Sears, 1987;
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Stevens, 1989). During latency, viral transcription can only be detected 
from the long repeat region of the genome giving rise to products known 
as the latency associated transcripts (LATs) (Croen et a /.,1987; Rock et  
al. ,1987; Spivack & Fraser, 1987; Stevens et a /.,1987). Latent HSV DNA is 
maintained in a non-linear configuration, probably as a circular episome, 
and is assem bled into a chrom atin like structure (Rock & Fraser, 
1983,1985; Efstathiou et a/., 1986; Melerick & Fraser, 1987; Deshmane & 
F raser, 1989). Thus during latency, the transcrip tion  pattern  and 
physical organisation of the HSV-1 genome is very different from that 
found during productive infection.
In vivo and in vitro models for HSV latency have been developed. 
The pioneering work in the mouse model latency system was described 
by Stevens & Cook (1971) who inoculated the mouse footpad with HSV.
This was followed by centripetal m ovem ent of the virus through the
peripheral and central nervous system. After 3 weeks the virus could be
recovered from the dorsal root ganglia demonstrating that the virus was
in a latent state in the nervous tissue.
This pattern of establishm ent of latency is sim ilar in other animal 
models like the rabbit eye model (Stevens et a/., 1972), the mouse ear 
model (Hill et a l ,  1972).
In vitro models have also been used to investigate HSV latency. The 
systems with most obvious relevance to latency in animals and humans 
utilize foetal neurons from rats or primates (W igdahl et al.y 1983, 1984; 
W ilcox & Johnson, 1988; W ilcox et al.y 1990). However extensive use of 
this system  is lim ited by the quality of such neurons available. An 
alternative method is to use non-primary tissue culture cells eg. human 
foetal lung (HFL) cells (W igdahl et a l ,  1981,1982). Russell & Preston 
(1986) reported the development of an in vitro latency system in which 
HFL cells were infected with low m ultiplicities of HSV-2 and incubated
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at the supraoptim al tem perature of 42°C for 6 days. Cultures were 
subsequently downshifted to 37°C and maintained without production of 
virus indicating that the HSV-2 virus was latent.
Using a mouse eye model (Tenser & Dunstan, 1979) and various 
dele tion  variants of HSV-1, Leib et al. (1989a) reported that the 
products of IE genes 2 and 3 were required for the establishm ent of 
la tency  in vivo  and that the IE1 gene product was required to 
reactivate virus from the latent state. However, Clements & Stow, (1989) 
contradicted this result since the deletion variant d l l 4 0 3  reactivated  
norm ally. Harris & Preston (1991) used the in vitro latency system to 
dem onstra te  that a varian t possessing  an in sertion  m utation that 
abolished Vmw65 tranactivating ability could establish latency and that 
V m w llO  was required to reactivate virus.
The only transcription that occurs during latency is from the long 
repeat region of the genom e and has been designated the latency 
associated transcripts (LATs). These consist of three herpes specific 
RNAs which map within IRl  and TRl  and are transcribed in the opposite 
direction to IE1 (Spivack & Fraser, 1987). These transcripts are present 
in reduced amounts in acutely infected mice (Spivack & Fraser, 1988b) 
and infected tissue culture cells (Spivack & Fraser, 1987).
The 2 and 1.3 Kb LATs share their 3' and 5’ ends and are derived by 
alternative splicing (W echsler et al., 1988). These LATs partially overlap 
the 3' end of IE1 and are antisense (com plem entary) to IE1 mRNA 
(Stevens et al .,1987). Zw aagstra et al. (1989) have dem onstrated that 
the LAT prom oter is 660 nucleotides upstream of the mapped 5' end of 
the stable LAT and have proposed that the LATs are in fact splice 
products of an 8.3 Kb prim ary transcrip t (Zw aagstra et al. , 1 9 9 0 ); 
(fig u re l.7 ) and suggest that the 6.3Kb exon may be the biologically 
active LAT. That the 8.3Kb primary transcript exists is supported by
F ig u re  1.7 A diagram of the LAT. 
Diagram of the LAT as proposed by Zwaagstra et al.,(1990).
6.3KB 
LAT 
(unstable 
and 
biologicallyctive)
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reports of viral mutants which lack this promoter failing to produce LAT 
RNA during latent infection (Dobson et al., 1989; Leib et al., 1989b ; 
M itchell et al., 1990; Steiner et al., 1989). However this would imply that 
the 2.0 and 1.3 Kb LATs are stable introns. Farrel et al. (1991) have 
proposed that LAT is a stable intron which controls latency by an 
antisense m echanism .
The function of LAT is unclear but recent studies of LAT deletion 
variants suggest that LAT may play a role in reactivation of the virus 
from the latent state (Dobson et al., 1989; Leib et al., 1989b; Steiner et al., 
1989; Trousdale et al., 1991). However this is not supported by all LAT 
mutants (Block et al., 1990, Ho & Mocarski, 1989).
1 .1 0 . ANTISENSE NTJCLEIC ACIDS IN BIOLOGICAL SYSTEMS.
Gene expression in prokaryotes and eukaryotes is normally controlled 
by regulatory  polypeptides, for exam ple, the im m ediate early gene 
products of HSV-1 (section 1.7). The products of these genes are called 
activators or repressors. The isolation of naturally occuring regulatory 
genes which direct the synthesis of RNA antisense to target RNA has led 
to the discovery of a new category of repressors which are highly 
specific inhibitors of gene expression. Binding of the antisense RNA to 
the target RNA renders the target RNA unavailable for translation. The 
fate of the RNA:RNA complex is unclear.
1.10,a. Systems in which antisense RNA is naturally involved.
Natural, prokaryotic antisense systems have been studied extensively. 
Inouye, (1988) separated the m echanism s by which antisense RNAs 
affect gene expression into three groups. This section discusses these
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groupings and gives an example of each. This is followed by examples of 
eukaryotic systems in which antisense RNAs are thought to function.
Class 1 antisense RNAs inhibit translation of mRNA by binding to the 
transcriptional initiation region of target RNA and it is likely that control 
takes place by the inhibition of ribosome binding. Some class 1 antisense 
RNAs require RNA selll for inhibition (Krinke & W ulff, 1987). This form 
of control is involved in the lysis/lysogeny pathways of two temperate 
bacteriophage, P22 and X. Phage P22 encodes an antisense repressor,
Ant, which inhibits DNA binding by the principal repressors of many 
lam boid phages including P22 (Susskind & Y ouderian, 1983). It is 
advantageous for P22 to express Ant early in infection as resident 
lam boid prophages w ill be induced, increasing the opportunity  for 
recom bination. However, Ant repressor must be carefully controlled, too 
m uch A nt w ill p reven t the estab lishm ent of P22 lysogeny. Ant 
expression is controlled in part by a P22 specified antisense RNA, s a r , 
which binds to the translational activation region of the Ant message 
and prevents its activation (Wu et al., 1987).
Class 2 antisense RNAs also inhibit at the level of translation but at a 
region distant from translational start signals of the target transcript. An 
extensively studied example of this is the plasmid C olE l. ColEl and its 
relatives are small multicopy plasmids whose replication is initiated by 
the transcription of a prim er RNA termed RNAII (Tomizawa, 1987). To 
prime DNA synthesis, RNAII must hybridize to its DNA template strand 
and then be cleaved by RNAse H at a specific site approximately 500
nucleotides from  its 5’ end. The C olE l antisense RNA, RNAI, is an
approxim ately 110 nucleotide RNA species expressed from the primer 
region and complem entary to the 5’ end of RNAII. When RNAI binds 
R N A II, it triggers a conform ational change in RNA II preventing
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productive hybridization to the tem plate DNA (M atsukata & Tomizawa, 
1986).
Class 3 antisense RNAs control target RNA at the level of transcription. 
This is not as well characterized a form of antisense RNA as class 1 and 
class 2, however, the Escheric ia  coli  CRP protein is thought to be 
regulated in this way. CRP mediates catabolic repression by modulating 
the activity of many bacterial prom oters (Gottesm an, 1984). For some 
time it has been known that the crp  gene is negatively autoregulated 
(Aiba, 1985). On the basis of in vitro experiments, Okamoto & Freundlich 
(1986) proposed that crp  autoregulation results from antisense control 
by an RNA called tic. The tic promoter, which is activated by CRP in the 
presence of cAMP, in itiates transcription a few nucleotides upstream 
and divergently from the crp  message. The tic RNA is partially antisense 
to the 5' end of the c rp  m essage and it is thought that this binding 
induces a conform ational change in the m essage resu lting  in the 
term ination of transcription. This is called transcrip tional attenuation 
and has been invoked as a possible control mechanism of the human and 
murine myc  gene families (Nepveu & Marcu, 1986; Krystal et al ., 1988).
Some examples of eukaryotic antisense RNA control mechanisms are 
the follow ing. Katsuki et al ., (1988) constructed an antisense myelin 
basic protein (MBP) gene and used it to generate a transgenic mouse 
strain in which the antisense MBP was expressed. The transgenic mouse 
strain was converted to the shiverer phenotype characteristic of myelin 
deficient mice dem onstrating that is was possible to control the MBP 
gene with antisense RNA.
A role for 'natural' antisense RNA in a eukaryotic system has been 
identified (Tosic et al., 1990). This group investigated the reasons why, 
although myelin deficient mice produced only about 2% of the wild-type 
concentration of myelin basic protein mRNA, the overall transcription
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rate of the myelin basic protein RNA is normal indicating a block during 
the processing or transport of the RNA. The group also found that, of the 
two genes which code for myelin basic protein in myelin deficient mice, 
one gene contains a large inversion of the 3' end resulting in the 
inversion  of the polyadenylation  signal and associated  term ination 
signals preventing processing of the RNA. The inverted region is also 
antisense (com plem entary) to the intact gene rem aining. Tosic et al. 
(1990) conclude that since the concentration of sense m yelin basic 
protein RNA in the nucleus is relatively high as is the concentration of 
nuclear antisense RNA and the concentration of myelin basic protein in 
the cytoplasm  is relatively low, post transcriptional regulation occurs 
through the formation of double stranded RNA molecules. The fate of the 
duplex RNA is uncertain and they do not assign the antisense RNA to 
any of the classes described above, but it is thought that it may 
eventually interfere with the processing or transport of mature RNA to 
the cytoplasm, that is, class 1 or class 2.
The antisense theory has also been implicated as a possible control 
m echanism  for the m aintenance of the HSV latent state (Stevens e t  
a l . ,1987; D eatly  et fl/.,1987). This group dem onstrated by in situ 
hybridization that during latency the only region of the genome that 
could be visualised corresponded to IE1. Later work has shown that 
there are at least two stable latency associated transcripts (LATs) and 
that part of these transcripts is com plem entary to IE1 (W echsler e t  
al., 1988). Zwaagstra et al. (1989, 1990) suggested that the primary LAT 
transcript is 8.3 Kb and is spliced into products including the stable 
LATS, which are possibly introns, and an unstable 6.3 Kb LAT which is 
possibly an exon involved in the maintenance of latency.
It has also been proposed that the introns them selves may control 
latency by an antisense m echanism  (Farrell et al., 1991). It has been
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dem onstra ted  that the stable LATs can inh ib it transactivation  by 
V m w llO  in transient transfection assays. The proposed m echanism by 
which this occurs is by the hybridization of the stable LAT to the 3’ end 
of IE1 RNA leading to the production of hybrid molecules (class 1 or 
class 2 antisense RNA). It has previously been shown that V m w llO  
which is encoded by IE1 is implicated in the de novo synthesis of HSV 
proteins (Cai & Schaffer, 1989). In co-transfection  experim ents with 
infectious DNA of an IE1 null mutant and a plasm id expressing wild- 
type V m w llO , titres of infectious virus were significantly  enhanced 
relative to transfection with mutant DNA alone, demonstrating a role for 
V m w llO  in de novo protein synthesis. These findings were consistent 
with the proposed role for V m w llO  in the reactivation from latency 
(Leib et al., 1989a), a process which is also thought to require de novo 
protein synthesis, and it is thought that by the hybrid arrest of IE1 RNA 
no V m w llO  is synthesized and HSV transcription is prevented.
The above theory is not supported by the isolation of an HSV-1 
deletion varian t (M acLean & Brown, 1981) which does not express 
detectable LATs during latency (Steiner et al., 1989). The variant is able 
to establish latency but is delayed with respect to reactivation compared 
to w ild-type virus.
l . lO .b .  Antisense  nucleic acids as control mechanisms.
W ith the developm ent of oligonucleotide technology, it has become 
possible to use antisense oligonucleotides to regulate gene expression. 
S m ith  et al. (1986) synthesized an oligo which was complem entary to 
the splice acceptor junction of HSV imm ediate-early polypeptides -4 and 
-5 and dem onstrated that this could negatively control viral growth. 
K aw am ura et al. (1991) used an oligo which was complementary to the
♦The locations of transcriptional termination signals in HSV-1 are not 
known, however termination of transcription by RNA polym erase II is 
ach ieved  by a com bination  of a p o ly ad e n y la tio n  signal and 
transcrip tional term ination regions in the m ouse B m a j globin gene
(Logan et al., 1987). The termination signals for that gene are located
600-1500 bp downstream  of the polyadenylation signal. This is in
agreem ent with results previously obtained by W hitelaw  and Proudfoot, 
(1986) who dem onstrated that transcriptional term ination  and 3' end
processing of mRNA are coupled^events for the mouse a 2  globin gene^_
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splice donor site of a Mareks disease virus (MDV) transform ed cell line 
to control its growth.
Sandri-G oldin et a l . ,1987 constructed  severa l ce ll lines which 
expressed d ifferent am ounts of antisense IE1 mRNA due to the cells 
harbouring variable copy num bers of a recom binant plasm id expressing 
a portion of the IE1 gene in an antisense m anner. D uring in vitro 
transfection assays and lytic HSV-1 infections, the quantity of V m w llO  
produced from these cell lines was lower than from wild-type, indicating 
that the antisense transcrip t was controlling V m w llO  production. The 
study also dem onstrated that the antisense transcript had to be present 
in a ten fold excess to obtain this effect.
1,11. AIMS OF PROJECT.
Initial characterization of the HSV-1 17+ deletion  varian t 1703 
demonstrated a 7 .5x l0^m ol. wt. deletion in Ul /IR l  which removed the 
3' end of UL55, all of UL56 and the 3' end of the IRl  copy of IE1 
(M acLean & B row n, 1 9 8 7 a).P o ly p ep tid e  an a ly sis  o f 1703 had 
demonstrated that Vmw63 was apparently not produced by 1703 under 
immediate-early conditions despite the fact that the deletion term inated 
about 500bp downstream of the 3' end of IE2.*
Vmw63
is an essen tia l im m ed ia te -ea rly  po lypep tide  (Sacks et a l ., 1985;
McCarthy et al., 1989) and the isolation of a variant which apparently did 
not express the protein  under im m ediate-early  conditions presented an 
anomaly for which M acLean & Brown gave three possible explanations: 
1* There was a sm all dele tion /po in t m utation in the prom oter, open 
reading frame or term ination signals of IE2, 2. Lack of the products of
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the deleted genes UL55 or UL56 led to incomplete transactivation of IE2 
under im m ediate-early conditions, or alternatively the deletion removed 
a downstream transactivator elem ent of IE2, 3. The reagents available 
for polypeptide analysis were not sensitive enough to detect low levels 
of Vmw63 produced by 1703.
The aim of this project was to find out why 1703 apparently failed to 
produce Vmw63 under im m ediate-early conditions. This was done by:
1. The dideoxynucleotide sequence analysis of IE2 .i.;and the end points 
of the deletion in 1703, 2. The detection of IE2 mRNA and protein, 3 .
The construction of a recom binant virus to dem onstrate that there was
no deletion or m utation in any other region of the 1703 genome which 
would result in the underproduction of Vmw63 under im m ediate-early
conditions, 4 . The in vivo characterization of 1703. The aim of this 
project was extended by a suggestion that Vmw63 production by 1703 
could be con tro lled  by the production  of an an tisense  transcrip t 
in itia ting  from  the IE1 p rom o ter (D r J. M cL auch lan  personal 
communication). The term ination signals of the I R l  copy of IE1 in 1703 
have been deleted thereby allow ing the possibility  that transcripts are 
not terminated until reaching the term ination signals of the next gene in 
the co rrect o rien ta tion , that is, U L51. T here w ere two ways of 
estab lish ing  th a t an tise n se  tra n sc r ip ts  w ere c o n tro llin g  Vmw63 
production: 1. The detection of the long antisense transcript, 2. The
insertion of a po lyadeny la tion  signal in the co rrect orien tation  to
term inate the long an tisense transcrip t before reaching  IE2 coding 
sequences. This study reports the characterization of an HSV-1 variant 
which controls Vmw63 production in infected cells under im m ediate- 
early conditions by the production of an antisense transcript.
♦genotype:  s u p E 44 h s d R l l  r e c A l  e n d A J  g y r A 46 thi  r e l A  1 l a c \  F1
[/?re>A£+ l a d  lacZ M13 TnlO (tetT)].
C H A PT ER  2
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M a t e r i a l s
g&lla
Unless otherwise stated, baby ham ster kidney 21 clone 13 (BHK21 
C l3) cells were used for this work (M acpherson and Stoker, 1962). 
Human foetal lung cells (HFL) were used when stated.
V i r u s
Herpes simplex virus type 1 Glasgow strain 17 syn+ (HSV-1 17+ ) was 
the w ild-type used throughout this study (Brown et al.y 1973). The 
deletion variant 1703 which is the subject of this pro ject has been 
partially characterized (MacLean and Brown, 1987a).
B a c t e r ia
The bacteria used for the growth of plasmids was E.coli strain XL-1* 
which were grown in L-broth or 2YT broth, am picillin being added 
(lO O pg/m l) where appropriate.
HSV-1 recom binant  plasmids
The fo llow ing recom binant plasm ids carry  restric tion  enzym e 
fragm ents of HSV-1 cloned into pAT153 (Twigg and Sherratt, 1980). 
They were supplied by Dr V.G. Preston.
Plasmid Restriction fragment Map Location
pGX51 S a i l  digested BamVLlb  1 1 4 5 1 7 -1 2 0 9 0 2
pGX55 S a i l  digested B a m U l z  143481-144677
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P lasm ids used  fo r c lon ing  1703 DNA fra g m e n ts
Commercially available pUC19 m pl8 and 19 and M13 mp8 (cut S m a l );
(Messing, 1983) were used throughout this study.
T issue  c u ltu re  m ed ia
BHK21 C13 cells were routinely cultured in Glasgow modified Eagles 
medium (Busby et al, 1964) supplied by Gibco-BRL. The medium was 
supplemented with 100 units/m l penicillin, 100|ig/m l streptom ycin, and 
0.002%  (w /v) phenol-red . To this was added 10% (v/v) tryptose 
phosphate broth and 10% newborn calf serum (ETC 10%). HFL cells were 
cultured in the same medium with the exception that the 10% newborn 
calf serum was replaced with 10% foetal calf serum (ETF 10%). Variants 
of the media were:
E m e t/5 C 2  : E ag les m edium  con ta in ing  o n e -fifth  the norm al
concentration of methionine and 2% newborn calf serum.
E m e t/5 F 2  : E agles m edium  con ta in ing  one fifth  the norm al
concentration of methionine and 2% foetal calf serum.
PIC  : Phosophate free Eagles medium containing 1% newborn calf serum. 
EMC 10% : Eagles medium containing 1.5% methyl cellulose and 10% 
newborn calf serum.
Stock solutions.
Phosphate buffered saline-A (PBS-A1: 170mM NaCl, 3.4mM KC1, ImM 
N a2H P 04 , 2mM KH2PO 4 ph7.2 (Dulbecco & Vogt, 1954)
Phosphate buffered saline (PBS1: PBS-A supplemented with 6.8mM CaCl 
and 4.9mM MgCl2-
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PB S/calf serum : PBS containing 5% newborn calf serum.
TBE : 90mM Tris base, 90mM Boric acid, 2.5 M EDTA pH8.3.
30% acrvlam ide: 29.25% (w/v) acrylamide, 0.75% (w/v) N -N ’-methylene 
b isac ry lam id e .
T ry p s in : 0.25% (w/v) Difco trypsin dissolved in Tris-saline (140mM NaCl, 
30mM KC1, 280mM N a 2 H P 0 4 , lm g/m l glucose, 0.0015% (w/v) phenol- 
red, 25m M  Tris. HC1 (pH 7.4), 100 unit/m l pen ic illin , lO O p g /m l
strep to m y c in .
V e r s e n e : 0.6 mM EDTA dissolved in PBS containing 0.002% (w/v) 
p h e n o l-re d .
T ry p s in -v e rse n e : One volume of trypsin plus four volumes of versene. 
Giem sa sta in : 1.5% suspension of Giemsa in glycerol heated at 56°C for 
1 . 5 - 2  hours and diluted with an equal volume of methanol.
L -b ro th : 170mM NaCl, 0.5% (w/v) yeast extract (Difco) 1% bactotryptone 
(Difco).
2 YT broth: 85mM NaCl, 1% (v/v) bactotryptone (Difco), 1% yeast extract. 
L-broth agar: L-broth containing 1.5 (w/v) agar (Difco).
Top agar: 1% (w/v) agar in water.
C h e m ic a ls
Most chemicals were supplied by BDH Chemicals UK or by the Sigma 
C hem ical C om pany and w ere of an a ly tica l g rade . A m m onium  
persulphate (APS) N ,N ,N \N ’-tetram ethylethylenediam ine (TEM ED) and 
colour developm ent reagent were supplied by B io-rad Laboratories, 
Boric acid was supplied by May and Baker, Nytran paper by Amersham, 
nitrocellulose by Schliecher and Schuell and unlabelled nucleotides by 
Pharm acia Ltd.
R a d i o c h e m i c a l s
Radiochemicals were obtained from Amersham International pic at the 
following specific activities:
5 ’ [<x-32p] dNTPs-3000 Ci/mmol 
[y_32p] dA TPq-5000 Ci/mmol 
[35 s] methionine > 1000 Ci/mmol 
[35s] dATP > 1000 Ci/mmol 
[32p] orthophosphate 3000 Ci/mmol 
[Me-3H] thymidine lm C i/m l
E n z v m e s
R estric tion  enzym es were obtained from  B ethseda Research 
Laboratories (BRL), New England Biolabs, or NBL enzymes Ltd. DNA 
polymerase 1, Klenow polymerase, T4 DNA ligase and T4 polynucleotide 
k inase  w ere supplied  by the B oehringer M annheim  C orporation. 
Lysozme and BSA were supplied by the Sigma Chemical Company.
Restr ic t ion  enzvme buffers
In general, the buffers used were as recommended by BRL or the 
Boehringer M annheim Corporation. These were supplied with enzymes 
as lOx stock solutions which were stored at -20°C. A buffer was made to 
digest HSV DNA with H p a  1 and is also suitable for X b a  1, Bglll ,  Hindll l  
and EcoKX digestions. The buffer consists of: 60mM Tris pH 7.4, 1M NaCl, 
60mM MgCl2, 0.01% (w/v) BSA.
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Chemicals used for the purification of DNA or RNA
P h e n o l : Phenol (BDH) was saturated before use by mixing 2:1 with 
phenol saturation buffer (lOmM Tris, HC1 pH 7.5, lOmM EDTA, lOOmM 
NaCl) and stored at either -20°C or 4°C for up to one month.
C h lo ro fo rm  : Chloroform was mixed 24:1 with isoamylalcohol to reduce 
foaming during extraction and to facilitate the separation of the organic 
and aqueous phases.
Phenol : Chloroform (1 :1 ) : This was a 1:1 mixture of saturated phenol 
and chloroform  isoamylalcohol (24:1).
A n i m a l s .
3 and 4 week old Balb/c mice were obtained from Bantin and 
K ingm an.
A n ti-n en t id e  serum .
Anti-peptide serum was supplied by Dr H Marsden and raised against 
the carboxy-terminus of Vmw63 (NATDIDMLI DLGLDLS).
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M e t h o d s
2.1 Growth of cells.
BHK21 C l3 cells were grown in 80oz roller bottles containing 100ml
ETC 10% at 37°C in a hum idified atm osphere of 95% air, 5% C 02-
C onfluent cells (approxim ately 3 x l0 ^ /ro lle r bottle) were harvested by 
w ashing the m onolayers twice with trypsin/versene, and the detached 
cells were resuspended in 20ml of ETC 10%. Cells from one roller bottle 
were sufficient to seed a further 10. For experiments cells were plated 
on 50mm or 30mm petri dishes or limbro trays at a density of 4x10^, 
2 x 106 or 2x10^ cells per plate respectively. HFL cells were grown in a 
sim ilar manner, except that ETF 10% was used and for routine passage 
800ml flasks were split 1 in 3.
2.2 Growth of  virus stocks.
Almost confluent BHK21 C13 cells in 80oz roller bottles were infected 
at a m ultiplicity of infection (moi) of 0.001 plaque forming units (pfu) 
per cell in ETC 10% at 31°C. The infection was allowed to proceed until 
the cytopathic effect (cpe) was complete (usually 3-4 days). The virus 
was then harvested by shaking the cells into the medium and pelleting 
by centrifugation at 2000 rpm for 10 m inutes at 4°C in a Beckman
benchtop cen trifuge. The cell pe lle t was resuspended in 5ml of 
supernatan t, son icated  in a bath son icato r (50W  at 4°C) until 
hom ogeneous and centrifuged as before. The supernatant was removed 
and stored on ice (supernatant 1). The pellet was resuspended in a
further 5ml of the original supernatant, sonicated and centrifuged as
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above to give supernatant 2. The cell pe lle t was discarded and
supernatants 1 and 2 combined to give cell associated virus stock.
The supernatant from the original 2000 rpm spin was centrifuged at 
12000 rpm for 2 hours at 4°C in a Sorval GSA rotor, and the virus 
con ta in ing  p e lle t resuspended  in 5-10m l of the supernatan t and
sonicated until hom ogeneous. This was term ed the supernatant virus 
stock.
Virus stocks were checked for sterility, titrated at 37°C and stored in 
lm l aliquots at -70°C.
2.3 Titration of  virus stocks.
Stocks to be titrated were serially diluted 10 fold in PBS/calf serum.
Aliquots of 0.1ml were added to BHK21 C13 cell monolayers which were
70% confluent from which the medium had been removed. Following 
incubation at 37°C for one hour, the plates were overlaid with 4ml EMC 
10% and incubated for 2 days at 37°C or 3 days at 31°C. Monolayers 
were fixed and stained with Giemsa at room tem perature for not less 
than one hour. After washing, plaques were counted using a dissection 
m icroscope.
2.4 Sterility checks on virus and cell stocks
Brain heart infusion agar (BHI) plates, and BHI plates containing 10% 
horse blood (BHI blood agar), were obtained from  the Cytology 
Department. Cell or virus stocks were checked for fungal contamination 
by streaking on BHI plates in duplicate. The plates were sealed with 
parafilm  and incubated at room tem perature for seven days. Similarly 
yeast or bacterial contamination was detected by streaking on BHI blood
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agar plates and incubating at 37°C for 7 days. If no contamination 
became apparent within that time the stocks were considered sterile.
2,5 Preparation of virion DNA.
This method is based on that described by W ilkie (1973) and Stow and 
W ilkie (1976). BHK21 C l3 cells in 80 oz roller bottles were infected and 
harvested as described previously (method 2.2). The cell supernatant 
was stored at 4°C. To extract cytoplasm ic virus the cell pellet was 
resuspended in RSB (lOmM KC1, 1.5mM MgCl2, 10mM Tris. HC1 pH 7.5 
containing 0.5 % [v/v] Nonidet P40) incubated on ice for ten minutes
and centrifuged at 2000 rpm in a Beckman benchtop centrifuge for 5 
minutes. The supernatant from this spin was added to the previous cell 
supernatant. The pellet was suspended in RSB/Nonidet P40, extracted as 
before, and the final supernatant added to the initial cell supernatant. 
The supernatant pool was centrifuged at 12000 rpm in a Sorval GSA 
rotor for 2 hours. The virus pellet was resuspended in 8ml NTE (lOmM 
Tris.HCL pH 7.5, lOmM NaCl, 1mM EDTA) by sonication and lysed by the 
addition of SDS and EDTA to a final concentration of 2% (v/v) and 0.8mM 
respectively. The released virus DNA was carefully extracted three times 
w ith an equal volum e of phenol and once w ith chloroform  and 
precipitated by the addition of 2 volumes of ethanol. The DNA was 
pe lle ted  by cen trifuga tion  at 2000 rpm  in a Beckm an benchtop 
centrifuge for 10 minutes, dried at 37°C for 1 hour, redissolved in water 
containing 50|ig/m l Rnase A and quantified by spectrophotometry.
1 0D unit260nm  = 50^ig/ml DNA.
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2.6 Transfection of virus DNA bv CaPO^ precip itation /D M SO  
b o o s t
To 50mm Petri dishes containing sem i-confluent BHK21 C l3 was 
added 400ml HEBS buffer pH 7.05 (130 mM NaCl, 1.6 mM Na2HPC>4, 5.5 
mM D-glucose, 21 mM HEPES) containing lOpg/ml calf thymus DNA at a 
5:10 molar ratio of plasmid:virus DNA and 110 mM CaCl2. Following 
incubation at 37°C for 40 minutes, the plates were overlaid with 4ml ETC 
10%, 4 hours later 1ml of HEBS containing 25% (v/v) dimethylsulphoxide 
(DMSO) was added, and the plates incubated at room temperature for 4 
minutes. The DMSO was removed and the plates were washed twice with 
ETC 10% and overlaid with EMC 10%.
2.7 Growth of plaques isolated from a transfection
EMC 10% was removed from the transfection plate and the monolayer 
was washed twice with PBS/calf serum. Separated plaques were picked 
using a 100ml Eppendorf pipette into linbro trays containing confluent 
BHK21 C l3 cells. The trays were then incubated at 37°C until cpe was 
com plete and the viral DNA was analysed by the method of Lonsdale 
(1979 ).
2,3 Preparation and isolation of 2-2.P labelled virion DNA
This method is a modification of that described by Lonsdale (1979). 
Monolayers of BHK21 C l3 cells were maintained in ETC 10% in linbro 
trays until confluent, and then infected with 50pl of virus from a plaque 
which had been isolated and grown from a transfection. After one hour 
at 37°C the medium was removed and the monolayer washed twice with 
PIC and overlaid with 450p.l PIC. After a further incubation at 37°C for 2 
hours, lp C i of 3 2 p _ orthophosphate was added and the incubation
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continued at 37°C for 48 hours. The cells were lysed by adding sodium 
dodecyl sulphate (SDS) to a final concentration of 2.5% (v/v) and 
incubating at 37°C for 5 minutes. The DNA was extracted once with an 
equal volume of phenol and precipitated by the addition of 2 volumes of 
ethanol. The DNA was dried at 37°C for 15-20 minutes (with the tubes in 
an inverted position) and redissolved in 150p.l of H2 O con ta in ing  
50pg/m l Rnase A. Usually 10% of each sample ( 15|al) was digested with 
the appropriate restriction enzym e and electrophoresed in an agarose 
gel (method 2.9) for 16-24 hours at 70-85 V. Gels were air dried and 
set up for autoradiography against Kodak X -O m at XS-1 film  and 
developed after 48 hours at room temperature.
2.9 Agarose gel e lectrophoresis
A garose gels [0 .5-1.5% (w /v)] were p repared  by boiling the 
appropriate quantity of agarose in 250ml of lxTBE until dissolved. Once 
cool, the solution was poured onto a glass plate (152cmx85cm) whose 
edges had been sealed with masking tape onto which had been placed a 
teflon coated well forming comb (26, 15 or 12 teeth). Once set, the gel 
was placed in a horizontal gel tank containing lxT B E . For non­
radioactive samples, the gel contained 0 .5pg/m l ethidium  bromide. For 
plasm id DNA, gels were electrophoresed at either 20-50V overnight or 
80-120V for 3-6 hours. For HSV DNA, gels were electrophoresed at 60- 
80V overnight. As a rule, to resolve DNA fragments of high molecular 
weight, low percentage agarose gels were used, while for low molecular 
weight fragm ents, higher percentage agarose gels were used.
56
2.10 Thym idine kinase assay.
The method used is a modification of that of Jamieson and Subak- 
Sharpe (1974). BHK21 C13 cells in 35mm petri dishes were infected at a 
moi of 20 pfu/cell. After adsorption at 37°C, cells were overlaid with 
2ml of ETC 10% and incubated for 6 hours at 37°C. Cells were washed 
tw ice with cold PBS, scraped into 1ml cold PBS and pelleted in a
microfuge for 2 minutes. The pellet was resuspended in 150jil ice cold 
lysis buffer (20mM Tris.HCl pH7.5,2mM MgCl2, 10mM NaCl, 0.5% (v/v) 
NP40, 6.5mM  2-m ercaptoethanol), m aintained on ice for 5 minutes, 
mixed briefly and placed on ice for a further 5 minutes. The samples 
were then centrifuged and the supernatant retained and stored at 
70°C. 5p l of extract was mixed with the reaction buffer in a total volume
of 50pl (Reaction buffer: 0.5M N a 2 P 0 4  pH6.0, 100 mM MgCl2, 2m M
dTTP, 100 mM ATP, 5p l aqueous [Me-^H] thym idine lm C i/m l). After 
incubation for 1 hour at 30°C, the reaction was stopped by the addition 
of EDTA and thymidine to a final concentration of 20mM and ImM, 
respectively . The sam ples were heated for 3 m inutes at 100°C and
placed  on ice for 3 m inutes. A fter cen trifugation , 40 |il of the
supernatant was spotted onto DE81 discs and washed three times (10 
m inutes each at 37°C) with 4mM ammonium formate pH6.0 containing 
IO jiM thym idine. After a further two washes with ethanol, the discs
were dried and radioactivity due to thymidine was determined using 
a scintillation counter.
2.11 Glvcerol stocks of bacteria
Bacterial stocks were prepared from 5ml shaking cultures grown
overnight in L-broth in the presence of the appropriate antibiotic at
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37°C. These stocks were stored at both -20°C and -70°C in 50% (v/v) 
g lycerol.
2.12 R estr iction  enzvme digestion
Viral and plasmid DNA was digested with the appropriate restriction 
enzymes (2.5 units/p g DNA), in the presence of lx  recommended buffer, 
in a final volume of 20-200pl and incubated at 37°C for 2-16 hours. The 
reaction was stopped by the addition of 20% restriction enzyme stop 
solution (RE stop- 5xTBE, 100 mM EDTA, 10% v/v Ficoll, 0.1% (w/v) 
brom ophenol blue) prior to electrphoresis (M aniatis et al> 1982), or by 
purifying the digested DNA once with chloroform , and precipitating in 
ethanol, washing with 70% ethanol, and vacuum drying prior to ligation 
(method 2.14), transfection (method 2.6) or end labelling (method 2.28).
2.13 Elution of DNA fragments from agarose gels
The DNA was digested with appropriate restriction enzymes and 
electrophoresed on agarose gels in the presence of 5pg /m l ethidium  
brom ide. The gel was v isualised  under long wave U.V. and the 
appropriate fragment cut out using a sharp scalpel. The isolated gel slice 
was placed in an electrophoresis chamber containing lxTBE. The DNA 
was electroeluted from the agarose gel onto the dialysis membrane of 
the electrophoresis cham ber (preboiled in lxTB E  for 10 m inutes) at 
200V  fo r 1 hour. The DNA was c o llec ted , ex trac ted  w ith 
phenolichloroform  (1:1) and precipitated at -20°C overnight with three 
volumes ethanol and 0.1 volume 3M sodium acetate. DNA was washed 
with 70% ethanol, vacuum dried and redissolved in water.
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2.14 Construction of recombinant p UC19 plasmids.
Plasm id vectors pUC19 and pUC18 were linearised with S m a l  and 
treated with calf intestinal phosphatase (both at concentrations of 5 
u n its /p g  of plasmid DNA). After incubation at 31°C for 1-3 hours, the 
DNA was extracted tw ice w ith phenolichloroform  (1:1), once with 
chloroform  and precip ita ted  with two volum es of e thanol in the 
presence of 0.1 volume 3M sodium acetate. The DNA pellet was washed 
with 70% ethanol, dried and resuspended in the appropriate amount of 
water to give 40ng/pl. A 3-4 molar excess of the purified HSV DNA
fragm ent relative to the phosphatase treated vector (40ng) was ligated
overnight at room tem perature in a 20 |il reaction containing 2 units of 
T4 ligase and lx  ligase buffer (10 mM Tris.HCl pH7.5, 10m M MgCl2, 10 
mM DTT, 1 mM ATP).
2.15 Transformation of bacterial cells with plasmid DNA.
E.coli strain XL-1 cells were made competent for transform ation with 
plasm id DNA by the method of Chung and M iller, (1988). 5 |il  of a 
glycerol stock of XL-1 cells was added to 10ml of L-broth and incubated 
with shaking at 37°C overnight. The cells were then diluted 1/100 in L- 
broth and incubated at 37°C with shaking until an OD600 of 0.3-0.6 was 
reached. The suspension was then pelleted at 2000 rpm for 10 minutes 
in a benchtop centrifuge and resuspended in a 1/10 of the original 
volume of ice cold transform ation and storage buffer (TSB: L-broth pH
6.1, 10% PEG Mw 3350, 5% DMSO, 20 mMMg+[10 mM MgCl2, 10 mM
M g S 0 4 ]).T h e  cells were then incubated on ice for 10 minutes. 5 |il of each
ligation  m ixture (m ethod 2.14) was added to lOOpl of com petent 
bacterial cells and incubated on ice for 10-30 minutes. 900pl of TSB 
containing 20mM glucose was then added and the cells were incubated
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at 37°C with shaking for 1 hour. IOOjj.1 of each sample was spread on L- 
broth agar p lates contain ing  100pg/m l am picillan  and incubated 
overnight at 37°C. Single bacterial colonies were picked from the plates 
and analysed, (method 2.16).
2.16 Small scale preparation of plasmid DNA bv alkaline lvsis
This method is essentially as described by Birnboim and Doly (1979). 
Colonies from an agar plate were inoculated into 5ml L-broth containing 
the appropriate antibiotic and shaken overnight at 37°C. 1.5ml of cells 
were added to an Eppendorf tube and pelleted by centrifugation in a 
Beckman microfuge for 30 seconds. The pellet was resuspended in lOOpl 
of solution 1: (50mM glucose, lOmM EDTA, 25mM Tris. HC1, pH8.0) 
containing 4mg/ml lysozyme, and incubated at room tem perature for 5 
m inutes, 200pl of solution 2: (0.2M NaOH, 1% SDS [w/v]) was added and 
incubation continued on ice for 5 minutes. 150p.l of ice cold solution 3 
(3M KAc, pH4.8) was added, and following incubation on ice for 5 
m inutes, the cell debris was pelleted by centrifugation in a Beckman 
m icrofuge for 5 minutes. DNA was extracted by mixing with an equal 
volume of phenolichloroform  (1:1), centrifuging for 2 minutes in a 
Beckman m icrofuge and rem oving the upper aqueous layer. This was 
added to 2 volum es of ethanol and the DNA precipitated  at room 
tem perature for 2 minutes, pelleted by centrifugation for 5 minutes in a 
Beckm an m icrofuge, washed in 70% ethanol, dried in a vacuum 
desiccator and redissolved in 50 |il water containing 50pg/m l RNase A. 
Usually 10(il of this was used per restriction digest.
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2,17 Large scale preparation of plasmid DNA bv alkaline lvsis
This method is essentially that described by Birnboim  and Doly 
(1979), and modified by Maniatis et al.f (1982). Single colonies from an 
agar/L-broth or 25pl from a bacterial glycerol stock were inoculated 
into 5ml of L-broth containing the appropriate antibiotic and shaken at 
37°C overn ight. The culture was transferred  in to  500m l L-broth 
containing the appropriate antibiotic in a 2 litre flask and shaken at 37°C 
for 12-24 hours. The bacteria were pelleted by centrifugation at 8000 
rpm for 5 minutes in a Sorval GSA rotor, the pellet resuspended in 7ml 
solution 1 (method 2.16) containing 4mg/ml lysozyme and incubated at 
room  tem perature for 10 minutes. Freshly made solution 2 (14ml) was 
added and incubation continued for a further 10 minutes on ice. Ice cold 
solution 3 (10.5m l) was added, incubation continued for a further 10 
minutes on ice and the bacterial cell debris pelleted by centrifugation at 
12000 rpm for 30 minutes in a Sorval SS34 rotor. DNA was extracted 
twice with an equal volume of phenolichloroform (1:1) and once with an 
equal volum e of chloroform . The DNA was p recip ita ted  at room 
tem perature for 15 minutes by the addition of 2 volumes of ethanol, 
centrifuged at 12000 rpm for 30 minutes in a Sorval SS34 rotor at RT, 
washed in 70% ethanol, pelleted as before, and dried in a vacuum 
desiccator. The DNA pellet was dissolved in water containing 50pg /m l 
RNase A. The DNA was quantitfied by running a small sample on an 
agarose gel containing 0 .5 |ig /m l ethidium  bromide and com paring its 
intensity against that of a known standard under UV light.
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2*18 Synthesis and purification of a synthetic oligonucleotide.
A synthetic oligonucleotide was synthesized on a Biosearch 8600 DNA 
synthesizer. The DNA was eluted from the column by resuspending the 
beads in 1ml of ammonia and incubating at 55°C for 5 hours. The 
am m onia was rem oved by lyophilisation in the ‘speedivac* vacuum 
desiccator, and the dried sample purified by denaturing polyacrylamide 
gel electrophoresis. 75ml of 16% sequencing gel mix (16% acrylamide, 
containing 1 part in 30 n-n’-methylene bisacrylamide, and 8.3M urea in 
lxTB E  ), polym erised with 400pl of 10% ammonium persulphate and 
40 jil TEMED, was poured between two 20x22cm glass plates separated 
by 1.5mm spacers. W ells of approximately 1cm in width were formed 
using an 8-tooth teflon comb. The DNA samples were resuspended in 
5 0 | i l  of w ater by vortexing, then m icrofuged for 3 m inutes. The 
supernatant was transferred to 50 |il of sample buffer (28 |il lOxTBE, 
1 1 7 |i l  H2 O, 800pl deionised form am ide), boiled for 10 minutes then 
quenched on ice and loaded immediately. 2pl of formamide dye mix was 
loaded in a separate well to act as a molecular weight marker. The gels 
were electrophoresed slowly, at 3.5-4mA overnight in TBE.
To visualise the DNA the gel was removed, wrapped in cling film and 
viewed against a white chromatographic plate by angled long wave light. 
If the synthesis had been successful then a predom inant, strong band 
with possibly a few minor lower molecular weight bands was seen. The 
top band was cut out with a scalpel, mashed with a glass rod, and 
incubated at 42°C for 16 hours in 1ml elution buffer (0.5m ammonium 
acetate, Im M  EDTA, 0.5% SDS). This was filtered through glass wool to 
rem ove the acry lam ide, phenolich loroform  (1:1) ex tracted , ethanol 
precipitated, washed in 70% ethanol, dried and dissolved in water. To
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quantify the DNA, the OD2 6 O w as read. The conversion factor for
synthetic oligonucleotides is taken as 1 OD unit = 20pg/m l.
2.19 3 2 P-labelling o f  a synthetic  o ligonucleotide.
100-200ng of oligonucleotide was labelled in a buffer containing 
60mM Tris pH7.5,10mM MgCl2, lOmM DTT, 50pCi y32pdATP, and 1 unit 
T4 polynucleotide kinase made up to a final volume of 9 .5 |il. The 
m ixture was then incubated at 37°C for 30 m inutes after which an 
additional unit of T4 polynucleotide kinase was added and the mixture 
incubated at 37°C for a further 30 minutes. The labelled probe was then 
denatured by boiling for 10 minutes and used for Southern blotting 
(m ethod 2.21).
2.20 3 2 p .la b e ll in g  o f  non-svnthetic  DNA.
Purified virion, plasmid or infected cell DNA was 32p_iabelled using 
the method of random  priming. 10-100ng of DNA was boiled for 10 
m inutes before  labe lling  in a buffer w hich was m ade from  3
com ponen ts:
5x reaction mix for random priming.
Reaction mix was made up from solutions A, B and C at a ratio of 10: 25: 
15 respectively:
Solution A : 1ml solution q: 1.25M Tris.HCl pH7.8, 0.125M MgCl2- 
18pl 2-m ercaptoethanol 
5pl lOOmM dGTP 
5pl lOOmM dATP 
5pl lOOmM dTTP.
Solution B : 2M HEPES pH6.6.
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Solution C : Hexadeoxyribonucleotide (Pharm acia) evenly resuspended in 
TE at 90OD units/pl.
5 p l of this buffer is added to the boiled DNA together with lp l  of 1% 
BSA, 20|tiCi a 3 2 p  dCTP, lunit of Klenow polymerase and made up to 25pl 
with water. The mixture was incubated at room tem perature overnight, 
or at 37°C for 30 minutes, boiled and used for Southern blotting (method 
2 .21).
2,21 Southern blotting and hybridization to 3 2 P -labelled  DNA
This method is based on one described by Sambrook et al.y (1989). 
Purified virus, plasm id or infected cell DNA was digested with the 
appropriate restriction  enzyme and run on an agarose gel for 16-24 
hours at 60-80 V (method 2.9). The gel was visualised under short wave 
UV to confirm  digestion of the samples and to partially fragment large 
DNA molecules to aid their transfer. The gel was placed in 1 litre of gel 
soak 1: (200mM NaOH, 600mM NaCl) for 1 hour and transfered to 1 litre 
of gel soak 2: (1H Tris. HC1 pH8.0, 0.59M NaCl) for 1 hour. The gel was 
then transferred to 1 litre of 20xSSC (3MNaCl, 0.3M trisodium citrate) 
for 1 hour and blotted onto a nytran membrane (Amersham) in the 
following manner: one or two pieces of membrane, cut to the size of the 
gel, w as p laced  to g e th er w ith 3-6 p ieces of 3mm W hatm an 
chromatography paper, also cut down to gel size, in 20xSSC and allowed 
to soak. If a single blot only was required  two pieces of dry 
chrom atography paper were placed upon a stack of correctly sized “Hi- 
D ri” towels followed by 3 pieces of soaked chrom atography paper, the 
soaked nytran membrane, and the gel; ensuring that no bubbles were 
left between the gel and the membrane. A glass plate was then placed 
on top of the gel followed by a weight. This set-up acted as a wick to
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draw the SSC through the gel and onto the nytran membrane. If desired, 
the gel can be double blotted by placing another piece of soaked 
m em brane onto the gel instead of the glass plate and building up 
another wick on this side of the gel. The glass plate then goes on top of 
the final stack of “Hi-Dri” towels followed by the weight. After 12-24 
hours, the DNA is fixed to the membrane using a UV crosslinker 
(Stratagene) set at 12000 |ijou les/cm 2.
The nytran was hybridized to the 32p_ia5eu ed probe in hybridization 
buffer (7% SDS, 0,5M Na2HPC>4 pH7.4) at 42-65°C, 65°C for non-synthetic 
DNA, and 42-65°C for synthetic DNA depending on the size and G+C 
content of the oligonucleotide. Hybridization was allowed to proceed 
overnight after which the filter was washed twice with 2xSSC containing 
0.1% SDS for 1/2 hour each time. The filter was then sealed into another 
hybridization bag and set up for autoradiography against Kodak XS-1 
film  e ither w ithout a D upont im age in tensify ing  screen at room
tem perature or with one at -70°C.
2.22 Construction of M13 recombinant plasmids
The double stranded replicative form of M l3 mp8 was commercially 
obtained from  Am ersham  cut with the restriction enzyme Sma\ .  The 
fragm ents were purified once with phenol:chloroform  (1:1), ethanol 
precipitated , washed in 70% ethanol, dried and redissolved in water.
40ng of M13 vector DNA, 120-160ng of the DNA insert, 2 units of T4 
DNA ligase in ligase buffer (method 2.14) were mixed and incubated for 
24 hours at room temperature. (Sanger et al., 1977).
• 1 0  m i n s ,  1 3 0 0 0 r p m ,  r o o m  t e m p e r a t u r e  o n  a B e c k m a n  benchtop 
c e n t r i f u g e .
65
2.23 Transfection of bacterial cells with M13
E.coli strain XL-1 was grown in 2xYT broth to an OD of 0.3 to 0.6 and 
made com petent as described (m ethod 2.15). 5 -20pl of ligation mix was 
added to lOOpl of com petent cells and incubated on ice for 10-30
minutes. 3ml of m elted top agar at 42°C containing 25 p i  of 2.5% 
isopropyl-pD -thiogalactoside (IPTG) in water and 25pl of 2% 5-chloro-4- 
brom o-3-indolyl-B-D -galactoside (BCIG or x-gal) in dim ethylform am ide 
was added to the sam ple and the m ixture poured onto 90mm L-broth 
agar plates and incubated at 37°C overnight.
2.24 Preparation o f  tem plate DNA.
A culture of XL-1 cells was grown to saturation in 2YT broth. 
Colourless plaques from the M13 transform ation were picked into 1.5ml 
of saturated XL-1 cells diluted 1/100 in 2YT broth and grown with 
vigorous shaking at 37°C for 4.5-6 hours. Samples were then transferred
to 1.5ml Sarsedt tubes and pelleted for 5 minutes (MSE microfuge). The
supernatant was then transferred  to another tube and the procedure
repeated  ensu ring  tha t the su p ern a tan t was free  from  bac teria l 
contamination. To precipitate the M l3, 150pl of a solution of 20% PEG, 
2.5M NaCl was added, the sample vortexed and left at room  temperature 
for 10 minutes. The M13 was pelleted by centrifugation* and repelleted 
to get rid of residual PEG. The M l3 was then resuspended in water by 
vigorous vortexing, lysed and purified  by the addition of an equal 
volume of saturated phenol, and precipitated in the presence of 100% 
ethanol. The purified M13 DNA was then washed with 70% ethanol, 
dried in a vacuum desiccator and dissolved in 20pl of water. 5p l of this 
was used for each sequencing reaction.
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2.25 Sequence analysis of recombinant M13 clones.
5pl of single stranded DNA tem plate (method 2.24) was annealed to 
3ng of com m ercial oligonucleotide prim er (Bio-rad) in 40mM Tris.HCl 
pH7.5, 25mM M gCl2, 50mM NaCl in a total volume of lOpl at 55-60°C 
for 10 minutes in a 1.5ml sarsted tube and left at room temperature for 
15-30 m inutes. The tem plates were then labelled and extended in a 
buffer containing 0.75pM  dCTP, 0.75pM dGTP, 0.75pM dTTP, lOmM DTT, 
lO pCi 3 5 s  dATP, and 2 units of klenow polymerase in a total volume of 
6 0 pi. This was added to each prim er annealed tem plate (6p l in each 
sam ple) and labelling  was carried  out at room  tem perature for 5 
minutes. The extended tem plates were then term inated by the addition 
of ddNTP termination mix (figure 2.1). The plate contents were mixed by 
centrifugation  in a Beckm an benchtop centrifuge and the reactions 
carried out at 37°C for 10-30 minutes. The reaction was stopped by the 
addition of 2 p l of form am ide dye mix to each well (95% formamide, 
20mM EDTA, 0.5% (w/v) bromophenol blue, 0.5% (w/v) xylene cyanol). 
The samples were then boiled for 1 minute and electrophoresed through 
a polyacrylam ide gel (method 2.26).
2.26 E lectrophoresis  and autoradiography o f  sequencing gels.
Electrophoresis was carried out through vertical gels 42x34x0.04 cm in 
size. Spacers and gel combs were obtained from Gibco-BRL. Both plates 
were treated  with repelcote enabling the gel to be transferred  to 
W hatm an 3m m  chrom atography  paper to be d ried  dow n after 
e lectrophoresis under vacuum. Dried gels were then exposed to XS-1 
film (35x43 cm) and developed using an X-omat processor.
Figure 2.1
a. The concentration of nucleotides used to make the termination mixes.
b. 2 .5pl of each termination mix is added to the correct well, that is; 
2 .5jal of termination mix A is added to A1-A10, 2.5pl of G to G1-G10, 
and so on. To this is added 3pl of each extended template, that is; 3pl of 
sample 1 to each of wells 1A-1T, 3pl of sample 2 to 2A-2T etc.
a.
Component Termination mix (ul)
dNTPs (10mM) A C G T
dTTp 12.5 12.5 12.5 1.25
dCTP 12.5 1.25 12.5 12.5
dGTP 12.5 12.5 1.25 12.5
dATP 1.25 12.5 12.5 12.5
ddNTPs (5mM) A c G T
ddTTP - - - 50
ddCTP - 10 - -
ddGTP - - 15 -
ddATP 30 - - -
H£> 431.5 451.25 446.25 411.25
b. 1 2 3 etc . 10
A
C
G
T
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2.27 The formation of gradient sequencing gels.
Electrophoresis was carried out through TBE gradient gels (Biggin et al, 
1983). In this system  a buffer gradient is produced in the gel with 
0.5xTBE in the top and 5xTBE in the bottom of the gel. This was achieved 
using two acrylam ide gel m ixes. The top mix was of 0.5xTBE, 6% 
acrylamide and 9M urea. The bottom mix was composed of 5xTBE, 6% 
acrylam ide, 9M urea, 5% sucrose (w/v) and 0.1% brom ophenol blue 
(w/v) to v isualise  the gradient. W hen preparing a 42x33x0.04 gel,
ammonium persulphate and TEMED were added to both the top (0.016% 
and 0.16% respectively) and bottom (0.02% and 0.2% respectively) gel 
mixes. 45ml of top mix was drawn into a 50ml syringe followed by 15ml 
of bottom  mix. A few bubbles were passed through to allow some 
mixing. The syringe contents were slowly expelled between plates to the 
bottom. The gel comb was inserted into the gel plain side down and the 
gel rested  in a near horizontal position  until polym erisation was
complete. The tape was removed from the bottom of the gel, and the
plates set up with lxTB E  in the gel kit. After removing the comb, the
space was filled with lxTBE, the comb was reversed to form wells and
the boiled DNA samples loaded. The gel was run at a constant speed of 
70W for 2 hours.
2.28 Filling in 5 f overhangs with klenow polvmerase.
Restriction enzyme digested DNA containing 5' single strand extensions 
was extracted once with phenol: choroform  (1:1), ethanol precipitated,
washed in 70% ethanol, dried and redissolved in water at l |ig /1 0 |i l .  l|xg
of DNA was incubated in the presence of lxN T buffer (50mM Tris. HC1
pH7.8, 5mM M gCl2, 10mM 2-m ercaptoethanol, lOpg/ml BSA) containing 
0.2mM of the cold nucleotide triphosphates required to fill the overhang,
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and 2 units of klenow polymerase at 37°C for 1 hour. The reaction was 
stopped by extraction with phenol:chloroform  (1:1). If labelled DNA was 
required, one of the cold nucleotide triphosphates was replaced by 20pCi 
of the corresponding a - 3 2 P labelled nucleotide. The labelled DNA was 
purified by agarose gel electrophoresis (methods 2.9 and 2.13).
2.29 Preparation of cytoplasmic and nuclear RNA.
Immediate early RNA was prepared as follows: BHK21 C13 monolayers 
were m aintained in ETC10% until confluent and treated with 100(rg/ml 
cyclohexim ide in ETC 10% both 15 m inutes prior to and continually 
throughout infection. Roller bottles were infected with 20 pfu/cell of 
virus, and allowed to adsorb at 37°C for 1 hour, The cells were then 
washed tw ice w ith ETC 10%/ cyclohexim ide and m aintained in that 
media for a further 7 hours.
Early and late RNA was made in BHK21 C l3 cells again in roller 
bottles. In both cases, 10 pfu/cell of virus was adsorbed at 37°C for 1 
hour. Early RNA was harvested 7 hours post-infection and late RNA was 
harvested 16 hours post-infection.
2.30 Purification and harvesting cytoplasm ic and nuclear RNA,
Im m ediate-early, early and late cytoplasmic and nuclear RNA were 
prepared from roller bottles by a modification of a method by Kumar 
and L indberg, (1972). Follow ing rem oval of the medium, cells were 
washed with 30ml of cold PBS and harvested into 10ml of cold PBS. Cells 
were recovered by centrifugation in the cold at 2000 rpm for 2 minutes. 
The pe lle t was then w ashed with a fu rther 10ml cold PBS and
centrifugation was repeated. Cells were carefully resuspended in 1.5ml
of cold isotonic lysis buffer (ILB-150mM  NaCl, 1.5mM MgCl2, lOmM
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Tris.HCl pH 7.8, 0.65% (v/v) NP40), left on ice for a further 5 minutes 
and cen trifuged at 3000 rpm  for 10 m inutes to pellet the nuclei. 
Following the addition of an equal volume of phenol extraction buffer 
(PEB-7.0M urea, 350mM NaCl, lOmM EDTA, lOmM Tris.HCl pH 7.9, 1% 
(w/v) SDS) to the cytoplasmic fraction and the addition of 3ml PEB to the 
nuclear frac tio n , both  frac tions w ere ex tracted  three tim es with 
phenol .chloroform  (1:1) and once with chloroform. Both RNA fractions 
were p recip itated  by the addition of 3 volumes of ethanol and left 
overnight at -20°C. RNA was recovered by centrifugation at 3000rpm for 
15 m inutes, dissolved in 200pl of water and re-ethanol precipitated by 
the addition of 20p l 5M N H 4A c, 700p l ethanol. The RNA was then 
pelleted, dried and dissolved in 30pl of water. The concentration was 
then determ ined by spectrophotom etry.
1 OD unit260= 40pg RNA/ml.
2.31 SI nuclease mapping.
This method is an adaptation of that used by W hitton et al, (1983). 
>300 counts per second of an end labelled probe (method 2.28) was 
added to 15pg of RNA (method 2.30) and vacuum dried. The samples 
were then resuspended  in 2 0 p l of hybridization buffer [90% (v/v) 
deionised form am ide, 0.4M  NaCl, 40mM PIPES, Im M  EDTA] and 
denatured by boiling for 3 minutes, quickly transferring to a water bath 
at 57°C and incubating for 16 hours to allow the formation of DNA/RNA 
hybrids. Prior to nuclease SI digestion, the samples were quenched on 
ice. 200pl o f a solution containing 0.25mM  NaCl, 30mM NaAc pH4.5, 
ImM Z n S 0 4  and 150 units of the enzyme SI nuclease was added, and SI 
nuclease digestion of regions of single stranded DNA and RNA was 
carried out at 30°C for 2 hours. The RNA/DNA duplexes were then
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purified once with phenol: chloroform  (1:1) and once with chloroform, 
precipitated in the presence of carrier tRNA and ethanol, washed with 
70% ethanol, vacuum  dried and resuspended in 5jxl of sequencing dye 
mix (m ethod 2 .25), denatured  and e lectrophoresed  through a top 
sequencing gel (method 2.26) until the xylene cyanol dye mix was about 
half way down the gel. The gel was dried in the same maner as a 
sequencing gel and exposed to XS-1 Kodak film.
2.32 Purification o f  im m ediate-earlv . early and late 
p o l y p e p t id e s .
Im m edia te-early  po lypep tides w ere prepared  in the following 
manner: Confluent HFL or BHK21 C13 were incubated in Emet/5F2 or
E m et/5C 2  (depending on which cell line was used) containing 100|ig/m l 
cyclohexim ide for 15 m inutes at 38.5°C. 50 pfu/cell of virus was 
adsorbed onto the cells for 1 hour at 38.5°C, then the monolayer was 
washed tw ice w ith the appropriate m edium  containing cycloheximide 
and m aintained in the same medium for a further 5 hours. 15 minutes 
prior to the end of the 5 hours, the m edia was replaced with the
appropriate m edia containing 2.5 p.g/ml actinom ycin D and maintained
at 38.5°C until the 5 hour time point was reached. The media was then 
removed and the m onolayer washed at 37°C 4 times, 1 minute each
wash with PBS containing 2 .5 |ig /m l actinom ycin D which had been 
prewarmed to 37°C. The monolayer was then incubated at 38.5°C in the 
presence of PBS containing 50jiCi/ml 35 s  methionine for 2 hours. Then 
the m onolayer was washed tw ice with PBS and harvested into 200- 
300p.l of boiling mix [1ml stacking gel buffer (method 2.33),lm l glycerol, 
0.5ml 6-m ercaptoethanol, 20p.l bromophenol blue, 0.8ml 25% SDS- the 
working solution is a 1/3 dilution of this].
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Early polypeptides were made in BHK21 C l3 cells. Confluent cells 
which have been grown in ETC 10% were adsorbed with 20pfu/cell virus 
and incubated at 37°C for 1 hour. The monolayer was washed twice with 
E m et/5C 2  and incubated in this medium for 1 hour at 37°C. The medium 
was then replaced with the same medium containing lOpCi/m l 35 s 
methionine. After a further 5 hours at 37°C, the monolayer was washed 
twice with PBS and harvested into 200-300pl of boiling mix.
Late polypeptides were made in BHK21 C13 cells. 20pfu/cell of virus 
was adsorbed onto the monolayer for 1 hour at 37°C in Emet/5C2. Next, 
the medium was replaced with the same medium containing lO pC i/m l 
3 ^ s  m ethionine and incubated for a further 12 hours at 37°C. The 
monolayer was then washed tw ice with PBS and harvested into 200- 
300pl of boiling mix.
2.33 Analysis o f  polypeptides bv SDS-PAGE.
This is the method of Marsden et aly (1978). Slab gels were cast 
vertically in a sandwich consisting of two glass plates separated by 1mm 
thick perspex spacers and sealed with teflon tape. Single concentration 
gels containing 7.5% acrylam ide cross-linked with 2.5% N,N*-methylene 
bisacrylamide in resolving gel buffer (375mM Tris.HCl pH8.9, 0.1% [w/v] 
SDS) and polym erised with ammonium persulphate (0.006% [w/v]) and 
0.004% TEMED were poured between the two glass plates and overlaid 
with b u tan -2 -o l in o rder to ensu re  a sm ooth su rface  after 
polym erisation. P rior to addition of stacking gel, the butan-2-ol was 
washed o ff w ith deion ised  w ater. The stacking gel contained 5% 
acrylam ide (c ro ss-lin k ed  w ith the sam e ra tio  of N ,N ’-m ethylene 
bisacrylamide used in the resolving gel) in stacking gel buffer (0.1 ImM 
Tris.HCl pH 6.7, 0.1% [w/v] SDS), and was polymerised with ammonium
72
persulphate and TEMED as above. After the stacking gel was poured, a 
teflon coated com b was inserted  to form  the wells. Samples were 
prepared for analysis by boiling for 5 minutes and loading directly onto 
the gels which were electrophoresed in running gel buffer (52mM Tris 
base, 53mM glycine, 0.1% [w/v] SDS) at either 60mA for 3-4 hours or 
10-15mA for 16 hours (M arsden et a l , 1976, 1978). Follow ing
electrophoresis, the gels were fixed or stained for 1 hour in a solution of 
methanol: acetic acid: w ater 53:7:50, in the presence or absence of 
Coomassie brilliant blue, and destained for 3x30 minutes in methanol: 
acetic acid: w ater 5:7:88. The gels were then dried under vacuum and 
exposed for autoradiography at room  tem perature.
2,34 Analysis o f  proteins bv W estern blotting.
The W estern blotting technique is that used by Towbin et al ., (1979) 
with several m odifications. Cells were harvested into boiling mix at a 
concentration of lO ^cells/m l (method 2.32). Samples were boiled for 5 
m inutes and loaded  onto  a 7.5%  SDS- po lyacry lam ide  gel at 
approxim ately 10^ cell equivalents per well. Following electrophoretic 
separation at 10mA overn igh t, p ro teins were then transferred  to 
nitrocellulose using a Bio-rad transblot apparatus. Three foam pads and 
two sheets of W atman No 182 filter paper were presoaked in transfer 
buffer (192mM  glycine, 25mM Tris.HCl pH 8.3, 20% methanol) along 
with the nitrocellulose sheets to be used for the transfer. The gel was 
layered down on one sheet of the filter paper on top of two of the 
presoaked foam  pads and then covered w ith n itrocellu lose . This 
assemblage was rolled  with a glass rod to exclude air bubbles. The 
nitrocellulose was then covered with the other sheet of filter paper and 
a further foam  pad and the plastic folder was closed tightly over the
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sandwich. The sandwich was placed in the transfer tank with the gel 
towards the cathode and the nitrocellulose towards the anode. Proteins 
were transferred onto the nitrocellu lose electrophoretically  in transfer 
buffer at 250mA for a minimum of 3 hours.
Following electrophoretic transfer, nitrocellulose was removed from 
the sandwich and incubated for 2x30 minutes with shaking at 30°C in 
blocking buffer (20mM Tris.HCl, 500mM NaCl pH 7.5, 3% gelatin). Sheets 
were then washed 2x5 minutes in wash buffer (TBS: 20mM Tris, 500mM 
NaCl ph 7.5, 0.5% Tween 20). Antibody were made up to the desired 
concentrations in wash buffer containing 1% BSA and 0.01% sodium 
azide and added to the nitrocellulose in plastic dishes and incubated 
overnight at room  tem perature with shaking. A ntisera was removed 
with two washes in wash buffer. Bound antibody was visualised using 
the enzym e horseradish  peroxidase. Goat anti-rabbit conjugated horse 
radish peroxidase was diluted 1/1000 in wash buffer containing 1% 
gelatin and incubated with the nitrocellulose filter for 1 hour at room 
temperature with shaking. The membrane was washed twice with wash 
buffer and tw ice with wash buffer w ithout Tween, prior to colour 
reaction. The colour development solution was prepared from solution A 
and solution B. Solution A consists of 60mg HRP colour development 
reagent in 20ml ice cold high grade methanol. This should be protected 
from light and made fresh daily. Solution B was made immediately prior 
to use by adding 60pl of ice cold hydrogen peroxide (H2 O 2 ) to 100ml 
TBS at room temperature. Solution A and B are then mixed and added to 
the n itrocellu lose m em brane. The m em brane should not be in colour 
development solution for longer than 40 minutes. After developing, the 
colour developm ent solution was rem oved by washing the membrane 
with water.
7 4
2.35 Particle  counts.
5(0,1 sodium silicon tungstate, 5 |il of a known concentration of laytex 
beads and 5 |il of virus sample were mixed. 2-3 drops of the mixture 
were added to a support grid, left for 5 minutes and the excess liquid 
drained with blotting paper. Particles and laytex bead were visualised
by electron m icroscopy. C orresponding fields of vision were then 
counted. By comparing the number of particles to the number of laytex
beads, w hich are of a know n concentration, the num ber of virus
particles/m l can be estim ated.
2.36 V irus growth properties.
One step growth experiments were carried out essentially as described 
by D argan & Subak-Sharpe, (1985). C onfluent BHK21 C13 cells 
monolayers in 35mm petri dishes were infected at a moi of 5 pfu/cell
and virus adsorbed at 37°C for 1 hour. Following two washes with
PBS/calf serum, the cells were overlaid with 2mls ETC10% and incubated 
at 37°C. Samples were harvested at 0, 2, 4, 6, 8, 10, 12 and 24 hours post 
infection. V irus was released  by u ltrasonic disruption and titrated
(m ethod 2 .3) and the titre  expressed  as p fu /10^ cells. (This is 
equivalent to pfu/m l since 2x10^ cells were harvested into 2mls of
medium). Long term  virus growth experim ents involved infecting cells 
at a multiplicity of 0.001 pfu/cell. Virus was absorbed for 1 hour at 37°C. 
Following two washes with PBS/calf serum, the cells were overlaid with 
2ml ETC10% and incubated at 37°C. Samples were harvested at 0, 6, 12, 
24, 36, 48 and 72 hours post infection and treated as for one step 
growth experim ent.
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2.37 Procedure for LD50 in vivo v iru lence experim ents.
Three week old m ale Balb/C  mice (Bantin and Kingman) were
anaesthetized with ether and inoculated with 25pl of the appropriate 
virus, which had been diluted in PBS/calf serum, into the central region
of the left cerebral hemisphere. Groups of 4 mice were inoculated with a
single dilution of each virus stock (between 10^ and 10^ pfu/anim al). 
The virus stocks were retitrated  on BHK21 C l 3 cells on the day of 
inoculation to determ ine the precise quantity of virus inoculated. Mice 
were observed daily for 14 days post inoculation and their clinical states 
recorded. The 50% lethal dose LD50 was then calculated.
2.38 Procedure for in vivo latency studies.
Four week old m ale Balb/C  m ice (Bantin and Kingman) were
inoculated into the right rear footpad as described previously (Clements 
and Subak-Sharpe, 1983,1988). At the time of inoculation the virus was 
titrated on BHK21 C l3 cells to quantify the precise dose administered. A 
series of 10-fold dilutions of the virus were made up and inoculated into
the right rear footpad and mice were exam ined daily and scored for
clinical sym ptom s. M ice surviving 6 weeks were exam ined for the 
presence of latent virus. The mice were killed, dissected, and the two 
lower thoracic , six lum bar and the upper two sacral ganglia were 
removed from  the inocu lated  side, placed in culture medium and
screened for the re lease  of in fec tious virus every two days by
transferring the cu ltu re  m edium  to control BHK21 C13 cells. The 
inoculated BHK21 C l 3 cells were incubated at 37°C for 2 days before 
examining for the presence of virus plaques or cytopathic effect and
were then stained.
CHAPTER 3
RESULTS.
3.1. INITIAL CHARACTERIZATION OF 1703.
1703 was partially characterized after isolation (MacLean & Brown, 
1987a). A brief sum m ary o f this analysis is presented below (sections 
3.1.1 and 3.1.2).
3.1.1. The DNA profile o f  1703.
1703 DNA was labelled in vivo and prepared and analysed by the 
method of L onsdale, (1979). F igure 3.1 shows H p a  1 and B a m  H I  
restriction enzyme maps of the prototype orientation of HSV-1 17+ DNA. 
A Hpa  1 restriction enzyme analysis of 1703 DNA compared to 17+ DNA 
gave the follow ing inform ation (figure 3.2). Two new bands are present 
in the 1703 track, one (0.25M ) of 11x10^ mol. wt. running with b and 
one (0.5M) of approxim ately 1.7x10^ mol. wt. running below s . H p a lv  is
absent. This indicates that H p a  lm  has a 1.8x10^ mol. wt. deletion
located w ithin I R l  sequences which generates a novel 0.5M band of 
1 .7x10^ mol. wt. (designated m '), whereas H p a  lm  generated from T R l 
is unaltered and m igrates norm ally. Thus jo in t fragments containing m, 
usually 0.5M , w ill now consist of undeleted 0.25M  copies, a and d. a 
would run as the novel 0.25M  l lx lO 6 mol. wt. band comigrating with b , 
while the d'  band would run at about 7.2x10^ mol. wt. comigrating with 
g/h  and is therefore not detected. As H p a  l v  is absent and H p a  lm  is  
deleted, the H p a  l r  fragm ent is also expected to be absent. The 2M q!r
band is reduced in com parison to the 1703 2M  o / p  band and the
Figure 3.1 H p a \  and BamWX maps of HSV-1.
Hp a  1 and B a m H l  restriction enzyme maps of HSV-1 17+ DNA (Wilkie, 
1973; D av ison ,1981).
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Figure 3.2 Analysis of 17+ and 1703 DNA.
17+ and 1703 DNA was in v i v o 22 P labelled and digested with Hpa  1 or 
B a m  HI (0.8% gels). Missing or reduced bands are marked and novel 
bands are indicated with the letter of the band from which they are 
derived and a prime symbol (').
1703
•although a band runs in the Vmw63 position in the 1703 track. This 
appears to be a cellular band.
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corresponding band in 17+. On a Bam  HI digest (figure 3.2 ), the profile 
of 1703 again differed from  that of 17+. The B a m H l b  band (6.7x10^ 
mol. wt.) is absent and a b'  band now comigrates with si t  ( 1.9x 10^ mol. 
wt.) indicating a deletion  of about 4 .8x10^ m ol.wt. at the U l / I R l
junction. This data and the data from  other restric tion  enzym e digests 
and Southern blots (M acLean & B row n, 1987a; M acLean,1988) are 
consistent with a 4.9x10^ mol. wt. deletion in Ul /  IRL.
3.1.2. The polypeptide profile o f  1703.
The deletion described above results in the rem oval of the 3' end of 
the I R l  copies of IE1 and LAT, all of UL56, and the 3' end of UL55 
terminating about 500bp (base pairs) downstream  of the 3' end of IE2. 
The im m ediate-early polypeptide profile  of 1703 (figure 3.3) shows a 
reduction in the am ount of V m w llO  synthesized by 1703 due to the 
deletion of one copy of IE1. Vmw63 was apparently not produced by 
1703? This was confirm ed by Southern blot analysis of 17+ and 1703 
DNA using in vivo 32p  labelled 17+ RNA as a probe (MacLean & Brown, 
1987a). Dot blot assays dem onstrated that IE2 mRNA produced by 1703 
was at most 1/32 of that produced by w ild-type. Vmw63 is an essential
immediate-early polypeptide (Sacks et al ., 1985; M cCarthy et al., 1989)
and the isolation of a HSV-1 variant that apparently did not produce this 
protein presented an anom aly.
Thus the initial characterization of 1703 had shown that although the 
4.9x106 mol. wt. deletion in U l / I R L  did not affect IE2, the IE2 gene 
product Vmw63 was underproduced during im m ediate-early  conditions 
of infection. A num ber of possible explanations have been suggested by 
MacLean & Brown, (1987a) to rationalise  this anom alous data: 1 . A 
secondary m utation in the prom oter, open reading fram e or termination
Figure 3.3 Polypeptide profiles of 17+ and 1703.
Immediate-early  polypeptide extracts were labelled with 3 5§ 
methionine and run on 7.5% polyacrylamide gels. Molecular weights 
( x l 0 3 )  are indicated on the left and reduced bands are marked. A is 
actin.
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signals of IE2, 2 . The deletion removed a downstream  transactivator of 
IE2. UL55 and UL56 gene products are both absent as a result of the 
deletion and neither o f these genes has been assigned a function 
(McGeoch et al ., 1988a). There is also the possibility that the deletion 
removed a dow nstream  enhancer elem ent of IE2, although none has 
been demonstrated in the region deleted in 1703 and 3. The levels of 
Vmw63 synthesized by 1703 under im m ediate-early  conditions were 
undetectable with the reagents available.
The aims of this p ro jec t are outlined in section 1.11 of the 
introduction. The results section reports the experim ental work which 
led to the conclusion that antisense transcripts control the production of 
Vmw63 in 1703 infected cells.
3,2. C l o n i n g  a n d  s e q u e n c i n g  1703 DNA f r a g m e n t s : 1. i n  w h i c h
IH E DELETION END POINTS WERE LOCATED AND 2 . THE FRAGMENT  
CONTAINING I E 2 .
Analysis of 1703 began with the cloning and sequencing of H p a  Is in 
which IE2 is located, in order to detect any deletion/insertion in the 
promoter, open reading frame or term ination signals of the gene. Such a 
mutation was one of the possible reasons given for the defect in Vmw63 
synthesis at im m ed ia te -ea rly  tim es. A lthough  re s tr ic tio n  enzym e 
analysis of 1703 DNA had de-lim ited the end points of the deletion to 
about 500bp downstream  of the 3' end of IE2, it was necessary to find 
the exact end points in order to determ ine the genes affected. The 
deletion end points were located within H p a lm ' as shown by restriction 
enzyme analysis of 1703 3 2 p  v/v<9 labelled DNA (MacLean & Brown,
1987a; M acLean 1988). The cloning and d idoxynucleo tide  sequence 
analysis of both fragments are detailed in the next two sections.
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3.2.1 Sequencing the Vmw63 encoding gene IE2.
1703 DNA was digested w ith the restric tion  enzym e H p a  1 , 
electrophoresed through a 0.8% TBE agarose gel and the DNA fragment 
in which IE2 was located, H p a  Is excised and purified. / /p a ls  was then 
cloned into pUC19 ( S ma  1 d igested) and transform ed into com petent 
bacterial cells giving rise to recom binant colonies whose DNA was
analysed using  re s tr ic tio n  enzym es. O ne reco m b in an t p lasm id , 
pUC 19 / H p a  Is , thought to contain / / p a i s a s  an insert, was further 
analysed by Southern blotting. Figure 3.4 shows these results. The probe 
used for this experiment was a 70 base oligonucleotide corresponding to
a region of 1703 DNA at the 5' end of IE2 (n p ll3 7 1 4 -n p l 13784). In
lane 1, the probe detects the H p a  Is fragm ent which had been separated 
from its plasm id backbone using the restriction  enzym es E c o R1 and
HindlW (3251 base pairs). The fragment detected by the oligo in lane 2 
corresponds to linearised  p U C 1 9 // /p a ls  and is therefore larger than 
Hpa  Is alone (5941 base pairs). These results dem onstrate that H p a  I s  
has been cloned into pUC19.
In order to sequence IE2, H p a  Is was subcloned into M l3 m p8 which 
was supplied cleaved with S ma  1. p U C 1 9 ///p a ls  was also digested with 
Sma 1 and the resultant subfragments purified and random ly cloned into 
M l3 m p8. The DNA from  recom binant p laques was prepared and 
sequenced by the Sanger d ideoxynucleotide sequencing m ethod. The 
results from this experiment are outlined by figure 3.5.
The top of the figure 3.5 is a representation of the HSV-1 genome in 
the p ro to ty p e  o rien ta tio n  and the nex t lin e  is an expanded 
representation of H p a  Is  showing the positions of S m a  1 res tric tion  
enzyme sites within that fragm ent. Each subfragm ent was then given a
Figure 3.4 Southern blot analysis of pU C 19/ / /pa  1 s.
Autoradiograph of a Southern blot in which a 32p  /n vitro labelled 70 
base oligonucleotide, corresponding to a region of the 5' end of IE2 
(np l  13714-npl  13782), was hybridized to E c o R  1 / H i n d l l l  digested 
p U C  1 9 / / / p a  Is (lane 1) and E c o  R1 digested p U C 1 9 / / / p a l s  (lane 2). 
Numbers indicate the size of specific fragments in base pairs.
5941
3251
Figure 3.5 IE2 sequencing results.
Structure of the HSV-1 genome (a) showing U l  and U$ flanked by 
T R l / I R l  and I R s / T R s  respectively. Hpa  Is is expanded (b) and the Sma  1 
sites contained within (S ) are indicated as are the approximate locations 
of the promoter/regulatory regions of IE2. The S m a  I fragments are 
designated 1-9 from left to right. These fragments were subjected to 
dideoxynucleotide sequence analysis and the results of this analysis are 
given (c). 'No coding sequences'  means that there are no IE2 coding 
sequences in the subfragment , ' intact' means that the sequence is 
homologous to the published wild-type sequence (McGeoch et al., 
1988a).
TRTR L
US
polyA
TATATAATGARAT
Fragment no. Size Comment
12511
12896
13035
13403
13517
14192
14267
15128
15472
12896
385bp
13035
139bp
13403
368bp
13517
114bp
14192
675bp
14267
75bp
15128
861 bp
15472
344bp
15703
231 bp
no coding sequences, 
no coding sequences.
no coding sequences, 
intact.
promoter sequences, 
intact.
promoter associated sequences. 
13517-13690 intact.
intragenic region, 
intact.
intragenic region.
14267-14497 intact.
poly A signal, 
intact.
no coding sequences, 
intact.
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number 1-9 in a 5' to 3' direction and the sequencing status of each is 
detailed. Fragm ent 4, 5 and 8 contain the promoter, prom oter associated 
and term ination signals of IE2 respectively and sequencing has shown 
that each is homologous to the published wild-type sequence (McGeoch 
et a/., 1988a). The IE2 intragenic region has been partially sequenced and 
was shown to be free from  altera tion  com pared to the w ild-type 
sequence (fragments 5, 6 , 7 and 8). Fragments 2 and 9 are upstream and 
downstream of IE2 coding sequences respectively  and since both are 
intact, dem onstrate that any IE2 prom oter or term ination signals 139bp 
upstream  or 231 bp dow nstream  re sp e c tiv e ly  o f the  gene are 
homologous to the w ild-type sequence.
Thus the sequencing of IE2 and the surrounding DNA has conclusively 
dem onstrated tha t the prom oter, p rom oter assoc ia ted , term ination , 
termination associated sequences and most of the open reading frame 
are homologous to the w ild-type sequence, showing that the apparent 
lack of Vmw63 under im m ediate-early  conditions is not due to a 
secondary m utation within the IE2 gene.
12,2. Sequencing the end points o f the deletion in 1703.
The restriction  enzym e fragm ent in which the end points of the 
deletion in 1703 were located is H p a  lm \  1703 DNA was cleaved with 
the restric tion  enzym e H p a  1, the resu ltan t fragm ents separated by 
electrophoresis through a 0.8% agarose/TBE gel, the m'  subfragm ent 
excised, purified and ligated to pUC19 which had been cleaved at the 
Sma\  site. The ligation m ixture was then transform ed into com petent 
XL-1 cells, the plasm id DNA of recom binant colonies purified and the 
presence of m'  w ithin pUC19 detected by restriction  enzym e analysis 
and Southern blotting.
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Restriction enzyme analysis of a potential pU C 19///pa  lm ' recom binant 
with E c o K l  and H i n d  III gave two distinct bands, one corresponding to 
the plasm id backbone (2686 base pairs), and one which was slightly 
bigger, the H p a  lm ' insert (approximately 3000 base pairs). Figure 3.6 is 
an autoradiograph of the Southern blot analysis of 1703 DNA H p a  1 
digested and electrophoresed  through a 0.8% agarose/TB E gel. The 
probe, p U C ^ /Z /p a lm 1 had been 3 2 p  labelled in vitro and hybridized to 
Hpa  l m' ,  / /p a lm , the associated jo int fragm ent a , d , a'  and d'  and all of 
these fragm ents plus or minus extra 'a' sequences. The lanes on either 
side of the 1703 track are kilobase m arkers to aid the sizing of the 
fragments on the 1 7 0 3 ///p a l track.
Hpa  lm ' appeared to be a fragm ent of about 3000bp and, although the 
end points of the deletion were thought to be near one end of the 
fragment, it was decided that the fragm ent was too big to be directly 
cloned into M13 m p8. Thus a large scale stock of p U C 1 9 ///p a lm ' was 
grown, a portion of this was digested with S m a  1 and the resultant 
fragments random ly cloned into M l3 m p8 . The M l3 m p8 DNA from 
recom binant p laques was prepared  and sequenced by the Sanger 
dideoxynucleotide sequencing m ethod.
The sequencing profile of a clone in which the end points of the 
deletion are located is shown in figure 3.7. The sequence 'CGG' appears to 
be common to both deletion end points. Figure 3.8 demonstrates the end 
points of the deletion diagram m atically. The total length of the deletion 
is 7784bp, and the region deleted is between np (nucleotide position) 
123623 and np 115839 rem oving UL56, 343bp of the 3' end of UL55, 
leaving 555bp between the deletion end point and the 3' end of UL54 
(IE2). This dem onstrates that the genes affected by the deletion are 
UL55, UL56 and one copy of IE1 and correspondingly, one copy of LAT. 
Neither of the two UL genes has been assigned a function (McGeoch et
Figure 3.6 Southern blot analysis of pUC19///z?a 1 m ' .
Autoradiograph of a Southern blot in which random primed 3 2p  ;n 
vi t ro  labelled p U C 1 9 / / /p a  lm' was hybridized to H p a  1 digested 1703 
DNA (0.8% gel). The fragments detected are indicated as are the sizes of 
marker DNA (M) (xlO^ bp).

Figure 3.7 The DNA sequence of the 1703 deletion end points.
A portion of an autoradiograph of a sequencing gel showing the 
deletion in 1703. The deletion is between np23623 and npl5839.  The 
sequence 'egg' is common to both deletion end points.
A C G T
Figure 3.8 Exact map of the deletion in 1703.
Structure of the HSV-1 genome (a) showing U l  and U§ flanked by 
T R l / I R l  and IR $ /T R s  respectively. A portion of U l / I R l  *s expanded and 
the genes contained within are shown (b). B a m  HI (B ) and H p a  1 (H)  
restriction enzyme sites are indicated (c) as is the deletion (d). The 
resultant 1703 Hpa  1 (H)  and B a m H l  (B)  DNA fragments are shown (e).
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al.y 1988a) and only one copy of IE1 is required for the virus to grow as 
wild-type (Harland & Brown, 1985; M acLean & Brown 1987a,b). Since 
the deletion term inates 555bp downstream of the 3' end of IE2 leaving 
the 3' term ination signals intact, an explanation for the apparent lack of 
Vmw63 under im m ediate-early conditions had not yet been established. 
The data gained from sequencing the end points of the deletion is in 
agreement with the restric tion  enzym e analysis (M acLean & Brown, 
1987a) in that the H p a  \ restriction  enzym e fragm ents affected are v,r, 
and m and the partially deleted v and m fragm ents together become m \ 
The sequence analysis indicated that the deletion also removed a 
BamHl  site which had been previously shown to be present (MacLean & 
Brown, 1987a). This was confirmed by Southern blot analysis of pUC19/ 
Hpa  InT which had been rem oved from  its plasm id backbone (figure 
3.9), 1703 DNA Hpa  1 cleaved and 17+ DNA also H p a l  cleaved. The probe 
was an 30-base oligonucleotide which corresponded to a region between 
the sequenced end poin t of the deletion and the apparently  deleted 
B a m  H I site  (n p l2 3 4 9 5 -n p l2 3 5 2 4 ) . The 3 2 p  / n v i t r o  labelled  
oligonucleotide did not hybridize to the pUC19/ H p a  lm ' fragm ent, but 
did hybridize to the following 1703 DNA fragments: m \  m , a , b, a'  and b'  
and the m, a, and b fragments of 17+ indicating that the deletion in the 
pUC19////?tflnT plasmid was not identical to that in 1703. Since the small 
scale preparation of pU C 19////?alm ' was cleaved with B a m H l  in order to 
find its orientation in pUC19 (section 3.7.3) it is probable that the 
deletion was extended during the large scale preparation of plasmid 
DNA due to the instability of this region in E. col i  strain XL-1, the host 
bacteria for the plasmid.
Figure 3.9 Southern blot analysis of p HCl 9 I Hp a  1 m ' .
Autoradiograph of a Southern blot in which a 3 2p  jn vitro labelled 30 
base oligonucleotide (np l23695-np l23524) ,  corresponding to a region 
of 1703 DNA between the B a m H l  site deleted in p\JCl9/Hpa  lm' and the 
sequenced deletion end point of 1703 and hybridized to p\ JCl 9/ Hpa  1 m' 
E c o R l / H i n d l l l  digested, 1703 DNA H p a l  digested and 17+ DNA H p a l  
digested. 17 + and 1703 H p a l  fragments detected by the oligonucleotide 
are indicated, reduced bands indicated by the letter of the band from 
which they are derived plus a prime symbol, and missing bands marked.
m  1703 17*
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3.3 . W ESTER N BLOT ANALYSIS OF 1 7 ± ,  1 7 0 3  AND MOCK INFECTED  
POLYPEPTIDES.
HSV protein synthesis in infected cells falls into three categories: 1. 
Im m ediate-early polypeptides which are produced in the absence of 
prior pro tein  synthesis and are stim ulated by the virion tegum ent 
protein Vm w65 in the p resence  of ce llu la r tran scrip tio n  factors 
including oct-1. There are five HSV-1 im m ediate-early  proteins, IE1, 
IE2, IE3, IE4 and IE5, the first three of which function to transactivate 
both them selves and later classes of genes and the last two which are 
dispensable in tissue culture (for a detailed description of the function of 
im m ediate-early  po lypep tides see section 1.7). 2 .  Early genes eg.
thymidine kinase and 3 .  The late genes. This section of the results 
describes the detection  of the im m ediate-early  po lypep tide  Vmw63 
whose production is affected by the deletion in 1703. By comparing the 
amount of Vmw63 produced by 1703 to that produced by 17+ under 
immediate-early, early and late conditions it was possible to asses the
temporal regulation of the protein in 1703 infected cells.
To synthesize im m ediate-early polypeptides, BHK21 C l 3 or HFL 
monolayers w ere in fec ted  w ith 50pfu /ce ll of 17+ or 1703 in the
presence of cyclohexim ide and with 20pfu/ cell in the absence of any 
inhibitor fo r early  or late  po lypep tide  syn thesis. A fter 7 hours, 
immediate-early and early polypeptides were harvested into denaturing 
buffer. Before harvesting, im m ediate-early polypeptides were translated 
from the accum ulated im m ediate-early mRNA by washing the infected 
cell m onolayer with PBS containing actinom ycin D to rem ove the 
cycloheximide and incubating in the presence of actinom ycin D to 
prevent fu rther mRNA synthesis. L ate  po lypep tides w ere harvested 
after 16 hours. A m ock infected protein  preparation was used as a
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control. 3 5 S-m eth ionine was incorporated  in to  the po lypeptides to
facilitate analysis by SDS-PAGE. The antiserum  used throughout these 
experim ents was d irec ted  against the carboxy term inus of Vmw63 
(peptide NATDIDMLIDLGLDLS) and could also detect the HSV-2 Vmw63 
equivalent, Vmw65. This was supplied by Dr Howard Marsden.
P olypeptides were separated  by SD S-PA G E, transferred  to a 
nitrocellulose m em brane and incubated w ith antiserum . F igure 3.10a 
shows the resu lts  o f th is experim ent. W estern  b lo t analysis of 
im m ed ia te -ea rly  p re p a ra tio n s  o f 17+,  1703 and m ock infected
polypeptides dem onstrate that Vmw63 is produced by w ild-type but
that the amounts produced are relatively small. N either mock infected 
or 1703 lanes show a band that corresponds to Vmw63. Analysis of the 
early extract dem onstrates that Vmw63 was produced by 1703 but that
the am ounts w ere about half that of w ild-type. L ater results (figure
3.18) suggest tha t Vmw63 p roduction  under early  cond itions is 
equivalent to w ild-type. Late extracts show that Vmw63 production by 
1703 is equivalent to w ild-type. In both early and late mock infected 
tracks no band appears in the Vmw63 position indicating that the strong 
band appearing in the 17+ and 1703 lanes is indeed Vmw63.
The low amount of Vmw63 synthesized by 17+ at im m ediate-early 
times was unacceptable and it was therefore decided to use HFL cells to 
synthesize im m edia te-early  po lypep tides and to carry  out W estern 
blots. This was because HFL cells have previously been demonstrated to 
synthesize im m ediate-early  polypeptides m ore effic ien tly  than BHK21 
C13 cells (M acD onald, 1980). Figure 3.10b shows the resu lt of this 
experiment. Substantial amounts of Vmw63 are present in the wild-type 
lane and reduced amounts are dem onstrable in the 1703 track. In the 
mock infected lane there is no band at the Vmw63 position proving that 
the band in the 17+ and 1703 tracks are virus specific. Thus 1703
Figure 3.10 Western blot analysis of 17+ . 1703 and mock infected
polypeptide extracts.
a.  Immediate-early, early and late extracts of 17+, 1703 and mock 
infected BHK21 C13 cells, b. Immediate-early extracts of 17+, 1703 and 
mock infected HFL cells, c. Immediate-early extracts of 17+, serially 
diluted in mock infected extract as indicated, 1703 and mock infected 
HFL cells.
All polypeptides are run on a 7.5% polyacrylamide gel, blotted and 
hybridized to an antiserum which recognises the carboxyterminus of 
Vmw63 (peptide sequence NATDIDMLIDLGLDLS) and was supplied by 
Dr Howard Marsden. The position of Vmw63 is indicated and faint bands 
are marked.
I
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produces Vmw63 under im m ediate-early  conditions, albeit in reduced 
amounts com pared to w ild-type virus infections. This resu lt supports 
the suggestion by M acLean & Brown,( 1987a) that the reagents available 
at the time of initial characterization of 1703 were not sensitive enough 
to detect Vmw63 synthesized during im m ediate-early times of infection. 
Vmw63 production by 1703 was further analysed by titrating the 17+ 
polypeptide ex trac t in m ock in fec ted  ex trac t and com paring  the 
intensity of the bands obtained by W estern blotting to that produced by 
1703. Figure 3.10c is the result of this experim ent and dem onstrates 
that the amount of Vmw63 produced by 1703 is approxim ately 1/8 of 
that produced by 17+.
Hence W estern blot analysis has conclusively dem onstrated that 
Vmw63 is produced by 1703 under im m ediate-early conditions at 1/8 
the level o f th a t p roduced  by w ild -type  v iru s. E xposing  the 
nitrocellulose filter to an autoradiograph and ensuring that each lane 
demonstrated equivalent loading and band intensity acted as a control 
for this series of experiments (results not shown).
3.4. SI NUCLEASE MAPPING OF M R N A  PRODUCED BY 1703 U N D E R  
IMMEDIATE-E A R L Y . EARLY AND LATE CONDITIONS.
To determ ine w hether the im pairm ent of Vmw63 synthesis at 
immediate-early tim es was the result of interference w ith transcription, 
post-transcription or translation, the synthesis of mRNA by 1703 was 
analysed. Although originally used to map the 3' and 5' ends of genes, SI 
nuclease m apping was the m ethod of choice since it was sensitive 
enough to de tect low abundance transcrip ts o f w hich IE2 mRNA 
produced by 1703 under im m edia te-early  cond itions was typical. 
Synthesis and purification of im m ediate-early, early and late RNA was
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carried out as described in the m aterials and m ethods section. Two 
probes were used: pGX51 and pGX55, which detected IE2 (and IE1
mRNA) and IE5 mRNA respectively. The latter was a control for the 
experim en t.
p G X 5 1 :  is the S a l  1 fragm ent of B a m H lb  cloned in to  the plasm id 
pAT153. S a l  1 digestion gives two fragm ents, one of about 6000bp
corresponding to the HSV-1 fragment, and one of about 3000 bp which 
is the p lasm id  backbone. The fragm en ts are end lab e lled  by 
incorporating a 32p  labelled nucleotide. The Sal  1 fragment is purified by 
agarose gel electrophoresis, excised, and electroeluted from the gel. At 
this stage the probe can be used for SI nuclease mapping. pGX51 has 
been used previously to map the 3' end of IE2 mRNA (W hitton e t  
al ,  1983).
p G X 5 5 : is the S a l l f B a m H l  fragm ent of HSV-1 B a m H l z  cloned into 
pAT153. B a m  H I d igestion of pGX51 gives one fragm ent of about 
6000bp. The fragment is 32p  en(i labelled as described. pGX55 has been 
previously used to map the 3' end of IE5 (Rixon & Clements, 1982).
The derivation of both plasmids is outlined by figure 3.11. Figure 3.12 
demonstrates the m ethod of SI nuclease mapping which relies on the
fact that the enzyme SI nuclease digests areas of single stranded RNA
and DNA leaving double stranded molecules intact.
3A 1 . S I nuclease mapping o f  mRNA synthesized bv 1703 
under im m ed ia te -ea r lv  co n d it io n s .
The result of this experiment is given in figure 3.13. The RNA has been 
separated into cytoplasm ic and nuclear fractions dem onstrating that the 
amount of IE5 mRNA produced by 17+ and 1703 in both fractions is 
approximately equivalent, w ith a slight reduction of in tensity  in the
Figure 3.11 Map of pGX51 and pGX55.
Structure of the HSV-1 genome showing U l  and U$ flanked by 
T R l / IR l  anc  ^ I ^ s / T R s  respectively. Portions of Ul / IR l  and U s /T R ^  are 
expanded to show the locations of the HSV-1 DNA fragments contained 
within pGX51 and pGX55.
pgx51: a Sail digest of BamHl b cloned 
into pATl 53.
pgx55: a Sail digest of 
BamHIz cloned into pAT153.
Figure 3.12 The method of SI nuclease mapping.
pGX51, 3 2 p  in v itro end labelled is used to illustrate the SI 
mapping procedure.
* represents the site of end labelling
nuclease
pGX51 Sail digested , 32P- 
labelled.
HSV-1 mRNA.
Production of RNA/DNA 
hybrids. (pGX51 hybridises 
to IE2 and IE1 mRNA).
Protected RNA/DNA 
hybrids.
(Single-stranded a reas  of 
DNA and RNA digested 
with S1 nuclease).
Hybrids denatured  and 
separa ted . (790bp for IE2, 
240bp for IE1).
Figure  3.13 SI nuclease map of 17+ and 1703 immediate-early
RNA.
Immediate-early preparations of 17+, 1703 and mock infected RNA 
(BHK21 C13 cells) subjected to SI nuclease mapping procedures. Lanes 
are labelled along the top of the gel and the size of the resultant 
fragments (base pairs) indicated. Bands reduced in intensity are marked.
n u c -n u c le a r  
cy t-cy top lasm ic  
IE2-fragments detected by pGX51 
IE5-fragments detected by pGX55 
Mi-mock infected
4<0
O
♦ M
B cw o
1703 
M
l
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1703 nuclear IE5 band. Similarly, the amount of IE1 mRNA produced by 
17+ and 1703 in the cytoplasm ic fraction is equivalent whereas IE2 
production by 1703 is much less than that produced by wild-type virus. 
This resu lt is consistent with the am ount of Vmw63 synthesized by 
1703 as shown in W estern blotting experim ents (section 3.3). However 
IE1 mRNA synthesis by 17+ and 1703 is not equivalent in the nuclear 
fraction. The IE2 mRNA band in the 1703 nuclear track is seen as a 
slight darkening of the area in which the band would be expected to run, 
and the IE1 mRNA band in the same track is correspondingly less 
intense than the 1703 IE1 mRNA band in the cytoplasm ic track. The 
band in the 1703 IE5 nuclear track is also less in tense, hence an 
explanation for the reduced amounts of IE1 mRNA in the 1703 nuclear 
track could be that the concentration of total RNA in the 1703 nuclear 
fraction is less than in the other RNA preparations. Thus it would appear 
that production of IE2 mRNA by 1703 under im m ediate-early conditions 
corresponds to the amount of Vmw63 produced by the virus implying 
that the block in Vmw 63 synthesis occurs at the transcriptional level. 
This is supported by the low amounts of IE2 mRNA in the 1703 nuclear 
fraction w hich im plies that only a sm all am ount of IE2 RNA is 
polyadenylated. The 1703 IE2 mRNA and protein bands run at the same 
position as the eq u iv a len t w ild -ty p e  bands in d ica tin g  tha t an 
uninterrupted mRNA molecule is synthesized excluding the possibility of 
a mutation within the IE2 coding region.
3.4.2. SI nuclease mapping o f  mRNA synthesized bv 1703 
under ea r lv and late conditions.
At early and late times, the amount of IE2 mRNA produced by 1703 
returns to norm al, in agreem ent with the W estern blot analysis data.
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Figure 3.14 is an SI map of early RNA. Although not as clear as the 
immediate-early map, the synthesis of IE1, IE2 and IE5 mRNA in the 
cytoplasm ic and nuc lear tracks of 17+ and 1703 appears to be 
equivalent. At late times it was obvious that the amount of IE2 mRNA 
synthesized by 1703 was directly comparable to wild-type (figure 3.15). 
In all SI nuclease mapping experim ents a m ock infected control was 
incorporated. This consisted of uninfected cells which had gone through 
an identical process to that of infected cells.
3.5. Th e  i n  v i v o  c h a r a c t e r i z a t i o n  o f  1703 .
Vmw63 is an essential imm ediate-early polypeptide both for in vitro 
virus grow th (Sacks et al . y 1985; M cC arthy  et  a / . ,1989) and the 
establishment of latency (Leib et al.y 198S&. It was therefore necessary to 
examine the neuroviru lence and latency charac teristics  of 1703 to 
determine if  the underproduction  of Vmw63 under im m ediate-early  
conditions affected these characteristics. As reported by M acLean & 
Brown, (1987a), 1703, then called X2D, did not express thym idine 
kinase. For this reason the fragm ent of X2D in which the deletion end
points were located was co-transfected with 17+ DNA to give a wild type
recombinant, 1703 (M acLean, 1988). In order that 1703 could be used 
in v iru lence experim ents, and as thym idine kinase is a virulence 
determinant (F ield  & W ildy, 1978), thym idine kinase production by 
1703 was determ ined.
3 J .1 .  T h y m id in e  k in a se  p ro d u ctio n  bv 1703.
Table 2.1 gives the results o f this experim ent. thym idine is 
incorporated into thym idine kinase and the resu lts are expressed in
Figure 3.14 SI nuclease mapping of 17+ and 1703 early RNA.
Early preparations of 17+, 1703 and mock infected RNA (BHK21 C13 
cells) subjected to SI nuclease mapping procedures. Lanes are labelled 
along the top and the resultant  protected fragments  (base pairs) 
indicated .
n u c -n u c lea r  
cy t-cy top lasm ic  
IE2-fragments protected by pGX51 
IE5-fragments protected by pGX55 
Mi-mock infected
1703 
Ml 
17* 
1703 
Ml 
17* 
1703 
Ml 
17* 
1703 
M
l
Figure 3.15 SI nuclease map of 17+ and 1703 late mRNA.
Late preparations of 17+, 1703 and mock infected cell RNA (BHK21 
C l 3) subjected to SI nuclease mapping procedures. Lanes are labelled 
along the top of the gel and fragment sizes (base pairs) are given.
n u c -n u c lea r  
cy t-cy top lasm ic  
IE2-fragments detected by pGX51 
IE5 fragments detected by pGX55 
Mi-mock infected
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Table 3.1. Thymidine kinase 
characteristics of 17* 1703, X2D and mock 
infected cells
Radioactivity (cpm)/5ul sam ple
Virus Experiment 2 Experiment 2
Mock 7350 5183
infected.
17 + 19511 24225
1703 29063 23091
X2D 4796 5030
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counts per minute due to thym idine. The thym idine kinase positive 
viruses, 17+ and 1703, had 2-3 times more counts per minute than the 
1703 parental virus X2D and mock infected cells indicating that 1703 
expressed thym idine kinase.
3.5.2. 1703__ n eu rov iru len ce .
Serial ten-fold dilutions of 1703 and 17+ were made in PBS/calf serum 
and inoculated into 3 week old male Balb/c mice via the intracranial 
route. Deaths were recorded and the LD50 found to be c l O ^ p f u / m o u s e  
(Table 2.2). The LD50 of 17+ in 3 week old Balb/c mice has recently 
been found to be <10pfu/m ouse (M acLean et al ., 1991b), but this was 
not known at the time of this experiment, hence, it is probable that 1703 
is as v iru len t as w ild -type although its v iru lence  has not been 
determined at clO pfu/m ouse.
3.5.3. 1703 latency.
Serial ten-fold dilutions of 1703 and 17+ were made in PBS/calf serum 
and inoculated into the right rear footpad of 4 week old male Balb/c 
mice. 17+ was the control for this experiment but the inoculum did not 
contain > 10^ pfu/ mouse due to the ability of 17+ to kill at higher 
dilutions via this route. 1703 was able to establish and reactivate from 
latency in the same manner as wild-type.
3,6. Transfer o f  the 1703 deletion to 17±- DNA.
The resu lts of the sequence analysis o f the 1703 IE2 gene 
demonstrated that the alteration of the tem poral regulation of Vmw63
Table 3.2. LD50 of 17 and 1703 following 
intracranial inoculation of 3 week old 
Balb/c mice.
Dose (pfu / animal)
LD50
Virus 1 0 2 10 3 10 4 1 0 5 pfu/animal
1703 4/4* 4/4 4/4 4/4 <10 2
17 + 4/4 4/4 ND ND <10 2
* number of animals dead/number of animals inoculated.
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•p ro b ab ly
in 1703 in fections was* not due to a secondary m utation in IE2. 
Confirmation that it was a direct result of the downstream  deletion has 
been achieved by transfer of a fragm ent spanning the deletion into a 
17+ genome. The 1703 B g l l l f  DNA fragment was used since H p a lm ', the 
fragment used to sequence the deletion end points was not large enough 
for efficient recom bination. The BglWT  fragm ent from 1703 DNA was 
obtained by separation  of B g l II c leaved  1703 DNA through an 
agarose/TBE gel and electroelution and co-transfected with 17+ DNA into 
BHK21 C l 3 cells. R esultant plaques were analysed by the method of 
Lonsdale, (1979). One recom binant plaque with the required DNA profile 
(outlined below) designated 1750 was isolated and plaque purified three 
times.
3.6.1. Analysis o f 1750 DNA.
32p in v iv0 labelled 17+, 1703 and 1750 DNA was digested with the 
enzymes B a m H l  and H p a  1. DNA profiles are shown in figure 3.16. 
Evidence that B g l l l f  had been recombined into 17+ DNA was provided 
by a reduction in intensity of bands H p a  lm  and H p a  la . The presence of 
Hpalvri  in the H p a  1 DNA profiles of both 1703 and 1750 is not clear as 
the band com igrates with a cellu lar band present in all four tracks, 
however the reduction in bands H p a  lm  and H p a  la  and the absence of 
Hpa  lv  and H p a  l r ,  characteristic  of the 1703 H p a \  DNA profile , 
demonstrates that the 1703 and 1750 DNA profiles are identical. The 
loss of B a m U l b  in the 1703 and 1750 DNA profiles compared to wild- 
type c o n c lu siv e ly  d em onstra ted  that 1750 w as a B g / I I f ' / 1 7  + 
recom binant. 1750 was fu rther charac terized  by the m ethods of 
Western blot analysis and SI nuclease mapping.
Figure 3.16 Analysis of 17+ .1703. 1750 and!703PA DNA.
17+, 1703, 1750 and 1703PA DNA was in vivo 3 2 p  labelled and 
digested with H p a  1 (a) or B a m W l  (b). Missing or reduced bands are 
marked and novel bands are indicated with the letter of the band from 
which they are derived and a prime symbol (').
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3.6.2, Analysis of 1750 IE2 transcrip ts  and protein products.
SI nuclease mapping of 17+, 1703 and 1750 transcripts using the 
probes discussed in section 3.4 (figure 3.17) dem onstrated that IE5 
mRNA production by 1703 and 1750 was reduced in comparison to 17+ 
and indicated that the total RNA in the form er samples was less than 
the latter. IE1 mRNA production by all four viruses dem onstrated the 
same pattern, 1703 and 1750 reduced in comparison to 17+, IE2 mRNA 
production by both 1703 and 1750 under im m ediate-early  conditions 
was not apparent, that is, below the level of detection. W estern blot 
analysis of Vmw63 production by 17+, 1703 and 1750, synthesized 
under im m ed ia te -early  cond itions (figure  3 .18) dem onstra ted  that, 
compared to w ild-type, the production of Vmw63 by 1703 and 1750 
was reduced. The reduction in Vmw63 seen in the 1750 track appears to 
be less m arked than the same band in the 1703 track indicating that 
there m ay have been a loading  d iscrepancy  betw een the tracks. 
However the mock bands in all five lanes are identical in concentration 
implying that the difference in the intensity  of the 1703 and 1750 
Vmw63 bands reflected a genuine difference in the synthesis of the 
polypeptide by the two viruses. At early and late times of infection, the 
synthesis of Vmw63 by 1750 is directly com parable to that of wild- 
type. At all times of infection, a mock infected cell extract (uninfected 
cells) was analysed with the infected extracts to allow the elimination of 
cellular bands in the analysis of the blot.
This inform ation dem onstrates conclusively that the underproduction 
of Vmw63 under im m edia te-early  cond itions was not due to an 
mutation in a part of the 1703 genome distant from the deletion.
Figure 3.17 SI nuclease map of 17+ . 1703. 1750 and 1703PA
immediate-earlv mRNAs.
Immediate-early preparations of 17+, 1703, 1750, 1703PA and mock 
infected cell (BHK21 C l 3) cytoplasmic RNA was subjected to the SI 
nuclease mapping procedure. Bands reduced in intensity are marked 
and the sizes of resultant fragments in base pairs indicated.
IE2-fragments detected by pGX51 
IE5-fragments detected by pGX55
17031750 
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Figure  3.18 Western blot analysis of 17+ . 1703. 1750. and 1703PA 
immediate-earlv. early and late polypeptide extracts.
Immediate-early (a), early (b) and late (c) extracts of 17+ , 1703, 1750, 
1703PA and mock infected polypeptides run on a 7.5% polacrylamide 
gel, blotted and hybridized to an antiserum which recognised the 
carboxyterminus of Vmw63 and was supplied by Dr Howard Marsden. 
The position of Vmw63 is indicated.
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3.7. THE INTRODUCTION OF A POLYADENYLATION SIGNAL BETWEEN THE 
5' END OF IE1 AND THE 3* END OF TE2.
It becam e increasing ly  apparen t that the dow nregulation  of 
transcription of IE2 was due to the production of a transcript initiating 
from the IE1 prom oter and interfering with the synthesis of IE2 mRNA. 
Deletion of the normal IE1 polyadenylation signal and of UL56 (the only 
adjacent gene whose polyadenylation signal is in the same orientation as 
that of IE1) could result in the production of a long transcript (about 
15kb), part of which would be antisense to transcripts initiating from 
the IE2 promoter. Previous data (sections 3.3 and 3.4) has demonstrated 
that sm all am ounts of IE2 mRNA and protein are produced by 1703 
under im m ediate-early conditions implying that a small amount of IE2 
mRNA is processed. To confirm  that IE2 mRNA synthesis was being 
con tro lled  by an an tisen se  tran sc rip t, a p o ly ad en y la tio n  signal
was introduced between the 5' 
end of IE1 and the 3* end of IE2 in 1703 in the correct orientation to 
polyadenylate mRNA initiating from the IRl  copy of the IE1 promoter
before reaching IE2 coding sequences. This required the m anipulation of 
plasmids containing relevant 1703 DNA fragments.
3.7.1. T he p o lyad enylation signal.
A plasmid pSAU3 containing a polyadenylation signal which had been 
cloned into the B a m  H I  site of pGEM , was supplied by Dr John 
McLauchlan. As the polyadenylation signal was HSV-2 in origin it was 
anticipated that the construct could be used as a probe when detecting 
1703/polyadenylation signal recom binant viruses since its surrounding 
DNA should be heterologous to HSV-1 1703. However this proved not to
9 3
be the case as the plasm id hybridized to other 1703 DNA fragments 
(figure 3.23).
There was about 150bp 5' to the polyadenylation 
signal which was used to transcript map the novel RNA synthesized as a 
result of the insertion of the signal into 1703 DNA. The structure of 
pSAU3 is shown in figure 3.19a.
The construct will be
referred to as the polyadenylation signal (PA). It could not be directly 
cloned into 1703 DNA as its surrounding sequences were not present in 
sufficient quantity, nor were they compatible with 1703 DNA. Thus, the 
1703 DNA fragm ents H p a  Is and H p a  lm ' were cloned around the signal 
in the orientation described below:
3.7.2. C loning Hpa  Is  into pSAU3.
Hp a  Is  was previously cloned into pUC19 in order to sequence the end 
points of the deletion in 1703 (section 3.2.1) since IE2 was located 
within this fragment. To find the orientation of H p a  Is within pUC19, the 
construct was cleaved with the restriction enzyme B a m H l  (figure 3.19b). 
A B a m  H I  site is located on the HSV-1 genome at n p l 13322 cleaving 
H p a  Is  in to  one 2441bp fragm ent and one 811bp fragm ent. Upon 
digestion of H p a  Is with B am  H I, one fragment of 2441bp (a portion of 
Hpa  Is), and one of about 3500bp (the remaining 811bp of H p a  Is plus 
the p lasm id ) w ere de tec ted  dem onstra ting  tha t H p a  Is had the 
orientation within pUC19 shown by figure 3.19b. To clone H p a  I s  in to  
pSAU3, p U C 1 9 // /p a ls  was cleaved with the restriction enzyme X b a l , 
blunt ended at that site and digested with E c o R1 resulting in a fragment 
of about 3251 bp (figure 3.19d). pSAU3 was linearised by cleaving at the 
S ma  1 and E c o R l  sites (figure 3.19c) resulting in both pSAU3 and
F ig u r e 3 .1 9  Cloning H v a Is into pSAU3.
a and b are pSAU3 and pUC19/ / /pa  Is respectively. The dotted lines 
indicate the plasmid backbone and the orientation of each fragment 
within  the plasmid is marked by an arrow. Restr ic t ion enzyme 
fragments are represented by the first one or two letters of the enzyme 
name (a key for this is given below), d and c demonstrate  the ends 
obtained by digestion and blunt ending of pU C 19 / / /pa Is  and pSAU3. The 
ligation of both gives a fragment whose structure is shown in e. The 
genes conta ined within the HSV-1 fragments are shown and the 
fragments resulting from a BamWX  ( e l )  and B a m H  1 / X b a  1 (e2 ) digest 
are indicated.
B E -Blunt ended S- Ss t l
B - B a m  HI S p - S p h  1
E- Ec o  R1 Sa-Sal  1
H n - H i n d l l l P - P s t l
H  c -Hi nc l l X - X b a  1
K - K p n  1 — plasmid backbone 
orientation of fragment
270bp
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p U C 1 9 / / /p a l s  having one blunt and one sticky end each and ensuring 
that the orientation of H p a  Is within pSAU3 was correct. Both fragments 
were purified by agarose gel electrophoresis and ligated together. As 
there was no colour selection available to identify recom binants, colonies 
arising from  the transform ation  were all picked and the resu ltan t 
plasm id DNA analysed  using re s tric tio n  enzym es (figu re  3.19e). 
Digestion of plasmid DNA with B a m H l  (figure 3 .19e l) resulted in two 
fragm ents, one of 2441bp (a portion of H p a  Is) and one of 3831bp 
(270bp of the polyadenylation signal, 2700bp of the plasm id backbone 
and 811bp of the rest of H p a  Is). Cleavage of pS A U 3////?a ls reco m b in an t 
plasmids with the enzymes B a m H l  and X b a  1 (figure 3.19e2) gave three 
fragments: one of 2441bp (a portion of H p a  I s  ), one of 270bp (the 
polyadenylation signal) and one of about 3500bp (the rest of H p a  I s  
together w ith the pGEM  backbone). Thus it was dem onstrated that 
H p a  Is  was cloned  in to  pSAU3 in the co rrec t o rien ta tion . The 
recombinant plasmid was called p S A U 3 ///p a ls .
17 .3 . Cloning Hpalm'  into p S A U 3 /J /p a ls .
The end points of the deletion w ithin 1703 were located within 
H p a lm ' and this fragment was already cloned into pUC19 (section 3.2.2). 
The orientation of H p a  lm ' in pUC19 was dem onstrated by B a m  H I  
restriction enzym e analysis of the construct (figure 3.20a). A BamHl 
restriction enzyme site is located within the HSV-1 genome at n p l23459 
and cleaves H palm ' into two distinct fragm ents, one of approxim ately 
500bp (a portion of H p a  lm ') and one of about 5000bp (the rest of 
H p a l m ' p lu s  the plasmid backbone). At this point, a large scale plasmid 
preparation of p U C 1 9 ////?0 lm ' was grown and the B a m H l  site within 
Hpa  lm ' was lost (section 3.2.2). The structure of pJJCl 9 / Hpa  lm ' is
F ig u r e 3 .2 0  Cloning H v a lm' into pSAU3///o<31 s.
a and c are p U C 1 9 ///p a  lm ' and p S A \ J 3 / H p a  Is respectively. Dotted 
lines indicate  the plasm id backbone and the orientation  of each 
fragment within the plasmid is marked by arrows. Restriction enzyme 
sites are represented by the first one or two letters of the enzyme name 
(a key for this is given below), b and d dem onstra te  the fragments 
obtained  by d igestion  and blunt ending to give H p a  lm ' and 
p S A U 3 / / /p a I s  with suitable ends for ligation, e is the result of ligation of 
both fragm ents and the genes within are indicated, e l  shows the 
fragments obtained by a B a m H l  digest, e2 is a K p n l  digest and e3 is a 
Ss t  1 digest.
B E -b lun t ended S - S s t l
B - B a m H l  S p - S p h  1
E- Ec o Rl  S a - S a l l
H c - H i n c  I I
H n - H i n d l l l P - P s t l
X - X b a l
K - K p n l --- plasmid backbone
► orientation of fragment.
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shown in figure 3.20 as are the m anipulations of pSA U 3////?a Is  and 
p U C l9/ H p a l m '  which resulted in the isolation of pSA U 3////?als////?tf lm '. 
These are summarized as follows:
pU C19////?a lm ’ was cleaved with the enzyme E c o R l ,  blunt ended at 
that site, purified and further digested with X b a  1 (figure 3.20b). This 
separated H p a  lm ' from its plasmid backbone and resulted in it having 
one b lunt end and one sticky end. The same ends were given to 
p S A U 3 /// /? 0 Is by first digesting with Hi nd l l l ,  blunt ending at that site, 
and cleaving with X b a l  (figure 3.20d). The fragments were ligated in the 
correct orientation. All colonies from the transform ation were picked, 
and the resultant DNA analysed using restriction enzymes (figure 3.20e). 
Cleavage of the construct with B a m H l  (figure 3 .20e l) gave one 2441 bp 
fragment (a portion of H p a  Is), one of 270bp (the polyadenylation 
signal), and one of 5500bp (the plasmid backbone, H p a  lm ', and the rest 
of H p a  Is). Digestion with K p n l  (figure 3.20e2) gave two fragments one 
of which is the H p a  ls /p o ly a d en y la tio n  signa l// / /?a lm ' whose size was 
about 6000bp, and one of 2770bp corresponding  to the plasm id 
backbone. Confirm ation of the orientation of the 1703 DNA fragments 
within pSAU3 was obtained by digestion with Sst  1 (figure 3.20e3) which 
gave the fo llow ing restric tion  enzym e cleavage pattern : a 3232bp 
frag m en t { H p a  Is ) , one of 1752bp (part o f H p a  lm ' and the 
polyadenylation signal), one of 1334bp (the rest of H p a l m ' )  and one of 
2770bp (made up of the plasmid backbone). Further confirm ation of the 
orientation of the fragm ents within pSAU3 was achieved by Southern 
blot analysis.
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3.7.4, Confirmation of the structure of p S A U 3 / / /p f l l s / / /p f l l  m 1 
bv Southern blot analysis.
Figure 3.21 is an autoradiograph of the Southern blot analysis of 
pS A U 3 / H p a  1 s / Hp a  lm ' and 1703 DNA hybridized to various probes. 
3.21a shows 1703 DNA cleaved with H p a  1 and electrophoresed through 
a 0 .8%  T B E /ac ry lam id e  gel. The p ro b e  is random  prim ed
pS A U 3 / / / p a  1 s / H p a  lm ', which hybridizes to the follow ing H p a  1 
fragments: m \  s, m , and the m ’ and m jo int fragments a , d , a \  and d'. The 
probe detects several bands other than those described above indicating 
that the polyadenylation signal hybridizes non-specifically to 1703 DNA. 
3.21b dem onstrates the hybridization of random  prim ed 3 2 p  /n v itro 
labelled 1703 DNA to B a m H l  digested pSA U 3////?a l s / H p a  lm ' which 
gives two fragm ents, one of 2441bp (a portion of H p a  Is) and a large 
fragment of about 7000bp (the rest of H p a  Is, the plasmid backbone, and 
Hpal m' ) .  The probe hybridizes to all fragm ents except that containing 
the polyadenylation signal. H ybridization of random  prim ed pSAU3 to 
the B a m H l  digested construct (3.21c) gave a signal corresponding to the 
polyadenylation signal and the fragm ent containing pGEM , the plasmid 
backbone. This data is consisten t w ith the plasm id construct first 
discussed in section 3.7 which was subsequently used to construct the 
1703 recom binant virus contain ing  a polyadenylation  signal in the 
correct orientation to p o ly a d e n y la te  the antisense transcript.
17 .5 . C onstruction and analysis o f  the 1703PA recom binant  
n c n o m e .
The plasmid construct described in section 3.7.4 was cleaved with the 
restriction enzym e K p n l  and the ///?**! s/po lyadeny la tion  signal////?** 1 m '
Figure 3.21 Southern blot analysis of p S AU3 / Hp a  1 s / Hp a  1 m*.
Autoradiograph of Southern blots in which: a. random primed 32p i n 
vi t ro  labelled p S A V 3 / H p a  1 s / Hp a  lm ' is hybridized to H p a  1 digested 
1703 DNA (0.8% agarose), b. random primed 32p  in vitro labelled 1703 
DNA is hybridized to B a m  H I digested p S A H 3 / H p a  1 s / H p a  lm ' (1% 
agarose: lane 1) c. random primed 3 2 p  ;n vitro labelled  pSAU3 is 
hybridized to B a m H l  digested p S A V 3 / H p a l s / H p a l m '  (1% agarose; lane 
2). Marker tracks are indicated (M) and the size of bands labelled (kbp). 
The size of fragments detected by the probes are indicated.
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fragment was purified by agarose gel electrophoresis. Co-transfection of 
the fragm ent with 1703 DNA and analysis of resultant progeny by the 
Lonsdale (1979) m ethod iden tified  a 1703 /po lyadeny la tion  signal 
recom binant called 1703PA whose restric tion  enzym e profile  is now 
described :
Figure 3.16 shows H p a  1 and B a m K l  profiles of 17+ , 1703, 1750 and 
1703PA 3 2 p  in v ivo labelled DNA. Sections 3.1.1 and 3.6.1 summarize 
the restriction enzyme profiles of 1703 and 1750 respectively, thus only 
the profile of 1703PA will be discussed here. The H p a  1 site between 
Hpa  Is and H p a  lm ' has been lost due to insertion of the polyadenylation 
signal at that site resulting in the loss of H p a  Is and H p a  lm '.  A novel 
0.5M band consisting of H p a  Is, the polyadenylation signal, and H p a l m '  
which has a m olecular w eight of 4 .1x10^, runs with H p a  lm  and is 
therefore not detected. Insertion of the construct also results in the 
Hp a  lm ' containing jo in t fragm ents H p a  la* and H p a  Id ' returning to 
almost the equivalen t size as w ild-type, that is 14.5x10^ m ol. wt. 
(Hpa la") and 11.1x 10^ mol. wt. (Hpa  ld M) respectively. Due to the intact 
copy of H p a l m  in T R l ,  the joint fragments a and d  are also present. The 
Bam  H I  profile of 1703PA is slightly more com plicated (figure 3.16b) 
since in sertion  of the po lyadeny la tion  signal also resu lts  in the 
introduction of two novel B a m  HI sites, one on either side of the signal. 
This results in a B a m H l  site at almost exactly the position of the H p a  1 
site deleted during the construction of p S A U 3 / / /p a ls / / /p a lm '.  Thus 
B a mHl b '  becom es Ba mHl b " ,  a 1M fragment of 1.63x 106 mol. wt. which 
migrates between m / v  and sit. B a m U l k  is also slightly altered due to the 
extension of the deletion in the H p a l m ' fragm ent used to construct 
pSA U 3 / / / p a l s / / / p 0 lm '. B a m H l k  becomes B a m H l k \  a 1M fragment of 
3 .9 0 x 1 06 mol. wt., only slightly sm aller than B a m  H lk . In B a m  H I
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digested 1703PA DNA, the polyadenylation signal is cleaved but runs off 
the gel because it is only 270bp in length.
The above analyses are shown diagram m atically by figure 3.22. The 
data is consistent with the insertion of the polyadenylation signal in the 
desired region of 1703 DNA. 1703PA DNA was further analysed by 
Southern blot analysis.
3.7.6. C o n firm a tio n  of the  p resence  of PA w ith in  1703.
Southern blot analysis of 1703PA DNA which had been digested with 
Hp a  1 and hybridized with 3 2 p  in vitro labelled pSAU3 (figure 3.23) 
shows that the polyadenylation signal is capable of hybridizing to a 
variety of fragm ents dem onstrating that it has sequences in common 
with HSV-1 17+ polyadenylation signals. However, the probe hybridizes 
to a band near the 6000bp marker band which is diffuse in appearance 
indicating that it is probably an end. The H p a  Is  fragm ent in which the 
polyadenylation signal was recombined is an end and is thought to have 
a size of approxim ately 6500bp (3251bp \ Hpa  Is], 3000bp [Hpalm' ]  and 
270bp [polyadenylation signal]). Restriction enzyme analysis of 1703PA 
DNA indicated that the polyadenylation signal lies within this fragment. 
R estriction enzym e analysis and Southern b lotting has dem onstrated 
that the polyadenylation signal has been recom bined into the correct 
fragment of 1703 DNA and careful cloning of H p a  Is and H p a  lm ' into 
pSAU3 has ensured that the polyadenylation signal is in the correct 
orientation w ithin 1703PA to term inate the antisense transcrip t before 
reaching IE2 coding sequences. Knowing these facts, it was now possible 
to proceed with the analysis of 1703PA IE2 products.
Figure 3.22 Map of 1703 showing inserted polyadenylation signal.
Structure of the HSV-1 genome (a) showing U l  and U§ flanked by 
T R l / I R l  and IR s /T R s  respectively. A portion of the U l / I R l  junction is 
expanded and the genes within are shown (b). BamYi l  (B ) and H p a  1 (H)  
restriction enzyme sites are indicated (c) as is the deletion (d), the 
resultant 1703 DNA fragments (e) and those obtained after insertion of 
the polyadenylation signal (e l) .

Figure 3.23 Southern blot analysis of !703PA.
Autoradiograph of Southern blot in which random primed 32p  ;n viiro 
labelled pSAU3 (the plasmid containing the polyadenylation signal) is 
hybridized to H pa  1 digested 1703PA DNA (0.8% gel). Marker fragments 
are labelled  (M xlO^ base pairs) and the 1703PA DNA fragments 
detected are indicated.
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3.8. A n a l y s i s  o f  1 7 0 3 P A  IE2 g e n e  p r o d u c t s .
The methods of SI nuclease mapping and W estern blot analysis have 
been described elsew here (sections 3.4 and 3.3 respectively), however 
an additional probe was used in the SI nuclease mapping experiments 
and is described in detail in section 3.8.2.
3.8.1. W estern blot analysis o f 1703PA polypeptides.
Figure 3.18 is a Western blot analysis of 17+, 1703, 1750 and 1703PA 
p o ly p e p tid e s  w h ich  d e m o n s tra te s  th a t u n d e r im m e d ia te -e a r ly  
conditions, the production of Vmw63 by 1703PA has returned to wild- 
type levels. In the lane before 17+, a low intensity band at the same 
molecular weight as Vmw63 in the other four track is present. This band 
is also present in the mock infected tract im plying that it is either a 
cellular band or is a result of overflow from the 17+ and 1703PA tracks. 
Repeating this experim ent dem onstrated that the band was a result of 
overflow (results not shown). Synthesis of Vmw63 by 1703PA is also 
comparable to w ild-type at times other than im m ediate-early. In section
3.3, it was indicated that production of Vmw63 by 1703 under early 
conditions was about half that produced by wild-type implying that the 
block in the synthesis of Vmw63 may not be fully overcome at early 
times. This blot dem onstrates that Vmw63 production by 1703 was 
equivalent to wild-type during early conditions of infection and that the 
slight underproduction dem onstrated in the other blot (figure 3.10a) 
may have been due to a loading artifact, or to variation from  one 
experiment to another.
Thus, W estern blot analysis of 1703PA has dem onstrated that the 
production of Vmw63 in 1703 infected cells is at the transcriptional
^ h e  1703PA IE2 mRNA fragment appears to be increased is size relative 
to the 17+ IE2 mRNA fragment. This may reflect a genuine increase in 
molecular weight of the fragment or may be due to unequal migration of 
the bands (ie. a gel artifact).
1 0 0
level and is con tro lled  by the p roduction  of transcrip ts that are 
antisense to IE2 mRNA initiating from the IRl  copy of the IE1 promoter.
This was shown conclusively by SI nuclease mapping IE2 mRNA and by 
detection of the novel transcript resulting from the integration of the 
polyadenylation signal.
2i£JL SI nuclease m apping of 1703PA transcripts.
There were three d ifferen t probes used during this experim ent, 
pGX55, pGX51 (described in section 3.4) and pS A U 3///p tfls ////? tflm '. The 
last probe was prepared by cleaving the construct with B a m U l , filling in 
the 5’ overhang incorporating a 32p  labelled nucleotide and isolating the 
270bp fragm ent in which the polyadenylation signal was situated. This 
ensured that the novel transcrip t resulting from the insertion of the 
polyadenylation signal would be detected. Figure 3.24 dem onstrates the 
manner in which pSA U 3////?a 1 m ' / H p a  Is  was cleaved with restriction 
enzymes to give the DNA fragm ent used as a probe and the protected 
fragment obtained after SI nuclease m apping. Figure 3.17 shows the 
results of an SI nuclease map with the probes which detected IE2, and 
IE5 mRNA. The results agree with the W estern blot analysis since 
synthesis of IE2 mRNA by 1703PA has returned to w ild-type levels.* 
Because the pro tein  data had dem onstrated that the production of 
Vmw63 was equivalent to wild-type during early and late times, it was 
obvious that SI nuclease mapping of these mRNAs would give identical 
results. For this reason, these mRNAs were not mapped. Detection of the 
novel transcrip t using the polyadenylation signal as a probe (figure 
3.25) conclusively dem onstrated that a transcript antisense to the IE2 
mRNA initiated from the IE1 prom oter
This is the first example of a variant which
Figure 3.24 The probe used to detect the novel transcript.
Diagram of the probe used to detect the novel transcript created by 
insertion of the polyadenylation signal.
d.
150bp
Figure  3.25 SI nuclease map of 17+ . 1703. 1750 and 1703PA
immediate-early RNA.
SI nuclease map of 17+ , 1703, 1750 and 1703PA RNA subjected to SI 
nuclease mapping. The probe used is described in figure 3.24. Lanes are 
labelled along the top of the gel and fragments detected are indicated.
1 -7 0 3
17+ 17031*750 PA Mf
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has been shown to control the product of one of its genes by the
synthesis of an antisense transcript.
3,9 Growth properties of the three variants.
Growth characteristics of 1703, 1750 and 1703PA are similar to strain 
17 + . A one-step growth experim ent over 24 hours showed no marked 
difference in the growth characteristics of the three variants compared 
to 17+ (figure 3.26). The long term growth properties of 1703, 1750 and 
1703PA indicated that the three variants were slightly growth restricted 
compared to 17+ since 1703, 1750 and 1703PA all clustered around a 
final titre of about one log lower than 17+ > although the slope of all four 
curves was sim ilar indicating that their growth rates were the same. 
1703PA, the virus in which Vmw63 production has returned to wild-
type virus levels, showed a sim ilar curve to that of the other two
variants indicating that the defect in growth exhibited by the three 
variants was not due to reduced p roduction  o f Vmw63 during 
immediate-early conditions of infection. The particle/pfu ratios of 17+, 
1703, 1750 and 1703PA are 12:1, 57:1, 9:1 and 94:1 respectively and 
typical stock titres are 1x 10^ 0 , 8x 10^ , 6x 10^ and 2x 10^ pfu/m l 
respectively. These results show that long term  growth of the three 
variants is one log lower than 17+ but the stock titres and particle:pfu 
ratios are acceptable for wild-type virus. Long term growth experiments 
mimic the grow th of v irus stocks in that the in fec ting  dose 
(O.OOlpfu/cell) and the time allowed for growth (typically 72 hours) are 
the same. This im plies that the defect in virus growth seen in this 
experiment is the result of variation among BHK21 C l3 cells.
Figure 3.26 One-step growth characteristics of 17+ , 1703. 1750 and
1703PA .
One step growth curves of 17+ , 1703 , 1750 and 1703PA in BHK21 
C l 3 cells. Cells were infected at a multiplicity of infection of 5pfu/cell, 
the monolayers washed twice in PBS/calf serum, overlaid with ETC10% 
and incubated at 37°C. Plates were harvested at 0, 2, 4, 6, 8, 10, 12 and 
24 hours post infection and titrated as normal.
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Figure 3.27 Long term growth characteristics of 17+ . 1703. 1750 and
1703PA.
Long term growth curves of HSV-1 strain 17+ , 1703 , 1750 and 
1703PA in BHK21 C13 cells. Cells were infected at a multiplicity of 
0.001 pfu/cell, the monolayers washed twice in PBS/calf serum, overlaid 
with ETC10% and incubated at 37°C. Plates were harvested at 0, 6, 12, 
24, 36, 48, 60 and 72 hour post infection and titrated as normal.
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Chapter 4
1 0 2
D i s c u s s i o n .
The original aim of the project described in this thesis was to further 
characterize the HSV-1 deletion variant 1703 which, on initial analysis 
(M acLean & B row n,1987a; M acL ean ,1988), ap p aren tly  fa iled  to 
syn thesize  the e ssen tia l im m ed ia te -ea rly  p o ly p ep tid e  Vm w63 at 
imm ediate-early times of infection. In depth characterization as detailed 
in the results section was achieved by: 1 . The d id eo x y n u c leo tid e  
sequence analysis of the 1703 DNA fragm ents in which IE2 and the 
deletion end points were located. 2. The in vivo characterization of 1703. 
3. The analysis of 1703 IE2 gene products and 4. The production of a 
1703 w ild-type recom binant. The purpose of the investigation was to 
find a reason for the apparent lack of production of Vmw63 under 
immediate-early conditions and to examine its in vivo effect. The project 
was extended to investigate an idea proposed by Dr John M cLauchlan, 
that synthesis of Vmw63 in 1703 infected cells could be controlled by a 
transcript antisense to IE2 mRNA.
Vmw63 is an essential immediate-early polypeptide (Sacks et al., 1985; 
M cCarthy et a l . ,1989) which functions to transactivate later classes of 
genes, especially those which are not synthesized in the absence of viral 
DNA replication, that is, the true late genes. IE2 deletion variants are not 
viable in tissue culture (except in cell lines expressing Vmw63), they 
induce synthesis of greatly reduced levels of viral DNA and early-late 
polypeptides and overexpress early proteins. IE2 deletion variants are 
also unable to establish latency (Leib et al., 198£). 1703 exhibited no 
aberrant charac te ristics , grow ing alm ost norm ally  in tissue culture 
(MacLean & Brown, 1987a; this thesis). The growth characteristics of
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1703 as established by MacLean & Brown, (1987a) were similar to 17+. 
However, results obtained during this project indicate that 1703 and the 
two recom binants 1750 and 1703PA exhibited a reduction in growth of 
one log during a long term growth experiment. The shape of the curves 
obtained ind icated  that the rates of grow th w ere equ iva len t but 
eventual titres different. The stock titres of the three variants were 
within the acceptable range for HSV-1 indicating that perhaps the batch 
of BHK21 C13 cells used for the latter experim ent did not support the 
growth of the varian ts as w ell as those used in the form er, 
dem onstrating a possible requirem ent for the products of the genes 
deleted in the varian ts in som e batches o f BHK21 C13 cells. 
Alternatively, the difference in results obtained in this thesis and those 
obtained by M acLean & Brown, (1987a) may be due to variation 
between experim ents and would have to be repeated several times to 
establish the involvem ent of the products of genes deleted in 1703, 
1750 and 1703PA, in long term growth.
W estern blot analysis and SI nuclease mapping had established that 
Vmw63 production in 1703 infected cells was only affected during 
immediate-early conditions of infection and the block in synthesis was 
at the level of transcription. The synthesis of IE2 mRNA and Vmw63 
returned to levels equivalent to wild-type during early and late times of 
infection, and the small amount of polyadenylated IE2 mRNA present 
during a 1703 im m ediate-early  infection was reflected  in the small 
amount of Vmw63 synthesized, demonstrating that the block was not at 
the translational level. During im m ediate-early conditions of infection, 
IE2 mRNA was present in both the nuclear and cytoplasm ic RNA 
fractions ind ica ting  tha t a lim ited  quan tity  of IE2 m RNA was 
polyadenylated and therefore transported to the cytoplasm . To explain 
this, several ideas w ere proposed. These ranged from  a secondary
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mutation in the IE2 imm ediate-early specific promoter, TAATGARAT, to 
the possibility that the deleted genes in 1703 functioned to transactivate 
IE2, or that antisense transcripts initiating from the IRl  copy of the IE1
promoter controlled IE2 mRNA production. System atically, each of these 
possibilities was exam ined by: 1. DNA sequencing the IE2 prom oter 
region, 2. An extensive review of the literature examining the role of the 
1703 deleted genes UL55 and UL56, and 3 . The construction of a 
recom binant 1703 virus in which a polyadenylation signal had been 
inserted to term inate  synthesis of the an tisense  tran scrip t before 
reaching IE2 coding sequences.
A requirem ent for transactivation of IE2 by the Vm w 65/cellular 
factor com plex was dem onstrated by Ace et a l ., (1989). This group 
mutated the Vmw65 encoding gene in such a way as to abolish the 
transactivating function of the protein. Cells infected with the resultant 
recom binan t v irus ex p ressed  reduced  am ounts o f IE 2 mRNA 
demonstrating that the gene had a requirem ent, though not absolute, for 
functional Vmw65. 1703 expressed 1/8 of the w ild-type amount of 
Vmw63 during im m ediate-early  tim es of in fec tion  ind icating  that 
perhaps the IE2 im m ediate-early prom oter was not recognised by the 
V m w 65/cellu lar fac to r com plex , tha t is, a m uta tion  w ith in  the 
TAATGARAT im m ediate-early  consensus sequence. The products of 
immediate-early genes 3 and 4 were synthesized in amounts equivalent 
to wild type indicating that Vmw65 was able to transactivate normally. 
D ideoxynucleotide sequence analysis o f IE2 dem onstra ted  that its 
imm ediate-early prom oter was hom ologous to the published w ild-type 
sequence (M cGeoch et al ., 1988a). This demonstrated conclusively that a 
mutation in the prom oter region of 1703, IE2 was not responsible for 
the pattern of Vmw63 production during im m ediate-early times.
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Sequencing of the 1703 DNA fragment containing the end points of the 
deletion has shown that there are 555 base pairs rem aining between the 
3' end of IE2 and the deletion end point. The deletion removes 343 base 
pairs of the 3' end of UL55, leaving its prom oter elements and part of
the open reading frame intact. All of UL56 and the 3' end of the IRl
copy of IE1 are deleted as far as the first intron of IE1. It has already
been shown that UL55 and UL56 are dispensable in tissue culture and
that HSV-1 deletion variants lacking one complete copy of IE1 are viable 
in tissue culture (Brown et al., 1984; Harland & Brown, 1985; MacLean & 
Brown, 1987a,b). UL55 and UL56 have, how ever, been im plicated as 
possible HSV-1 gene regulators. Block et al.,( 1991) used several plasmid 
constructs in a transient expression assay to dem onstrate that UL55 and 
UL56, when co-transfected with plasmids encoding IE1, IE2 or IE3 and 
one encoding a region upstream of the 5' end of IE2 can together repress 
the activity of a Rous sarcoma virus-CAT hybrid and that when UL55 
contained a point mutation, or when UL55 and UL56 were not included 
in the assay, this effect was not seen. This indicates that either UL55 or 
UL56 gene products may act alone or together to repress HSV-1 
prom oter activ ity . 1703 infected  cells exh ib it reduced  synthesis of 
Vmw63 during im m ediate-early conditions of infection, the opposite of 
what would happen if UL55 and/or UL56 did indeed have the function 
described above.
Several variants have been isolated with deletions affecting UL55 
and/or UL56 (table 4.1; inform ation for this table was taken from the 
following sources; MacLean, 1988; MacLean & Brown, 1987 a, b; Junejo, 
1991: Junejo et al., 1991 and Rosen & Darai, 1985). Three variants, 1704, 
1705 and 1706 were isolated by M acLean & Brown, (1987b) whose 
deletions were w ithin the U l / I R l  region of the HSV-1 genome and
terminated 1232, 183, and 80 base pairs respectively  dow nstream  of
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the 3' end of IE2 (Junejo, 1991; Junejo et a l ., 1991). 1705 and 1706 
dem onstrate a two-fold reduction in Vmw63 synthesis (M acLean, 1988) 
probably reflecting the proxim ity of the deletion end point to the 3' 
term ination associated signals of IE2. 1704 does not dem onstrate any 
change in Vmw63 synthesis again reflecting the distance between the 
deletion endpoint and the 3' end of IE2. A YGTGTTYY (Y= pyrimidine, 
either C or G) m otif located downstream from the polyadenylation signal 
is required for efficient form ation of 3' end term ini (M cLauchlan e t  
a / . ,1985). This m otif is present 40 base pairs downstream of the 3* end 
of the IE2 gene in HSV-1. According to the sequence analysis of 1705 
and 1706, their deletion end points do not encompass this m otif but the 
proximity of the deletion to the YGTGTTYY sequence may
result in the slight inhibition of term ination and reduced levels of 
product. T here m ay be o ther, as yet und iscovered , term ination  
associated signals in the deleted region, the loss of which results in 
reduced levels of Vmw63, and the possibility of a secondary mutation in 
IE2 cannot be ruled out as the IE2 prom oter region of neither variant 
has been sequenced. It is interesting to note that in 1704, UL55 is intact 
and UL56 is deleted whereas 1705 and 1706 have both genes deleted 
possibly indicating a link between UL55 and the transactivation of IE2.
A deletion variant has been isolated in which UL55 remains, UL56 is 
deleted and Vmw63 is underproduced. This variant, HFEM , isolated by 
Rosen & Darai, (1985), has a 4.1kbp deletion in Ul / IR l  which affects
UL56, rem oving its prom oters. The data from  M acLean & Brown, 
(1987b), M acLean, (1988) and Junejo, (1991) indicate that UL55 may 
encode an IE2 transcriptional enhancer and that the deletion of this 
element could result in the reduced synthesis of Vmw63. This is not 
supported by the HFEM data which indicates that UL56 may encode a 
function which transactivates IE2, and that presence of UL55 has no
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bearing on Vmw63 synthesis. In addition, the data from Block et al .y 
(1991) im plicating UL55 and UL56 in the repression of HSV-1 genes 
com plicates m atters since it attributes no enhancing activity  to either 
gene product. The deletion of an as yet undiscovered enhancer element 
which is not encoded by either gene may be responsible for the pattern 
of Vmw63 production dem onstrated by the variants described above 
and cannot be discounted as a possible m echanism by which Vmw63 is 
underproduced by these variants.
The experim ental work has shown that the relevant regions of the 
1703 gene IE2 are hom ologous to the w ild-type sequence and the 
putative functions of UL55 and UL56 makes it im possible to conclude 
that either gene is a positive regulator of IE2.
In vivo characterization  of 1703 dem onstrated that the deletion of 
parts of UL55, one copy of LAT and IE1, the total deletion of UL56 and 
the reduced production of Vmw63 had no effect on the ability of 1703 
to grow in mouse brains, or to establish, m aintain and reactivate from 
latency.
These results correlate with those obtained for the variants HFEM, 
1704, 1705 and 1706. The deleted regions of these variants differ in
genes rem oved (table 4.1). V irulence of the four v iruses via the
intracranial route was, in all cases, com parable to that of wild-type, 
(Becker et al.y 1986; Junejo, 1991) indicating that w ild-type amounts of 
Vmw63, LAT, V m w llO , and the products of genes UL55 and UL56 are 
not required for virulence via this route. HFEM was characterized in
terms o f p a th o g en ic ity  by in o cu la tin g  v ia  the  in tra p e rito n ea l,
subcutaneous and in travenous rou tes w here it w as found to be 
avirulent, thereby implicating the product of either UL56 or LAT in the 
ability of this HSV-1 strain to replicate in the organs encountered during 
inoculation by these routes. Correction of the HFEM deletion by replacing
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it w ith the w ild-type fragm ent from  the iden tica l reg ion  restored 
pathogenicity in tree shrews but in mice only 19% of inoculated animals 
died, showing that the above two genes products may be necessary for 
the pattern of pathogenicity demonstrated by HFEM in tree shrews but 
not absolutely required for virulence in mice (Rosen et a/., 1986).
Wollert et al.,( 1991) implicate the region of the HSV-1 genome deleted 
in HFEM with its ability to grow in macrophages of mice and indicate 
that HFEM is unable to do so. This may be the reason that HFEM is 
unable to kill via routes other that intracranial, although intraperitoneal 
virulence appears to be dependent on the animal used. The use of tree 
shrews during the pathogenicity experiments by Rosen et a/.,( 1986) is of 
in terest since these anim als occupy a phy logenetic  niche between 
rodents and prim ates and therefore may mimic the responses of man to 
virus infection in a m anner which is more genuine than the mouse 
model.
1703 has not been characterised for virulence by any route other that 
intracranial and such an experim ent, incorporating perhaps, 1704, 1705 
and 1706 which differ with respect to the presence or absence of UL55, 
with UL56 being absent in all cases, may give inform ation concerning 
the roles that these genes play during pathogenicity. It is possible that, 
from the evidence presented by Rosen et al.y( 1986) and since none of 
the variants encode the UL56 gene product (like HFEM), they would be 
avirulent when inoculated  by routes o ther than in tracran ia l if  the 
UL55/UL56 effect is not lim ited to tree shrews, although results by 
Rosen et al ., (1986) indicate that it may be. It is worth remembering 
that m ost of these variants also underproduce Vmw63 and it would 
perhaps be difficult to dissociate the effects of that underproduction and 
the presence or absence of UL55 or UL56. There is a HSV-1 variant, 
constructed during the course of this project, called 1703PA in which
1 0 9
Vmw63 production is equivalent to wild-type and genes UL55 and UL56 
are deleted. The use of this variant as a control for the experim ent 
described above would enable the effects of reduced production of
Vmw63 and the absence of the products of genes UL55 and UL56 to be 
dissociated. The HFEM revertant exhibits wild-type pathogenicity in tree 
shrews indicating that e ither production of Vmw63 has returned to 
norm al levels or that UL56 is responsib le  for HFEM s virulence
characteristics. Spivack & Fraser, (1988£ attribute the defect in Vmw63 
production in HFEM infected cells to a mutation in IE2 hence it is likely 
that the latter is the case.
The above authors also document the latency characteristics of HFEM 
which, like 1703, has only one copy of LAT and, also like 1703, 
establishes, m aintains and reactivates from  latency w ith a sim ilar 
frequency to wild-type. The information gained from the latency studies
of both HFEM and 1703 indicate that UL55 and UL56 are dispensable for
that function and that w ild-type amounts of Vmw63, V m w llO  and the 
LAT gene product are not required.
As well as supporting the restriction endonuclease data obtained by 
MacLean & Brown, (1987a) which concluded that the deletion in 1703 
affected genes UL55, UL56, IE1 and one copy of LAT, sequencing has 
demonstrated that a B a m  H I site, shown to be present during the initial 
analysis of 1703, was now missing. The deletion in H p a l m '  had been 
extended during the cloning and sequencing of H p a  lm ’, the 1703 DNA 
fragment in which the deletion end-points were located. Spontaneous 
deletion of HSV-1 DNA also took place during the cloning of the long 
origin of replication of HSV-1 into a bacterial vector system , where 
deletions of >100 base pairs were recorded (Spaete & Frenkel, 1982). 
The deleting region was found to consist of a long perfect palindrome 
with an AT rich region at its centre when it was subsequently cloned
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into a yeast vector system. The sequence arrangem ent between the end 
points of the deletion and the B a m H l  site is not particularly unusual for 
HSV-1 DNA and the extended region of the genome (between the B a m H l  
site and the sequenced deletion end points) does not affect the three
imperfect repeat elements located in the intron (Perry et al.y 1986). The 
deletion in the sequenced H p a  lm ' fragm ent was 7784 base pairs in 
length and it is thought that the deletion in 1703 is about 7500 base 
pairs, closer to that estimated by MacLean & Brown, (1987a).
As this fragm ent was used to construct the recom binant virus 
containing the polyadenylation signal, 1703PA, the net result of the 
extension of the deletion in H p a  lm ’ was relevant. On the UL55 side of 
the deletion , it is not known for certain  if  the deletion had been
extended since there were no m arkers available. M acLean & Brown 
(1987a) estim ated 500 base pairs between the deletion end points and 
the 3' term ination signals of IE2. Sequencing put this at 555 base pairs 
indicating that it is unlikely that the deletion has been extended. The 
deletion extends slightly more into the first intron of the IRl  copy of IE1
which is detectable since the B a m H l  site can be used as a marker. There 
is no apparent reason why the extension should have any effect on the 
properties of 1703.
A wild-type recom binant of 1703 was constructed by co-transfecting 
B g l l l f  from 1703 into 17+ DNA. The reason for not choosing the already 
cloned H p a  lm ’ fragm ent for this procedure was that there was only 
about 55 base pairs betw een the deletion end-point and one end of 
H p a  lm ’, w hich  w ould resu lt in in e ffic ien t reco m b in a tio n . The 
recom binant 1750, generated from  the B g H l f ' / l l  + c o -tra n sfec tio n  
experiment produced IE2 gene products in sim ilar am ounts to those
produced by 1703, being reduced during im m ediate-early  tim es of
infection and returning to wild-type levels during early and late times
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thereby de te rm in ing  tha t the d e le tion  was re sp o n sib le  fo r the 
underproduction of Vmw63. 1750 produced about twice the amount of 
Vmw63 at imm ediate-early times of infection compared to 1703 in the 
W estern blot analysis of two different preparations of 1750 and 1703 
polypeptides indicating that the production of slightly more Vmw63 by 
1750 was not a gel or loading artifact. It is known that there is plaque
variation among HSV isolates, for exam ple, the isolation of a HSV-2
strain HG52 plaque which had heightened neurovirulence (Taha et al ., 
1988) dem onstrated that individual plaque iso lates o f HSV-2 strain 
HG52 differed with respect to neurovirulence, but had identical genome 
structures. Viruses with divergent genome structures in a population of 
HSV-2 strain HG52 showing deletions in R l  have been isolated with
significant frequency (up to 24%); (Harland & Brown, 1985,1988; Brown 
& Harland, 1987). Although there is less variation among HSV-1 strain 
17+ isolates (MacLean & Brown, 1987a,b), it is possible that 1750 is a 
'health ier' iso la te  than 1703 w ith respec t to Vmw63 production. 
A lternatively, the increased amounts of Vmw63 synthesized by 1750 
may be due to experim ental variation. The analysis of 1750 had 
therefore dem onstrated that underproduction of Vmw63 by 1703 was 
not due to a mutation in a region of the genome outwith the deletion.
The suggestion that Vmw63 synthesis in 1703 infected cells was 
controlled by the production of a transcript in itiating from the intact 
promoter of the IRl  copy of IE1 was supported by the exclusion of any
other m echanism  for the pattern of production of Vmw63 as discussed 
above. M echanisms by which gene expression is controlled by antisense
nucleic acids are discussed in section 1.10.
The construction of 1703PA, which is composed of a 1703 DNA 
backbone with an HSV-2 polyadenylation signal placed in the correct 
orientation to term inate the synthesis of a potential antisense transcript
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before reaching IE2 coding sequences, and the characteriza tion  of 
1703PA IE2 gene products, has shown that the synthesis of IE2 mRNA 
and Vmw63 has returned to wild-type levels during all transcriptional
conditions. The production of transcripts from the deleted IRl  copy of
p o ly a d e n y la te d
IE1, whose prom oters rem ain in tact, was at the inserted
novel polyadenylation signal and could no longer affect the synthesis or
processing of IE2 mRNA. The detection nf the small, novel transcript
. . . r , Tt > 1 p o ly a d e n y la tin g  , . ,in itia ting  from  the IE1 prom oter ana   «t the inserted
polyadenylation signal has conclusively proven that the prom oter was
capable of initiating the synthesis of a transcript antisense to IE2 mRNA.
This inform ation dem onstrated that an antisense transcrip t controlled
the synthesis of IE2 gene products in 1703 infected cells, but did not
identify the m echanism  by which this takes place. It is possible to
classify  the an tisense transcrip t into any of the th ree  categories
identified by Inouye, (1988), (section 1.10) and further work is required
to establish which is the correct class.
The in itial view of the m echanism  of inhibition of IE2 mRNA
production by the antisense transcript was that the transcript initiating
from the IE1 prom oter was transcribed until a polyadenylation signal
was encountered whose orientation resulted in its term ination. UL51 is
the closest suitable polyadenylation signal and the resultant transcript
would be about 15kb in length, possibly unstable, and as well as being
antisense to IE2 mRNA, would be antisense to the RNA products of the
adjacent genes U L53, U L52 and UL51 w hich encode a possible
m embrane protein , part of the prim ase-helicase com plex required for
viral DNA synthesis and a protein of unknown function, respectively.
Under im m ediate-early conditions, the production of RNA/RNA hybrid
molecules (figure 4.1) would render the complexed RNA unavailable for
further processing, and the complexes may become the target of double
Figure 4.1 Antisense RNA.
a. The genes IE2, UL55 and IE1 and their structures in the IRl / U l  
region of the 1703 genome. The termination signals of both UL55 and 
IE1 have been deleted as have sequences between both points. These 
genes therefore form one stretch of DNA bounded by promoter 
sequences, b.  During immediate-early times of infection, the promoters 
of both IE1 and IE2 are stimulated resulting in transcripts being 
generated from both. IE1 RNA is complementary to IE2 RNA and the 
antisense theory depends on both hybridizing (class 1 and 2) or 
interfering (class3) resulting in IE2 RNA not being available for 
translation, c. At times other than immediate-early, RNA is synthesized 
from the UL55 promoter which then forms a RNA duplex with IE1 RNA 
resulting in IE2 mRNA being translated and the production of wild-type 
quantities of Vmw63 (d).
IE2 UL55 IE1
JUT'b' IE1 RNA
IE2 mRNA
1
IE2 mRNA ..........
UL55 RNA
d. '
Vmw63 mRNA
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stranded RNA degrading enzym es. This is an exam ple of class 1 
antisense RNA.
Class 2 antisense RNAs are characterized by hybridizing to a region of 
the transcript distant from the translation initiation signals of the target 
RNA, changing its conform ation and resulting in the mRNA not being 
translated. H ybridization of the antisense transcrip t synthesized from 
the IE1 prom oter to a region of the IE2 transcript outwith translational 
initiation sites may result in the absence of IE2 gene products during 
im m edia te -early  cond itions of in fec tion  due to an a ltera tion  in 
configuration of the IE2 mRNA m olecule resulting in it not being 
tra n s la te d .
T ranscrip t m apping of IE2 mRNA produced by 1703 during 
im m ediate-early times of infection dem onstrated that small amounts of 
IE2 mRNA present in the nucleus are transported to the cytoplasm , a 
process that depends of the polyadenylation o f the 3' end of the 
message. This indicates that, as discussed above, the block in Vmw63 
synthesis occurs at the tran scrip tiona l level. Thus, the antisense 
transcript can also be assigned to class 3, the only class of antisense 
RNAs which function at the level of transcription. An antisense RNA that 
functions at the level o f transcrip tion  is one w hich controls c r p  
production (Okamoto & Freundlich, 1986). This is thought to function by 
the creation of a RNA polym erase conform ational term inator (termed 
r h o )  resu lting  in the term ination  of tran scrip tion . An additional 
m echanism  w hereby class 3 antisense transcrip ts function to control 
transcription of the target gene is transcriptional interference.
An exam ple of transcriptional interference is the avian retrovirus 
which controls the synthesis of c-myc mRNA by transcriptional overlap 
interference. In tegration of the avian retrovirus, avian leucosis virus 
(ALV) into the host DNA results in the viral coding sequences being
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flanked by two long inverted repeats (LTR) containing signals for both 
in itia tion  and term ination of transcrip tion . F igure 4 .2a dem onstrates 
th is. The observa tion  that c-m yc tran sc rip ts  in av ian  induced 
lymphomas contained U5, the LTR prom oter elem ent, and that provirus 
integrated 5’ of the c-myc gene contained deletions including the 5' LTR 
led to the theory that transcription from  the 5 ’ LTR controlled the 
initiation of transcription from the 3’ LTR.
Cullen et a/.,( 1984) studied the m echanism by which this occurs and 
found that the 3' end of the normal viral transcript overlapped the 5' 
end of transcripts initiating from the 3' LTR (Figure 4.2a). The deletion 
of the 5’ LTR, or the insertion of a termination signal in the viral open 
reading fram e, resulted  in the 3' LTR in itia ting  transcrip tion  of a 
reporter gene (in this case the preproinsulin gene). This conclusively 
demonstrated that transcripts initiating from the 5' LTR interfered with 
those initiating from the 3' LTR resulting in it being unable to initiate 
transcrip tion, probably because RNA polym erase could not bind the 
promoter region of the 3' LTR. A similar situation exists in the HSV-1 
genome (figure 1.3) in which the term ination signals and open reading 
frame of many genes overlap, for example, UL4/UL5, and UL13/UL14. 
T ranscrip tional in terference  has not been estab lished  as a control 
mechanism for either of these sets of genes.
T ranscrip tional in terference resulting  in the underproduction of 
Vmw63 in 1703 infected cells would not be due to transcriptional 
in te rference  as described , but to the in te rfe ren ce  of two RNA 
polym erase m olecules transcribing mRNA from opposite DNA strands 
(figure 4.2b) resulting in the production of truncated and mainly non- 
polyadenylated IE2 RNA. T ranscrip t m apping of 1703 IE2 mRNA 
produced under im m ediate-early  conditions alw ays gave full length 
molecules indicating that truncated forms may be unstable. In any case,
Figure 4.2 Transcriptional interference.
a .  The avian leucosis virus (ALV) integrates into cellular DNA, 
sometimes upstream of the oncogene c-myc. This can result  in 
leukaemogenisis and in most cases of this, the 5' LTR is deleted. LTR is 
the long terminal repeat, U3 and U5 are termination and promoter 
signals respectively. ALV genes gag, pol and env are indicated. Dotted 
lines indicate cellular DNA. Normally transcripts generated from the 5’ 
LTR interfere with those initiating from the 3' LTR and c-myc is not 
transcribed, a phenomenum known as transcriptional interference. If 
however the 5’ LTR is deleted, RNA polymerase is free to initiate 
transcription from the 3' LTR and c-myc protein is produced, b .  
Transcriptional interference in 1703. During immediate-early times of 
infection, RNA initiating from the IE1 promoter interferes with that 
being synthesized from the IE2 promoter resulting in premature 
termination of IE2 mRNA. Transactivation of the UL55 promoter at other 
times of infection generates RNA which interferes with that initiating 
from the IE1 promoter resulting in restored production of Vmw63 at 
these times of infection.
a. ---------------------------------  cellular DNA
- —  ----------- -----------  RNA generated from ALV promoters.
b. ------------------------------- ►- IE2 DNA
....................................... UL55 DNA
-----------------------------  IE1 DNA
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the probe only detects 790 base pairs of the 3' end of IE2 and RNA 
m olecules shorter than about 2600 base pairs (the IE2 transcript is 
about 3250 base pairs in length) would not be detectable by this 
m ethod. That the probe detected IE2 mRNA at all under imm ediate- 
early  conditions may be due to the form ation  of a quantity  of 
polyadenylated IE2 mRNA which is translated norm ally. This indicates 
that the position at which transcriptional in terference occurs may be 
variable along the length of the IE2 m olecule. Although transcriptional 
in terference as described by Cullen et a l ., (1984) does not involve 
antisense RNA, the principle of interference of two RNA polymerase 
m olecules is pertinent to describing the 1703 antisense transcrip t as 
class 3.
Vmw63 is synthesized  in reduced am ounts by 1703 during 
im m ediate-early conditions of infection as dem onstrated by SI nuclease 
m apping and W estern blot analysis, for which there are two possible 
explanations. The first relies on findings by Sandri-Golden et al ., (1987) 
which dem onstrates that the prom oter for the antisense transcript may 
have to be lOx stronger than that for the sense transcript for inhibition 
of the sense transcript to occur. The transactivator for IE2 and IE1 
during the im m ediate-early experim ents reported in the results section 
of this thesis in which cycloheximide was used as an inhibitor of protein 
synthesis was the Vm w65/cellular factor complex. Both genes have been 
shown to have an equivalent requirem ent for Vmw65 (Ace et a l .y 1989) 
dem onstrating that both may be transactivated  to the same extent. 
H ow ever in the case of 1703, the environm ent o f the antisense 
transcript is different from that in Sandri-Golden's experim ents in that 
the antisense transcript is synthesized from the same DNA template as 
the sense transcrip t and the coding regions of both are in close 
proximity. It is therefore possible that in an infected cell environment,
*It is also possible that at early and late times of infection increased 
levels of IE2 transactivators (eg. Vm wllO  and V m w l75)  generate 
higher levels of IE2 mRNA thereby overcoming the block imposed by 
the antisense transcript.
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the IE1 prom oter is capable of synthesizing enough antisense transcript 
to see this effect (class 1). The hybridization of the antisense transcript 
to a region of IE2 mRNA outwith the IE2 transcriptional start sites (class
2) may be inefficient resulting in the production of small quantities of
Vmw63 during im m ediate-early times of infection.
The production of IE2 gene products returns to w ild-type levels 
during conditions other than im m ediate-early which can be attributed to 
the transactivation of UL55 during early and late conditions of infection 
as follows; 1. The transcription of UL55 during early and late conditions
of infection leads to the production of UL55 m RN A /IEl mRNA duplex
m olecules (class 1), 2 . The same process results in the IE1 antisense 
transcript hybridizing to UL55 RNA changing its conform ation (class 2), 
and 3 . RNA polym erase transcribing UL55 in terferes w ith the RNA 
polym erase m olecule transcribing the IE1 gene (class 3). All of these 
allow wild-type quantities of IE2 mRNA to be produced by freeing IE2 
mRNA from constraints imposed by the antisense transcript.*
Future  prospects .
C riteria  for defining regulation  by natural antisense RNAs are 
threefold (Krystal, 1992). 1. The complementary RNA must be shown to 
coexist within the cell. This can be done by strand specific hybridization 
techniques, for exam ple, SI nuclease m apping using strand specific 
probes, 2. Evidence for the interaction of the two com plem entary RNAs 
should be provided, that is, the detection of the duplex molecules and 3. 
A function for the interaction of the complementary molecules should be 
dem onstrated. The com plem entary RNA strand was never detected in 
this stu dy , excep t a fte r te rm in a tio n  by the in se rtio n  o f the 
polyadenylation  signal, and the presence of RNA hybrids was not
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investigated. As m entioned in the in troduction, the detection of the 
antisense transcript was an aim of this project, however at that time it 
was thought that the transcript was about 15kb in length and the strand 
specific probe used corresponded to a region of HSV-1 DNA 5' to the IE2 
open reading fram e. No antisense transcripts were detected with this 
probe. In light of later evidence it became apparent that the transcript 
was probably not as long as 15kb, and further work could involve the 
use of m ore suitable strand specific probes to detect the antisense 
transcript. Duplex RNA molecules in the nucleus of 1703 infected cells 
could be detected by the use of single stranded RNA degrading enzymes 
to digest a preparation of 1703 im m ediate-early RNA, leaving double 
stranded RNA (the sense /an tisense  RNA duplex) in tac t, and the 
subsequent SI nuclease m apping or N orthern  b lo t analysis of the 
products. A function  for the com plem entary  m olecu les has been 
estab lished  and is the inh ib ition  of IE2 m RNA synthesis during 
im m ediate-early times of infection.
The role of LAT in HSV-1 latently infected cells is controversial and 
there is evidence that LAT may function to control latency in an 
antisense m anner. The use of the criteria described above to examine 
the in teraction of LAT and its possible target, IE1 mRNA, may give 
further inform ation concerning this possibility.
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